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ABSTRACT 
The  mammary  gland  is  a  perfect  system  to  study  the  pathways  regulating 
organogenesis during development of an individual. The proper development of the 
mammary gland requires a tight coordination of expression of many genes involved in 
proliferation and differentiation. The aim of this work was to identify novel genes and 
pathways involved in the development of the mammary gland and to find possible 
correlations  between  the  signaling  pathways  and  their  downstream  targets  that  are 
activated  during  proliferation  and  functional  differentiation  of  mammary  epithelial 
cells. In this study rapamycin has been used to inhibit the mTOR protein to analyze its 
role during mammary gland development. Further a genomic approach was used to 
identify genes differently expressed during this process.  
The analysis of the effects caused by the inhibition of the mTOR signaling pathway by 
using rapamycin on mammary epithelial cells for the first time demonstrate that mTOR 
plays  central  role  in  the  coordination  of  pathways  governing  the  proliferation  and 
differentiation of epithelial cells during mammary gland development. More detailed 
analysis led to the identification of Id1 and Id2 as two major downstream effectors of 
the mTOR signaling pathway regulating proliferation and differentiation, respectively.  
The genomics analysis revealed several interesting genes involved in the regulation of 
a proliferative or secretory phenotype of normal epithelial cells in vitro. Various genes 
identified by microarray analysis are of high interest and to determine their role in 
mammary gland development. Among the identified genes some contribute to process 
of proliferation like Nol5 and  Kpna2,  whereas  other  genes  are required for proper 
functional  differentiation  such  as  Nkd2  and  Cited4.  Importantly,  the  mentioned 
candidate genes are also interesting regarding cancer development, since deregulation 
of their expression migth contribute to tumor formation.  
The findings described in this work clearly contribute to our better understanding of 
the  mTOR  signaling  pathway  regulating  expression  of  the  genes  involved  in  the 
development  of  mammary  gland.  In  additon,  the  presented  results  should  allow 
broadening our view of the events that contribute to breast cancer development and 
help to design better anticancer therapies in the future. 
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1. INTRODUCTION 
The  development  of  all  life  forms  starts  from  a  single  cell.  The  formation  of 
complicated  tissue  structures  and  organs  in  higher  organized  organism  requires 
multiple cell divisions. This process also depends on coordinated signaling between 
single cells as well as between the thousands of cells forming a tissue structure or 
organ. The proliferation and functional differentiation of all cells needs to be tightly 
controlled,  since  deregulation  of  this  process  may  lead  to  tumor  formation. 
Investigating the genes, proteins and signaling pathways that control cell proliferation 
and differentiation will increase our understanding of how its deregulation leads to 
disease  and  cancer  development.  To  study  these  genes,  proteins  and  signaling 
pathways, which control organogenesis, the mouse mammary gland is a very attractive 
model. The development of the mammary gland occurs mainly after birth and unlike 
most  other  organs,  the  majority  of  the  studies  on  developmental  regulation  can 
therefore be performed in juvenile or adult organisms (Medina, 1996). 
1.1 Development of the mouse mammary gland 
The development of the mouse mammary gland including the cycles of proliferation, 
functional differentiation and apoptosis of the secretory epithelium which occur with 
each pregnancy is tightly controlled by hormones (Hennighausen and Robinson, 2005). 
To  understand  the  various  signaling  events  occurring  during  proliferation  and 
differentiation of the epithelial cells the anatomy and development of the mammary 
gland will be described in more detail. 
1.1.1 Embryonal development of the mammary gland 
In mice, embryonal development of the mammary  glands starts  at day 10 11  after 
fertilization  of  the  egg.  Five  pairs  of  embryonic  mammary  buds  are  formed  after 
invagination of embryonic epithelial cells at ten positions along the so called “milk 
line”.  The  milk  line  is  a  single  layer  of  ectoderm  with  enlarged  cells  positioned 
bilaterally  and  extending  from  the  anterior  to  the  posterior  limb.  At  day  E12  the 
mammary epithelium consists of several cell layers and has a shape of a light bulb. At 
this point it is surrounded by a specialized fibroblast layer known as dense mammary 
mesenchyme derived from the subdermis. In male embryos, the fetal testes start to 
produce androgens on day E13 causing the destruction of the mammary buds.  Introduction 
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In female embryos the embryonic fat cells start to proliferate extensively at day E14 
forming the mammary gland fat pad (Sakakura 1987). The fad pad is essential for the 
development of the mammary gland during puberty and the formation of the secretory 
compartment  during  pregnancy  (Neville  et  al.,  1998).  The  mammary  buds  remain 
quiescent until day E16. Then they start to elongate and penetrate into the surrounding 
mammary fat pad (Sakakura 1987). The adipocyte precursors in the embryonic fat pad 
start to accumulate the fat droplets and differentiate into monolocular adipocytes until 
three  days  after  birth  (Sakakura  et  al.  1987).  Simultaneously,  the  mammary  buds 
continue to elongate until birth (day E21) leading to the formation of a rudimentary 
ductal  tree  consisting  of  15 20  branching  epithelial  ducts  embedded  within  the 
mammary fat pad (Sakakura 1987). After the embryonic development is complete the 
mammary gland remains inactive until approximately 3 weeks of age when hormones 
are  secreted  by  the  ovary  glands  (Daniel  1987).  Postnatal  development  of  mouse 
mammary  gland  can  be  divided  in  two  steps.  Firstly,  out growth  of  a  ductal  tree 
initiated at puberty and secondly the formation of the alveolar compartment, which 
occurs during each pregnancy (Richert et al., 2000). 
1.1.2 Development of the mammary gland during puberty 
At birth the mammary gland consists of several ductal branches filling the stroma (fat 
pad).  Each  duct  consists  of  a  single  layer  of  epithelial  cells  surrounding  a  central 
lumen.  The  cells  building  the  lumen  are  called  the  luminal  epithelial  cells.  The 
rudimental ductal tree structure (Figure 1.1A) remains quiescent until around 3 weeks 
after  birth  when  the  ovaries  begin  to  secrete  puberty  hormones  (oestrogen, 
progesterone).  
 
 
Figure 1.1 Development of the mammary gland in mice during puberty. (A) A small ductal tree in 
the mammary gland of a new born pup. (10 x magnification). (B) Growing ducts in the gland of a 4 
weeks old virgin mouse with terminal end buds (TEB) present at their tips (arrow) (2 x magnification). 
(C) In a 12 weeks old virgin mouse the ducts reach the end of stroma (2 x magnification). (Figure B and 
C were adapted from Cardiff, R. D et al. “Tutorial for Comparative Pathology”).  
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Growing ducts in pubescent mice develop bulb shaped structures at their tips, which 
are  known  as  terminal  end  buds  (TEBs)  (Figure  1.1  B).  Here,  extensive  cell 
proliferation  occurs,  causing  extensive  branching  of  the  ductal  tree  into  the 
surrounding  stroma  (Dunbar  et  al.,  2001,  Silberstein  2001).  Two  morphologically 
distinct  cell  types  are  found  in  the  TEBs.  The  highly  proliferative  cap  cells  are 
organized in a single layer at the leading edges of the TEBs and give rise to basal cells. 
The body cells are organized in multicellular layers within the central cavity of the 
TEBs, and develop into luminal cells. Ductal elongation continues until the mice are 
approximately 12 weeks of age. At this point the branches have reached the borders of 
the  fat  pad  (Figure  1.1  C).  At  the  end  of  the  ductal  outgrowth  the  TEBs  are  not 
required any more and regress in an apoptotic way (Humphries et al 1996, Humphreys 
1999). 
1.1.3 Development of the secretory compartment during pregnancy 
At  the  onset  of  pregnancy  the  mammary  epithelial  cells  induced  by  pregnancy 
hormones (placental lactogens, progesterone) start to proliferate extensively and form 
terminal side branches and alveolar buds. During the second half of pregnancy the 
alveolar bud structures start to divide and differentiate into individual alveoli (compare 
Figure 1.2 A with 1.2 B).  
 
Figure 1.2 Development of the mammary gland in mice during pregnancy. Hematoxylin staining of 
whole mounts of the mammary gland during different stages of development. (A) Mammary gland of a 
virgin mouse, ducts with branches and terminal end buds are clearly visible. (B) During pregnancy, 
mammary epithelial cells start to form alveoli shown by the development of the terminal end buds. (C) 
During lactation, the secretory alveolar compartment is enlarged, filled with milk and covers almost the 
whole gland. (D) During involution, the secretory compartment is reduced via an apoptotis process 
(Adapted from Hennighausen, L., www mammary.nih.gov). 
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At day 18 of pregnancy the alveoli composed of secretory epithelial cells reach their 
terminal differentiation and are able to express milk proteins and produce lipids. The 
mammary  gland  development  cumulates  finally  with  the  formation  of  a  functional 
differentiated alveolar compartment secreting milk at parturition. (Nandi et al., 1958 
Daniel et al., 1987). Before lactation starts there are still areas within the gland that are 
filled with adipocytes. At this point around 30% of fat pad is accessible for growth of 
the  secretory  compartment.  When  lactation  is  established  the  remaining  fad pad  is 
metabolised and the secretory epithelial cells expand to fill the entire mammary gland 
(Richter et al., 2000). 
1.1.4 Lactation in the mammary gland 
After  21  days  of  pregnancy  the  pubs  are  fully  grown  and  birth  is  induced.  After 
parturition  the  mammary  gland  is  fully  functional  and  produces  milk  required  for 
proper growth and development of the newborn pups (Figure 1.2 B). The alveoli units 
are  filled  with  milk  proteins  and  lipid  droplets.  During  this  lactation  period  the 
secretory epithelial cells surrounding the alveolar lumen changed their shape from a 
cuboidal form, which was observed during pregnancy, to a more flattened phenotype 
(Figure 1.3 B). A discontinuous layer of myoepithelial cells, which helps to transport 
the secreted milk into the ducts, surrounds the alveoli. The adipocytes lost most of 
their  fat  content  and  are  present  as  very  long  projections  in  the  interstitial  space 
between the alveoli (Elias et al., 1973). The process of lactation lasts for approximately 
3 weeks after parturition, until the pubs are able to take solid food (Richter et al., 
2000).  
1.1.5 Involution of the mammary gland 
When pups do not require feeding by their mother anymore the milk stasis in the 
lumen  of  alveolar  units  initiates  a  process  of  massive  apoptosis  of  the  secretory 
epithelial cells. This massive death of secretory epithelial cells causes remodelling of 
the whole gland structure called involution (Quarrie et al. 1996).  
Initially involution is reversible and lactation can be reinitiated within 1 2 days by 
suckling.  During  this  reversible  stage  the  epithelium  becomes  flat  due  to  the 
enlargement of the alveoli caused by the stacking milk (Furth A. 1999). 
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Two  days  after  induction  of  involution  the  remodeling process  is  irreversible.  The 
secretory epithelial cells of the alveolar compartment massively die due to apoptosis as 
measured by nick end DNA labeling. Most cells die at day 4 of involution (Quarrie et 
al. 1995). The ductal epithelium is still not well organized, although the ducts can be 
readily visible with dense stroma around them. (Richter et al 2000). Slowly the stromal 
adipocytes repopulate the gland and are filled with fatty acids. They can be clearly 
seen interspersed among the decreasing alveolar units (Neville et al., 1998). At day 6 
of involution the majority of alveoli are collapsed leaving small clusters of epithelial 
cells (Strange et al., 1992). At day 8 14 the ducts within the increased stroma can be 
clearly detected, and are only surrounded by small disorganized clumps of alveolar 
cells  (Figure  2.1D).  The  process  of  involution  takes  up  to  21  days  before  the 
organization of the gland resembles that of a non pregnant mouse (Richter et al 2000). 
 
Figure 1.3 Schematic presentation of the mouse mammary gland development. (A) In the embryo 
the   mammary bud is comprised of mesenchyme and epithelial cells. During puberty the ducts start to 
branch and finally fill the entire gland stroma. The alveolar compartment develops during pregnancy 
and at onset of lactation alveolis fill the whole gland stroma. The secretory compartment is eliminated 
after  cessation  of  milk  suckling  by  pups.  During  this  involution  period  the  alveoli  disappear  in  an 
apoptotic way. The mammary gland enters this cycle, every time upon pregnancy. (B) Magnification in 
the mammary gland: the alveolar unit composed of secretory epithelial cells (red), luminal epithelial 
cells (blue), the adipocytes contributing to stroma surround the alveoli (pink). Milk is transported in 
direction of the arrows towards the nipple. 
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1.2 Signaling pathways playing a essential roles during mammary gland 
development 
During  evolution  the  mammary  gland  has  adapted  many  signaling  pathways  from 
other organs in order to be able to regulate its own very complicated development 
cycle (Oftedal 2002). Some of the most important signaling pathways are regulated by 
prolactin, insulin and insulin like growth factors. The prolactin pathway is important 
for  proliferation  and  differentiation  of  the  alveolar  epithelia  during  pregnancy 
(Ormandy  et  al.,  1997).  The  insulin pathway  is  essential  for  the  terminal  end bud 
formation, ductal morphogenesis during puberty and for proper lactation (Hadsell and 
Bonnette, 2000).  
1.2.1 Prolactin/Stat5 signaling in the mammary gland 
The  mammary  gland  development  and  the  milk  protein  expression  are  severely 
inhibited in both prolactin and prolactin receptor knock out mice. The ductal branching 
(wide main ducts and short site branches) and alveolar compartment (sparse lumina 
without milk inside) development during pregnancy are clearly reduced (Ormandy et 
al., 1997).  
Prolactin (also called lactogenic hormone or luteotropic hormone) is a small peptide 
hormone of about 23 kDa and is expressed in many animal species (Cooke et al., 1981; 
Sinha, 1995). Prolactin binds to the extracellular part of the prolactin receptor (Bole 
Feysot, 1998). The ligand induced dimerization of the prolactin receptor leads to cross 
phosphorylation and activation of the JAK2 kinases (Rui et al., 1994), which in turn 
phosphorylate the tyrosine residues in the C terminal tail of the prolactin receptor, 
creating docking sites for proteins containing Src homology (SH2) domains, including 
the signal transducer and activator of transcription 5 (Stat5) (Pezet et al., 1997). The 
proteins with an SH2 domain are activated by the JAK kinases and induce various 
signaling pathways. Stat5 is the major transcription factor in the prolactin pathway, 
responsible for transduction of signaling activated by prolactin in the mammary gland 
(Liu et al., 1997).  
Stat5  was  originally  identified  as  a  mammary  gland  factor  (MGF)  in  the  lactating 
glands (Wakao et al., 1992). The MGF was then cloned from sheep mammary gland 
and found to be a new member of the Stat family (Wakao et al., 1994). Molecular 
cloning of the Stat5 locus from mice showed that there are two Stat5 genes coding for 
Stat5a or Stat5b which are 93% identical on the amino acid level (Liu et al., 1994).  Introduction 
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Upon phosphorylation of the prolactin receptor Stat5 binds to the C terminal tail and is 
then  subsequently  phosphorylated  at  specific  tyrosine  residues  by  JAK2.  Upon 
phosphorylation Stat5 is released from the prolactin receptor and forms dimers with 
other phosphorylated Stat5 proteins through SH2 domain and finally after dimerization 
translocates to nucleus (Gouilleux et al., 1994). The activated Stat5 dimers bind to 
GAS (Gamma interferon Activation Site) elements in the promoter of several targets 
genes such as genes coding for milk protein and regulate their transcription (Wakao et 
al., 1994) (Figure 1.4).  
Stat5 is expressed during all stages of mammary gland development with only small 
changes noticed between virgin, pregnant, lactating and post weaning mice (Liu et al., 
1995). However, the kinetics of phosphorylation and activation of Stat5 is parallel to 
the  terminal  differentiation  of  mammary  gland  and  correlates  with  the  expression 
profile of the milk genes (Liu et al., 1996). Both Stat5a and Stat5b can induce the 
expression of β casein in the mammary gland (Liu et al., 1997). In tissue culture the 
Stat5 binding was crucial for terminal differentiation of epithelial cells as indicated by 
expression of the milk protein β casein (Schmitt Ney et al., 1991). 
The essential role for Stat5 in development and differentiation was demonstrated by 
gene targeting. Similar to prolactin receptor knock out mice (Ormandy et al., 1997), 
the  Stat5a  null  animals  clearly  showed  impaired  lobulo alveolar  development  and 
failed to lactate. Interestingly, by deleting Stat5a the expression level and the tyrosine 
phosphorylation of Stat5b was reduced as well (Liu et al., 1997). The Stat5b knock out 
mice also showed a  reduced lobulo alveolar development, but not as severe as for 
Stat5a. (Teglund et al., 1998). Stat5a/b null epithelium shows a perturbation of cell cell 
contact and resembles undifferentiated ductal epithelium (Miyoshi et al 2001). The 
conditional  inactivation  of  Stat5a/b  genes  also  confirmed  their  potential  role  in 
epithelial cell physiology. In conclusion, from the knock out studies it is now clear that 
Stat5 is essential for cell proliferation and differentiation during pregnancy as well as 
for  the  maintenance  of  alveolar  compartment  during  lactation  (Cui  et  al.,  2004). 
Nevertheless, Stat5 is not the only player in terminal differentiation of the mammary 
gland. It is known from in vitro experiments that for the maximum expression of the 
milk protein β casein, the mammary epithelial cells require the addition of insulin and 
dexamethasone in addition to prolactin (Henninghausen 1997).  
This indicates that for full terminal differentiation of mammary  epithelial cells the 
other pathways in addition to the prolactin/Stat5 signaling pathway are required. Introduction 
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Figure 1.4 The Prolactin Stat5 signal transduction pathway. Schematic presentation of the Stat5 
pathway activated by prolactin in the mammary gland. The Stat pathway plays an essential role in 
mediating  the  response  to  prolactin  in  mammary  epithelial  cells.  Prolactin  activation  leads  to 
homodimerization of the prolactin receptor resulting in activation of the associated JAK2 kinase, which 
then phosphorylate the receptor. The phosphorylated tyrosine residues in the C terminal tail of  the 
receptor recruit Stat5. The tyrosine phosphorylation in the SH2 (Src homology 2) domain of Stat5 by 
JAK2 kinase results in Stat5 dimerization, translocation to nucleus and finally to the activation of genes 
containing GAS (TTCCNGGAA) elements in their promoter.  
 
1.2.2 The insulin/IGF pathway in mammary gland development 
The  importance  of  the  insulin/IGF  pathway  in  the  regulation  of  mammary  gland 
development and the expression of milk proteins has been investigated in many studies 
(Kleinberg, 1998; Rosen et al., 1999). Insulin is a polypeptide hormone produced in 
the pancreas. Insulin like growth factors (IGFs) are polypeptides with high sequence 
similarity to insulin and are expressed mainly in the liver. Insulin and IGF can bind to 
the extracellular portion of the insulin and IGF receptor respectively (Hadsell et al., 
2000). Five distinct insulin and IGF receptors have been described: the insulin receptor 
(IR) isoforms A (IR A) and B (IR B), the IGF I receptor (IGF IR) and IGF IIR as well 
as a hybrid receptor (IR/IGF IR)(Frasca et al., 1999). IR A, IR B and the IGF IR can 
form heterodimers in the mammary gland, increasing the diversity of signals activated 
by insulin and IGFs during development of the gland (Bailyes et al., 1997). 
 
 
 
 
 
GAS
Prolactin
Nucleus
JAK2 JAK2
Target gene
Stat5 Stat5 Stat5 Stat5
Stat5 Stat5 Stat5 Stat5 Stat5 Stat5
Stat5 Stat5 Stat5 Stat5 Stat5 Stat5
cell membrane
GAS
Prolactin
Nucleus
JAK2 JAK2
Target gene
Stat5 Stat5 Stat5 Stat5 Stat5 Stat5 Stat5 Stat5
Stat5 Stat5 Stat5 Stat5 Stat5 Stat5 Stat5 Stat5 Stat5 Stat5 Stat5 Stat5 Stat5 Stat5
Stat5 Stat5 Stat5 Stat5 Stat5 Stat5 Stat5 Stat5 Stat5 Stat5 Stat5 Stat5 Stat5 Stat5
cell membraneIntroduction 
  18 
In response to binding of the ligand to the extracellular receptor domain the intrinsic 
tyrosine  kinase  of  the  receptor  is  activated.  This  leads  to  autophosphorylation  of 
tyrosine residues on the intracellular part of the receptor. The phosphorylated tyrosines 
serve as docking sites for signaling and adaptor proteins with an SH2 domain such as 
the  SRC homology 2 domain  transforming  protein  (Shc)  and  the  insulin  receptor 
substrate  proteins  (IRS)  (Butler  et  al  1998).  Phosphorylation  of  Shc  promotes  the 
association  with  Grb2  (Growth  factor  receptor  bound  protein  2),  which  is  tightly 
associated  with  SOS  (son of  sevenless)  a  guanine  nucleotide  exchange  factor.  The 
Grb2 SOS  complex  transfers  Insulin/IGF  signaling  to  the  Ras/Raf/MAP  kinase 
pathway, which results in activation of nuclear transcription factors, mainly involved 
in the activation of genes regulating the cell proliferation (Skolnik et al., 1993). The 
IRS proteins act as adaptor proteins and serve as docking sites for multiple proteins 
including  PI3K  (Giorgetti  et  al.,  1993)  and  allow  for  transferring  the  insulin/IGF 
signaling  to  PI3K/Akt/mTOR  pathway,  promoting  cell  growth  during  development 
(Pollak et al., 2004) (Figure 1.5).  
In  the  mammary  gland  IGF I  cooperates  with  estrogens  to  promote  full  ductal 
development during puberty (Kleinberg, 1998). Studies using whole mammary organ 
cultures also confirm that IGF I can stimulate extensive ductal development (Richter et 
al., 1999). Furthermore, the IGF I knock out mice have a significantly reduced ductal 
morphogenesis also indicating that IGF I is an essential factor in terminal end bud 
formation in vivo (Kleinberg et al., 2000). Similarly, deletion of the IGF I receptor also 
limits ductal development of the mammary epithelium (Hadsell et al., 2000). Apart 
from its role in ductal development IGF I was demonstrated to act as a survival factor 
for mammary cells in vivo (Neuenschwander et al., 1996) as well as in vitro (Geier et 
al., 1992). However, for growth of mammary epithelial cells in cell culture usually 
insulin is used instead of IGF I (Wood et al., 2000). In vitro insulin was shown to be 
able to stimulate expression of the milk protein β casein gene even more potently than 
IGF I  (Prosser  et  al.,  1987).  In  mammary  epithelial  cells  expression  of  β casein 
stimulated by the addition of insulin and IGF I was associated with an anti apoptotic 
effect of the ligands (Merlo et al., 1996).  
Insulin can activate the transcription of C/EBPβ (MacDougald et al., 1995), which has 
a potent function in controlling the functional differentiation of mammary epithelial 
cells in the mammary gland (Robinson et al., 1998). The C/EBPβ has been shown to 
regulate the expression of milk protein β casein (Raught et al., 1995).  Introduction 
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Like Stat5, C/EBPβ is a transcription factor, which affects β casein transcription by 
direct binding to multiple enhancer sites in the promoter of the β casein gene (Doppler 
et al., 1995). The insulin effect on C/EBP expression is independent of MAP kinase 
signaling (Hemati et al., 1997), indicating that the PI3K/Akt/mTOR pathway may be 
involved in the regulation of C/EBP expression. Moreover, insulin may also influence 
the  JAK/STAT  pathway  (Gual  et  al.,  1998)  and  therefore  may  modulate  prolactin 
signaling  during  proliferation  and  functional  differentiation  of  alveolar  mammary 
epithelial cells. Nevertheless, to unravel this mechanism more detailed studies have to 
be done in mammalian cells.  
The mammalian target of rapamycin (mTOR) is an important downstream target of the 
insulin  pathway.  mTOR  is  thought  to  be  involved  in  the  regulation  of  mammary 
epithelial cell growth and differentiation induced by insulin signaling. It also may link 
signaling  of  insulin  and  prolactin  pathway.  Because  of  its  important  function  in 
proliferation and differentiation of mammary epithelial cells the role of mTOR in cell 
signaling is explained in more detail below. 
 
Figure 1.5 Signaling pathways induced by insulin. Activation of the IGF 1 Receptor by binding of its 
ligand insulin like growth factor 1 (IGF1) leads to phosphorylation of the insulin receptor substrate 1 
(IRS1) and activation of two important downstream signaling networks. The PI3K Akt mTOR pathway 
regulates translation and controls cell growth. The RAS/RAF/MAPK, regulating gene transcription by 
activating the transcription factors (TF), ultimately controls proliferation.  
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1.3 Target of Rapamycin 
During  development  of  the  mammary  gland  the  epithelial  cells proliferate  to  form 
ducts and alveolar compartments. Finally cells differentiate and produce milk during 
lactation. The extensive protein expression during the mammary gland development 
requires high amounts of cellular energy. Protein synthesis can only be initiated when 
nutrients and growth factors are present in sufficient amounts. The target of rapamycin 
TOR plays a central role in sensoring nutrient and growth factor signals. As discussed 
above mTOR is a component of the insulin/IGF signaling pathway. Since the role of 
mTOR  has  been  the  topic  of  investigation  in  this  study,  the  following  chapter 
summarizes  the  most  important  features  of  mTOR  including  the  signaling  events 
involved in its regulation. 
1.3.1 Discovery of TOR  
TOR was originally identified in Saccharomyces cerevisiae. TOR was named as target 
of  rapamycin  due  to  the  fact  that  rapamycin  is  a  very  specific  inhibitor  of  TOR 
proteins.  Rapamycin  was  originally  discovered  as  an  antifungal  drug  produced  by 
Streptomyces hygroscopicus, a bacterial strain that was firstly isolated from Eastern 
Island  soil  (Vezina  et  all.,  1975).  Rapamycin  has  been  shown  to  posses 
immunosuppressant  and  anti  proliferative  activity  (Hidalgo  and  Rowinsky,  2000). 
Normally, if yeast cells are treated with rapamycin they are irreversibly arrested in the 
G1 phase of the cell cycle. Two genes TOR1 and TOR2 were identified during genetic 
screens of yeast for mutations making the cells resistant to anti proliferative action of 
rapamycin (Heitman et al., 1991). The mammalian target of rapamycin (mTOR) was 
identified and cloned shortly after discovery of the two yeast homologs (Brown et al., 
1994). The mTOR is also known as rapamycin target (RAPT1), rapamycin associated 
protein (FRAP), or sirolimus effector protein (SEP). 
1.3.2 Structure of mTOR 
TOR proteins are high molecular weight serine threonine specific kinases that contain 
several  distinct  and  conserved  domains  (Figure  1.6).  Human,  mouse  and  rat  TOR 
proteins are 95% identical at the amino acid level (Janus et al., 2005). The N terminus 
of mTOR contains up to 20 tandem HEAT (huntingtin, EF3, A subunit of PP2A, TOR) 
repeats grouped into two blocks.  
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Tandem HEAT repeats are responsible for protein protein interactions and are also 
present in many other proteins (Andrade et al., 1995). The HEAT repeats form two 
chains  of  40  amino  acids  in  length.  The  two  chains  contain  a  specific  pattern  of 
hydrophobic and hydrophilic residues together forming a pair of anti parallel α helices 
(Groves et al., 1999). The middle part of the protein contains a FAT domain (FRAP 
ataxia telangiectasia mutated, transformation/transcription domain associated protein) 
and a FRB domain. The FAT domain is around 500 amino acids long and is only 
found in members of the phosphatidylinositol 3 kinase related kinase (PIKK) family 
(Bosotti et al., 2000). The FAT domains may have a similar function as HEAT repeats 
serving as a protein protein interaction domain or as a scaffold for binding partners. 
The FRB (FKPB12 Rapamycin Binding) domain serves as a docking site for FKPB12 
(12 kDa FK506 binding protein) rapamycin blocking complex that specifically inhibits 
the activity of mTOR towards its downstream targets. In the C terminal end region of 
mTOR  a  domain  with  high  homology  to  the  catalytic  domain  of  PI3K  is  located. 
(Kunz et al. 1993). This catalytic domain (CD) with kinase activity phosphorylates 
Ser Thr Pro  motifs  present  in  interacting  proteins  (Brunn  et  al.,  1997)  as  well  as 
threonine residues flanked by hydrophobic amino acids (Brunett et al., 1998). Finally 
the very C terminal end of the TOR protein contains a short sequence of about 35 
amino  acids  termed  the  FATC  (FAT  C terminus)  domain.  Like  in  all  PIK  related 
kinase  family  members  this  domain  is  only  present  in  combination  with  the  FAT 
domain. The FATC and FAT domains may interact with each other to regulate the 
catalytic activity of PIK related kinases, including mTOR (Bossotti et al., 2000). 
 
Figure 1.6 Schematic presentation of the domain structure of m TOR. The protein consists of up to 
20 tandemly repeated HEAT – (huntingtin, EF3, A subunit of PP2A, TOR) motifs at the amino terminus 
end,  followed  by  FAT  domain  (FRAP ataxia telangiectasia  mutated,  transformation/transcription 
domain associated  protein)  and  FRB  (FKPB12 Rapamycin  Binding  domain),  and  the  CD  (catalytic 
kinase domain) and FACT (FAT C terminus) domains located near to carboxyl terminus. Adapted from 
Jacinto et al., 2003. Nature Review 4:117 226. 
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1.3.3 The function of the mTOR protein 
Protein kinases are involved in the regulation of many important cellular processes 
including  cell  metabolism,  cell  motility,  the  cell  cycle,  repair  of  DNA  damage, 
apoptotic  signaling  and  respond  to  the  micro environment  (Dancey  and  Sausville 
2003). They mediate the cellular response to external stimulation via phosphorylation 
of  hydroxyaminoacids  (Hanks  et  al.,  1988).  TOR  belongs  to  this  large  family  of 
protein kinases and, accordingly, controls a large and diverse set of growth related 
processes  including  actin  organization,  transcription  and  translation  in  respond  to 
nutrients  and  growth  factor  signaling  (Schmelzle  and  Hall,  2000).  To  be  able  to 
regulate these diverse tasks, TOR proteins are very large and have several docking 
sites for interacting partners. This was confirmed by the fact that mTOR is highly 
complexed with other proteins in the cytoplasm (Schmelzle and Hall, 2000). TOR is 
known  to  be  a  central  integrator  of  nutrient  and  growth  factors  signaling  and 
coordinator of the cellular growth and cell cycle progression (Fingar and Blenis, 2004) 
(Figure 1.7). 
 
 
Figure  1.7  mTOR  integrates  signaling  induced  by  nutrients,  growth  factors  and  energy 
metabolism leading to regulation of cell growth and cell cycle progression. Growth factors activate 
receptors and signal to PI3K, which can in turn be inhibited by PTEN. PI3K in turn activates PDK1 (not 
in  figure)  and  Akt.  Activated  Akt  phosphorylates  the  TSC1 TSC2  complex,  which  then  becomes 
unstable. TSC2 dissociates from TSC1. TSC2 can also be inhibited by the 14 3 3 protein. Inactivated 
and dissociated TSC2 is not able to block Rheb, which then has a positive effect on mTOR activity 
toward its downstream targets involved in transcription and translation. Nutrients positively influence 
the Raptor GβLmTOR complex, which also lead to mTOR activation and induction of transcription and 
cell  growth.  Energy  stress  activates  the  AMPK  protein,  which  phosphorylates  TSC2  causing  its 
association  with  TSC1.  The  activated  TSC  complex  blocks  the  Rheb  GTPase  activity  and  inhibits 
mTOR activity. 
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1.3.4 Regulation of mTOR activity 
Mammary  gland  development  requires  nutrients  and  is  controlled  by  the  action  of 
many growth factors. The role of mTOR in mammary gland has not been studied in 
detail although mTOR has been shown to be a central regulator of cellular growth and 
proliferation by linking the growth factor signaling and the nutrient availability. To 
understand the importance of mTOR in cellular signaling this chapter summarizes the 
molecules controlling the activity of mTOR.  
1.3.4.1 The PI3K/Akt signaling pathway is an upstream regulator of mTOR 
The insulin signaling is crucial for development and function of the mammary gland. 
The components of the insulin pathway PI3K and its downstream effector Akt act 
upstream of mTOR (Figure 1.7). PI3K/Akt signaling is activated by growth factors and 
miogenic  stimuli  (Janus  et  al.,  2005).  PI3K  phosphorylates  the  3 hydroxyl  of  the 
inositol  ring  of  phosphoinositide  phospholipids  (PIP).  The  3 phosphorylated 
phospholipides then serve as membrane tethers for proteins containing the pleckstrin 
homology (PH) region, such as Akt and Phosphoinositide Dependent Protein Kinase 1 
(PDK1). The PH domain of Akt binds to PI3Ps which leads to the translocation of Akt 
to  the  plasma  membrane.  This  enables  PDK1  to  directly  contact  Akt.  PDK1  is 
responsible for the phosphorylation of Akt, which leads to its activation. The tumor 
suppressor phosphatase  PTEN  negatively  regulates  the  activation  of  PI3K  and  Akt 
signaling by dephosphorylation of the phosphoinositol 3,4,5 triphosphate at the D 3 
position of the inositol ring (Dancey, 2003). Ultimately, Akt phosphorylates Ser2448 
of mTOR as shown by in vitro and in vivo experiments (Nave et al. 1999). There are 
several other studies confirming that mTOR is located downstream of the PI3K/Akt 
pathway. Insulin activates phosphorylation of mTOR at Ser2448 in vivo (Reynolds et 
al., 2002). Furthermore, overexpression of a constitutively active form of Akt in HEK 
293  cells  leads  to  phosphorylation  of  4E BP1,  which  is  a  down stream  target  of 
mTOR. This effect could be influenced by rapamycin showing that mTOR mediates 
the effect of Akt on 4E BP1. In the same study, overexpression of an inactive form of 
Akt inhibits insulin mediated phosphorylation of 4E BP1 confirming vise versa that 
Akt is transferring the signaling from insulin to mTOR (Gingras et al. 1998). The first 
genetic evidence that Akt acts upstream of mTOR in mammalian cells came from a 
study in which mice were used lacking two out of three forms of Akt. These mice 
showed a clear decrease in phosphorylation of 4E BP1 (Peng et al. 2003). Introduction 
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1.3.4.2 TSC negatively regulates mTOR 
Recent study indicates that tuberous sclerosis proteins (TSC1 and TSC2) are inhibitors 
of mTOR and antagonize the activation of mTOR by insulin and amino acid (Gao et 
al. 2001; Gao  et al., 2002). Two proteins TSC1 and TSC2 contribute  to Tuberous 
Sclerosis  Complex  and  only  dimers  are  functional  to  control  cell  growth  and 
proliferation.  TSC1  also  know  as  hamartin,  is  a  130  kDa  protein  with  coiled coil 
domains.  TSC2  alias  tuberin  is  a  200  kDa protein  with  coiled coil  domains  and  a 
carboxy terminal region, which shares homology to the Rap GTPase activating protein 
(GAP) (Scheffzek et al.1998). These proteins were first identified to play a role in 
Tuberous sclerosis, an autosomal dominant disorder characterized by the formation of 
hamartomas in various organs (Young and Povey 1998). 
From studies in flies it became clear that Tsc2 is a critical target of Akt in mediating 
growth  signals  from  the  insulin  pathway.  Akt  directly  phosphorylates  Tsc2  at 
conserved residues Ser 924 and Thr 1518. Phosphorylation of Tsc2 by Akt stimulated 
growth by inhibiting the formation of the functional Tsc1 Tsc2 complex (Potter et al., 
2002).  In  mammalian  cells  Akt  was  also  demonstrated  to  associate  with  the  TSC 
complex  in  response  to  insulin,  promoting  the  degradation  of  hamartin tuberin 
complexes  by  phosphorylation  of  TSC2.  (Dan  et  al.,  2002).  Mutation  of  the  Akt 
phosphorylation sites make the Tsc2 insensitive to Akt signaling and increases the 
stability  of  the  Tsc1 Tsc2  complex.  The  Akt  growth signals  were blocked  also by 
expression of mutant Tsc2 lacking the Akt phosphorylation sites (Potter et al., 2002). 
Inactivation of the Drosophila homolog of TSC1 (Tsc1) protein dramatically increased 
the  cell  size  and  the  proliferation  rate  and  as  a  consequence,  organ  size. 
Overexpression of Tsc1 and Tsc1 alone had no effect, whereas co expression of both 
Tsc1 and Tsc2 decrease cell size, cell number and organ size. (Potter et al., 2001).  
It was shown that mammalian TSC1 TSC2 inhibits phosphorylation of S6K1 and 4E 
BP1,  which  are  down  stream  targets  of  mTOR.  Function  of  TSC  is  negatively 
regulated by Akt in response to treatment with insulin. TSC2 is inactivated by Akt 
dependent phosphorylation, which destabilized TSC2 and disrupts its interaction with 
TSC1 (Inoki et al., 2002).  
1.3.4.3 Rheb a positive regulator of mTOR is suppressed by TSC 
TSC proteins are able to suppress mTOR signaling. However this suppression is not 
direct, but involves the Rheb proteins.  Introduction 
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Rheb (Ras Homolog Enriched in Brain) is widely expressed as a small GTPase and 
was initially isolated as a Ras homolog from brain tissue (Yamagata et al., 1994). 
Mouse and human cells express two Rheb genes, Rheb1 and Rheb2 (Patel et al., 2003). 
A  mutation  in  Rhb1  (Rheb  related  GTPase)  in  yeast  Schizosaccharomyces  pombe 
causes growth arrest and a starvation like phenotype, indicating  that Rheb proteins are 
involved  in  growth  signaling  in  response  to  nutrients  (Mach  et  al.,  2000).  In 
Drosophila melanogaster, Rheb is also required for cell cycle progression and cell 
growth (Patel et al., 2003).  
In recent studies Rheb was indicated to act upstream of mTOR in mammalian cells and 
to stimulate translation and cell growth. Rheb, positively influences mTOR signaling, 
since overexpression of Rheb activates S6K1 even during amino acid insufficiency via 
rapamycin  sensitive  mechanism.  Moreover,  Rheb  is  not  able  to  activate  a  S6K1 
mutant, which is unresponsive to mTOR mediated signals, confirming that Rheb is 
upstream of mTOR. (Tee et al., 2003). Rheb promotes also phosphorylation of another 
downstream target of mTOR; the eukaryotic initiation factor 4E binding protein 1 (4E 
BP1). This phosphorylation causes the dissociation of 4E BP1 from eIF4E, which is 
completely  sensitive  to  mTOR  inhibitor  rapamycin.  This  indicates  that  rapamycin 
blocks the positive action of Rheb on the mTOR pathway (Tabancay et al., 2003). 
Overexpression  of  Rheb  in  HEK293  cells  caused  a  significant  increase  in  mTOR 
Ser2448 phosphorylation,  whereas phosphorylation  of  Akt  was  not  affected.  These 
results indicate that Rheb activates mTOR directly (Inoki et al., 2003). In agreement 
with  this  idea,  it  was  shown  that  over expression  of  an  inactive  form  of  Rheb 
effectively  blocks  the  activation  of  mTOR  signaling  pathway  induced  by  growth 
factors and insulin (Tabancay et al., 2003).  
Studies in Drosophila have shown that Rheb is a molecular target of the TSC tumor 
suppressors (Zhang et al., 2003).The C terminal end of TSC contains a region that 
shares  homology  with  the  catalytic  domain  of  GTPase activating  protein  (GAP), 
suggesting that a GTPase might be the physiological target of TSC2 (Scheffzek et al., 
1998). A study using mammalian cells showed that TSC2 indeed, has the GAP activity 
towards Rheb (Tee et al., 2003). Overexpression of TSC1 TSC2 heterodimers inhibits 
Rheb mediated  phosphorylation  of  downstream  targets  of  mTOR  confirming  the 
model, where Rheb is a direct target of TSC. Both components act upstream of mTOR 
in nutrient signaling (Tee et al., 2003).  Introduction 
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1.3.4.4 AMPK activates TSC2 and negatively regulates the mTOR pathway 
The  level  of  translation  is  regulated  by  several  factors  including  growth  factors, 
nutrients  availability  and  the  intracellular  ATP  level.  The  mTOR  protein  was 
suggested to be a homeostatic ATP sensor (Dennis et al., 2001) although a very drastic 
decrease in the ATP level is required to inhibit the activity of mTOR (Proud, 2002). 
The level of translation, however also responds to small variations in the ATP level. A 
small decrease in ATP results in a relatively large increase in the AMP level. This 
stimulates the activity of AMPK (AMP activated protein kinase), which is a major 
sensor of cellular energy levels (Hardie et al., 1998; Hardie et al., 2003). TSC2 has 
been shown to be regulated by the cellular ATP level. Under energy starvation AMPK 
phosphorylates  TSC2  and  enhances  its  GAP  activity  towards  Rheb,  which  is  then 
deactivated preventing stimulation of the mTOR protein. The AMPK/TSC2 pathway 
preventing  translation  is  acting  opposite  to  the  PI3K/Akt/TSC2  signaling  pathway 
stimulating the mTOR and translation activity (Inoki et al., 2003; Hynes and Boulay, 
2006). 
1.3.4.5 Regulation of TSC by 14 3 3 proteins  
Apart from the fact that TSC protein activity is inhibited by Akt upon insulin/growth 
factors  stimulation,  this  protein  is  also  negatively  regulated  by  proteins  sensoring 
nutrients. In this context, 14 3 3 proteins were shown to associate in vivo with the TSC 
complex if nutrients are available. Accordingly, the interaction between 14 3 3 and 
TSC2 is decreased under serum–starvation indicating that the complex formation is 
modulated by factors influencing the nutrients availability (Li et al., 2002; Shumway et 
al., 2003). 14 3 3 proteins belong to a family of highly related proteins with numerous 
isoforms which have been shown to directly associate with many cellular proteins in 
order to regulate their function (Fu et al., 2000). TSC2 was shown to associate with 
different  14 3 3  isoforms  under physiological  conditions.  In  contrast,  TSC1  cannot 
interact with 14 3 3 as indicated in co immunoprecipitation studies. Interestingly, the 
interaction between 14 3 3 and TSC2 is stronger than with the TSC1 TSC2 complex, 
although 14 3 3 has no effect on the tuberous complex formation between TSC1 and 
TSC2.  Phosphorylation  of  a  single  residue  (Ser1210)  in  TSC2  is  required  for  the 
association  with  14 3 3.  Interestingly,  this  residue  is  not  known  as  an  Akt 
phosphorylation site suggesting that the phosphorylation the Ser1210 and binding of 
TSC2 to 14 3 3 are dependent on kinases other than Akt. Introduction 
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Moreover, mutations in all six predicted Akt phosphorylation sites (residues 939, 1086, 
1088, 1378, 1422, 1756) of TSC2 still allowed binding to 14 3 3 at the same level as 
wild type TSC2 (Inoki et al., 2002). Also the inhibition of Akt with Wortmannin or the 
inhibition of the ERK pathway by PD90589 has no effect on the association of 14 3 3 
with TSC2. Overexpression of 14 3 3 reduced the ability of the TSC1 TSC2 complex 
to  negatively  regulate  S6  kinase  phosphorylation.  It  enhanced  the  basal 
phosphorylation of 4E BP1 by mTOR confirming that 14 3 3 negatively regulates the 
function of the TSC complex. (Li et al., 2002; Shumway et al., 2003). Apart from the 
fact that 14 3 3 influences mTOR signaling by binding to the inhibitor TSC2 of this 
pathway, 14 3 3 has also been shown to interact directly with mTOR and positively 
modulate mTOR action (Bertram et al., 1998; Mori et al. 2000). Therefore, 14 3 3 
regulates  the  phosphorylation  of  S6K  and  4E BP1,  which  are  two  downstream 
components of the mTOR pathway by interacting with at least two: TSC2 and mTOR.  
1.3.5 Components of the mTOR complex 
The m TOR is a very large protein (289 kDa) with several distinct domains. These 
domains are known to be interaction sites for numerous proteins. As a consequence, 
mTOR  forms  a  very  large  complex  with  other  proteins  in  the  cell  (Bjornsti  and 
Hughton, 2004). Some of the important components present in this complex will be 
introduced. 
1.3.5.1 mTOR is complexed with Raptor and GβL 
In several studies Raptor (regulatory associated protein of mTOR) was indicated to be 
an  upstream  protein  that  regulates  the  catalytic  activity  of  mTOR  and  serves  as  a 
scaffold in the nutrient signaling pathway. Raptor is a high molecular weight protein of 
150 kDa that binds to mTOR as well as to two mTOR downstream targets 4E BP1 and 
S6 kinase. The binding of Raptor to mTOR is necessary for the phosphorylation of 4E 
BP1 by mTOR. Inhibition of the expression of Raptor using siRNA reduced the mTOR 
catalysed phosphorylation of 4E BP1 in vitro (Hara et al., 2002). The mTOR Raptor 
complex is sensitive to rapamycin treatment causing disruption of the complex (Kim et 
al., 2002). 
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GβL (G protein β subunit like protein) is an additional subunit of the mTOR raptor 
signaling complex. It is also a positive regulator of mTOR kinase activity (Kim et al., 
2003).  GβL  is  a  small,  36 kDa  protein  expressed  in  many  tissues  (Rodgers  et  al., 
2001). The structure of GβL consists almost entirely of seven WD 40 repeats with high 
sequence homology to those found in β subunits of G proteins (Rodgers et al., 2001). 
The GβL protein is conserved among all eukaryotes, including yeast, flies, worms, and 
plants  (Ochotorena  et  al.,  2001).  The budding  yeast  homolog  of  GβL  (Lst8p)  also 
interacts with Tor1p  and Tor2p  (Loewith  et al., 2002). Genetic studies with  Lst8p 
confirmed that it plays a role in the regulation of cell growth (Roberg et al., 1997; 
Loewith et al., 2002), a process mainly governed by TOR proteins. GβL was shown to 
interact  strongly  with  the  C terminal  half  of  mTOR  in  particular  with  the  mTOR 
kinase domain. 
A decrease in the expression of GβL reduced the phosphorylation state of S6K1 in vivo 
to a similar extend as caused by a decrease in the expression of mTOR. Targeting 
mTOR or GβL with siRNA results in a comparable reduction in cell size (Kim et al., 
2003). Co expression of GβL and mTOR significantly increased the mTOR kinase 
activity towards S6K1 and 4E BP1 and its autophosphorylation.  
The exact mechanism by which GβL stimulates the mTOR kinase activity is not well 
understood. Probably, GβL contributes to the stability or folding of the mTOR kinase 
domain. GβL has a positive role in the mTOR pathway transmitting both growth factor 
and nutrient signaling to downstream effectors of mTOR. It is also known that the 
binding  of  GβL  to  mTOR  and  stimulation  of  the  mTOR  kinase  activity  does  not 
require  Raptor  and  is  likely  an  important  mechanism  by  which  GβL  positively 
regulates mTOR. The GβL and mTOR interaction unlike the raptor mTOR association 
is  not  sensitive  to  nutrient  conditions  in  the  medium  nor  to  the  treatment  with 
rapamycin. A decrease in the amount of GβL reduces the amount of raptor–mTOR 
complexes indicating that an interaction between GβL and mTOR is also necessary for 
the nutrient sensitive association of raptor with mTOR. If the amount of nutrients is 
low raptor interacts with mTOR and decreases the mTOR kinase activity by inhibiting 
GβL.  Probably,  under  nutrient  poor  conditions  raptor  interacts  directly  with  GβL 
which  is  constitutively  docked  to  the  mTOR  kinase  domain,  and  prevents  the 
activation of mTOR by GβL. This is important to prevent cell growth signaling when 
nutrients are not available (Figure 1.8).  Introduction 
  29 
Rapamycin  was  shown  to  destabilize  the  interaction  between  raptor  and  mTOR 
regardless  of  nutrient  availability  (Kim  et  al  2002).  Since  the  rapamycin FKBP 12 
complex binds directly  to the N terminal of the mTOR kinase domain, which is a 
docking site for GβL, it is suggested that rapamycin also perturbs the Raptor mTOR 
interaction mediated by GβL (Kim et al., 2003). GβL, like raptor, also plays a role in 
the recognizing and recruiting mTOR substrates. GβL can interact directly with S6K1 
and independent of mTOR and raptor (Kim et al., 2003).  
 
Figure 1.8 Schematic  model for the regulation of  mTOR activity by Raptor and GβL.  mTOR 
interacts with Raptor in nutrient rich conditions (+) and GβL positively regulates the mTOR activity. 
Raptor in nutrient poor condition interacts with GβL and blocks (–) positive action of GβL on mTOR 
kinase activity. Adapted from Kim et al., 2003. 
1.3.5.2 Rictor is a component of the mTOR complex 
Another protein associated with mTOR is rictor (rapamycin insensitive companion of 
mTOR). Rictor is also a very large protein of 192 kDa. Unlike mTOR and raptor, this 
protein  is  not  well  conserved  among  eukaryotes.  Complexes  isolated  with  a  rictor 
antibody only contain mTOR and GβL, but not raptor, indicating that the association 
of rictor with the mTOR GβL complex is independent of raptor. Over expression of 
raptor can, however, suppress the interaction between rictor and mTOR showing that 
rictor and raptor compete for binding to mTOR. The rictor mTOR complex formation 
is not sensitive to rapamycin in contrast to raptor mTOR interactions. This is shown by 
the  fact  that  down regulation  of  rictor  does  not  decrease  rapamycin  sensitive 
phosphorylation of S6K. Purified rictor mTOR complexes also do not phosphorylate 
S6K1  in  vitro.  Therefore  rictor  is  unlikely  to  participate  in  rapamycin  sensitive 
functions of mTOR. Recent studies suggest that rictor may be a substrate for mTOR 
since down regulation of mTOR leads to a decrease in the phosphorylation of rictor. 
(Sarbassov et al., 2004).  
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Studies in yeast have shown that a rapamycin insensitive TOR complex controls the 
organization of the actin cytoskeleton through PKC (protein kinase C) (Loewith et al., 
2002). Reduction in the expression of rictor leads to a decrease in the phosphorylation 
of PKCα (protein kinase C alpha) and to a perturbed cell morphology due to an altered 
actin cytoskeleton. In rictor depleted cells the pattern of actin staining resembles that 
of cells with reduced expression of mTOR (Sarbassov et al., 2004), indicating that 
rapamycin insensitive rictor mTOR complexes are involved in the organization of the 
actin cytoskeleton via PKCα kinase. Activation of Akt requires phosphorylation of 
Thr308 by PDK1 (Stephens et al., 1998) and Ser473 by an unknown kinase. A recent 
study indicates that the rictor mTOR complex is involved in the regulation of Akt and 
directly phosphorylated Ser473 in vitro. This is indicated by the fact that reduction of 
mTOR or rictor expression inhibits Akt downstream effectors. The phosphorylation of 
Ser473 is required for full activation of Akt. If only Thr308 of Akt is phosphorylated 
by  PDK1  the  activity  of  Akt  is  fivefold  less  in  comparison  with  Akt  which  was 
previously  phosphorylated  on  Ser473  by  the  rictor mTOR  complex  prior  to 
phosphorylation of Thr308 by PDK1 (Sarbassov et al., 2005). These studies indicate 
that not only Akt phosphorylate mTOR but there is a feedback loop from the rictor 
mTOR complex, which regulates the activity of Akt.  
 
Figure 1.9 Regulation of Target of Rapamycin signaling by Raptor and Rictor protein. Sensitive to 
rapamycin treatment raptor mTOR complexes regulate cell growth. Rapamycin insensitive rictor mTOR 
complexes  regulate  proliferation  survival  as  well  as  actin  cytoskeleton  organization.  Adapted  from 
Sarbassov et al., 2005. 
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1.3.6 Downstream effectors of the mTOR pathway 
The development of the mammary gland requires a high expression level of proteins 
regulated  by  mTOR.  Components  of  the  protein  translation  system  belong  to 
downstream targets of the mTOR pathway. The mTOR pathway is involved in the 
positive stimulation of transcription activities of genes coding for proteins involved in 
ribosome biogenesis, activation of transcription of rRNA genes by RNA polymerase I 
(Pol  I),  transcription  of  ribosomal  proteins  by  RNA  polymerase  II  (Pol  II)  and 
transcription of tRNA and 5S unit by RNA polymerase III (Pol III) (Hannan et al., 
2003).  mTOR  is  known  to  influence  protein  expression  through  two  mayor 
downstream  targets:  4E BP1  and  S6K1,  which  are  required  for  the  recruitment  of 
ribosomes  to  the  mRNA  and  translational  enhancement  of  mRNA,  which  have  a 
terminal oligopyrimidine tract (TOP) at their 5’ end (Hay and Sonenberg, 2004). The 
regulation of these targets of mTOR will be discussed in the following chapters. 
 
Figure  1.10  Regulation  of  mTOR  and  its  downstream  effectors  in  mammalian  cells.  Arrows 
indicate activation, bars indicate repression. mTOR is activated upon stimulation with nutrients and 
growth factors, which in turn leads to activation of transcription (genes coding components of protein 
biogenesis  machinery)  and  translation  controlled  by  mTOR  signaling  pathway.  eIF4A,  eukaryotic 
translation  initiation  factor  4A.  eIF4E,  eukaryotic  translation  initiation  factor  4E.  4E BP1,  eIF4E 
binding  protein  1.  eIF4G,  eukaryotic  translation  initiation  factor  4G.  eIF4B,  eukaryotic  translation 
initiation factor 4B. S6K, ribosomal S6 protein kinase. PP2A, protein serine/threonine phosphatase type 
2A. PDCD4, programmed cell death protein 4. 
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1.3.6.1 Phosphorylation of 4E BP1 by mTOR leads to the activation of eIF4E 
In  mammalian  cells  the  first  step  in  translational  initiation  involves  ribosome 
recruitment to the 5' end of the mRNA. The process of ribosome binding is regulated 
by several eukaryotic translation factors, which guide the ribosome to the 5' end of the 
mRNA. The nuclear transcribed mRNA posses at 5' end the cap structure defined by 
m7GpppN, in which m represents a methyl group located at position 7 in guanine (G) 
connected with 5' to 5' bond (ppp) to any following nucleotide (N). This sequence is 
specifically  recognized  by  the  eukaryotic  translation  initiation  factor  4E  (eIF4E) 
(Gingras et al., 1999). The 4E binding proteins 4E BPs are translation repressors and 
compete with eIF4G proteins (eukaryotic translation initiation factor 4G) for the same 
binding site in eIF4E. The eIF4G is a scaffold protein containing three domains, which 
interact with other translation initiation factors (Raught et al., 2000b).  
The eIF4G is phosphorylated in response to stimulation with the growth factors insulin 
and serum, which all induce cell growth. The phosphorylation of these sites is sensitive 
to  PI3K  and  mTOR  inhibitors,  indicating  that  the  eIF4G  is  also  regulated  by  the 
mTOR  pathway  (Raught  et  al.,  2000).  Binding  of  4E BPs  to  eIF4E  leads  to  the 
inhibition  of  eIF4E  (Marcotrigiano  et  al.,  1999).  The  eIF4E  can  be  activated  by 
phosphorylation of 4E BP1, which is a direct target of mTOR kinase. (Miron et al., 
2001; Miron et al., 2003). The mammalian family of 4E binding proteins consists of 
three low molecular weight homologs (Lin et al., 1994). This protein contains seven 
phosphorylation sites of which mTOR directly phosphorylates the priming sites Thr37 
and Thr46 (Gingras et al., 2001). These two threonine phosphorylations are essential 
for subsequent phosphorylation of Thr70 and Ser65 as mutation of Thr37 and/or Thr46 
to alanine prevents phosphorylation of Thr70 and Ser65 (Gingras et al., 2001). The 
phosphorylation of all four sites results in deactivation of 4E BP1 and causes release of 
eIF4E from the inhibitory complex with 4E BP1. Inhibition of mTOR leads to hypo 
phosphorylation of 4E BP1, which then associates tightly with eIF4E. Upon activation 
of mTOR, eIF4E is released from its inhibitor 4E BP1 and is able to initiate the cap 
dependent translation (Gingras et al., 2001). This will cause protein synthesis required 
for  cell  growth.  The  eIF4E  protein  cooperates  with  S6  Kinase  and  both  pathways 
mediate  a  positive  effect  on  cellular  growth.  In  accordance,  the  overexpression  of 
eIF4E was shown to increase cell size (Fingar et al., 2002).  Introduction 
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mTOR has also been shown to control cell cycle progression through eIF4E and S6K1 
(Fingar et al., 2004).  
1.3.6.2 mTOR phosphorylates  S6 kinase promoting translation  
Mammalian cells contain two S6 kinase proteins (S6K1 and S6K2) which are very 
homologous.  They  are  activated  by  phosphorylation  at  specific  sites,  which  are 
conserved between the two proteins (Shima et al., 1998). Activation of S6 kinases is 
complex and requires interplay between several upstream kinases (Volarevic et al., 
2001).  In  response  to  nutrition  and  hormonal  stimulation  12  residues  can  be 
phosphorylated (Shah et al., 2000). TOR has been shown to phosphorylate only one 
site in vitro: the Thr389 in the regulatory domain (Dennis et al., 1996). Activated S6 
kinases are able to promote the translation of so called 5' TOP mRNAs, which contain 
a short polypyrimidine sequence of 4 14 nucleotides next to the cap motif at the 5' end.  
These  mRNAs  code  for  the  components  of  the  translation  machinery,  including 
elongation  factors,  poly A binding  proteins  and  proteins  contributing  to  ribosome 
complexes (Mayuhas and Hornstein, 2000). The S6 kinases are thought to control the 
rate of mRNA translation indirectly by phosphorylation of its downstream effectors. 
One of the most studied targets of S6 Kinases is the S6 protein, which is a component 
of the 40S small ribosomal subunit (Jefferies et al., 1997). The phosphorylation of S6 
protein  is  required  for  the  recruitment  of  the  40S  ribosomes  to  5' TOP  mRNA 
(Thomas, 2000). Phosphorylation of S6 by S6 Kinases correlates with an increase in 
the  translation  of  mRNA  possessing  the  5' TOP  sequence  (Jefferies  et  al.,  1997). 
However, the S6 protein is certainly not the only target of S6 Kinases mediating an 
effect on the translation of TOP mRNA and cell growth. This was shown by the fact 
that there is no correlation between the regulation of the G1 phase by S6K1 and the 
phosphorylation status of the S6 protein (Fingar et al., 2004). Furthermore, in S6K1 /  
embryonic cells the translation of 5' TOP mRNA can still be activated in response to 
serum although the S6 protein remains unphosphorylated (Stolovich et al., 2002). Even 
in cells lacking both, S6K1 and S6K2, translation of 5' TOP mRNA is activated in 
response to serum and, more importantly, the translation activation was still inhibited 
by rapamycin treatment (Pende et al. 2004). Therefore it is clear that other rapamycin 
sensitive targets of S6K1 are involved in the regulation of 5' TOP mRNA translation. 
One of these targets is eIF4B. Introduction 
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1.3.6.3 mTOR regulates the eIF4B through S6K 
eIF4B is an RNA binding factor required for efficient recruitment of ribosomes to the 
mRNA (Hershey and Merrick, 2000). This factor specifically activates the eukaryotic 
translation  initiation  factor  4A  (eIF4A)  protein  (helicase/ATPase)  involved  in 
unwinding the secondary structures of translated mRNA (Rogers et al., 2002). eIF4B is 
phosphorylated in response to a variety of extracellular stimuli, such as insulin and 
serum, which promote cell growth and proliferation (Ducan and Hershey, 1985). One 
of  the  phosphorylation  sites  of  eIF4B,  Ser422,  was  shown  to  be  specifically 
phosphorylated by S6 Kinase in vitro (Raught et al. 2004). In vivo studies show that 
phosphorylation of Ser422 by S6K is sensitive to the inhibition of PI3K, which is an 
upstream  component  of  mTOR  signaling  pathway  (Raugth  et  al.,  2004).  Thus,  in 
addition to the S6 protein, eIF4B may be an important factor mediating several effects 
of mTOR/S6K signaling on translation, cell growth and proliferation. 
1.3.6.4 mTOR activates degradation of PDCD4 through S6 kinase  
The  tumor  suppressor  programmed  cell  death  protein  4  (PDCD4)  is  another 
downstream  target  of  mTOR/S6K  signaling  pathway.  Normally,  PDCD4  blocks 
initiation  of  translation  of  mRNA  by  inhibiting  the  helicase  activity  of  eIF4A.  In 
response  to  growth  factors  the  PDCD4  protein  is  phosphorylated  on  Ser67  by  S6 
kinase. This leads to subsequent ubiquitination of PDCD4 by the E3 ubiquitin ligase 
complex  SCF
βTRCP  and  as  a  consequence  to  rapid  degradation  of  PDCD4  by  the 
proteasome.  The  elimination  of  PDCD4  allows  initiation  of  protein  expression 
required for cell growth and proliferation (Dorrello et al., 2006). Thus, deregulation of 
mTOR/S6K/PDCD4  signaling  pathway  may  lead  to  uncontrolled  cell  growth  and 
ultimately to cancer development.  
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1.3.6.5 Phosphorylation loops in the mTOR/S6K signaling pathway 
The direct phosphorylation of S6K by mTOR is not the only mechanism for regulation 
of translation. mTOR may regulate the action of S6K as well as 4E BP1 indirectly by 
inhibiting the action of associated phosphatases. Indeed, rapamycin and amino acid 
deprivation  activate  the  PP2A phosphatase,  which  causes  the  dephosphorylation  of 
S6K1  as  well  as  of  4E BP1  ultimately,  leading  to  the  inhibition  of  translation. 
Activated  mTOR  phosphorylates  and  deactivates  PP2A  preventing  the 
dephosphorylation  of  S6K1  and  4E BP1  and  inducing  the  activation  of  translation 
(Peterson et al., 1999).  
Very recent studies indicate that not only mTOR phosphorylates S6K1, but S6K1 is 
also  able  to  phosphorylate  mTOR  in  a  cell free  system  (Holz  et  al.,  2005). 
Overexpression  of  a  rapamycin–Wortmannin  resistant  form  of  S6K1  leads  to  the 
constitutive  phosphorylation  of  mTOR,  whereas  the  down  regulation  of  S6K1 
expression reduces the phosphorylation of mTOR despite the full activity of Akt (Holz 
et al., 2005). Many data have shown that mTOR is directly phosphorylated by Akt at 
Ser2448 in response to mitogenic signals. Recent data show, however, that rapamycin 
blocks  serum  stimulated  phosphorylation  of  mTOR  at  Ser2448  although  this  drug 
doesn’t inhibit the activity of Akt. Interestingly, the S6K was shown to phosphorylate 
mTOR  at  Ser2448  in  vitro  and  over expression  of  the  rapamycin resistant  S6K 
restored  Ser2448  of  phosphorylation  in  the  rapamycin  treated  cells.  Moreover,  the 
S6K dependent phosphorylation of Ser2448 was regulated by the cellular amino acid 
status through the TSC Rheb pathway (Chiang et al., 2005). To obtain further insights 
in the regulation of the mTOR pathway (especially regulation by the Akt, TSC, Rheb, 
S6K) it has to be investigated in more detail. Cell culture models as well as in vivo 
studies can be used to unravel possible regulation mechanisms of the mTOR pathway. 
This  is  of  importance  since  many  of  the  components  of  the  mTOR  signaling  are 
involved in cancer development. 
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1.4 The mTOR pathway and cancer development 
Recent studies with cancer models indicate that signaling molecules acting up  and 
down stream of mTOR are involved in essential processes regulating tumor growth. 
For  example  the  upstream  acting  PI3K  and  Akt  proto oncogenes  are  frequently 
deregulated in tumors. More specifically, the catalytic subunit of Akt and PI3K are 
encoded by genes frequently found amplified in human cancers (Vivanco and Sawyers, 
2003). In addition, PTEN is a tumor suppressor gene able to down regulate the action 
of PI3K and Akt and loss of function mutations in PTEN occur in human cancers with 
a frequency comparable to the rate of mutations found in the tumor suppressor gene 
p53  (Cantley  et  al.,  1999).  Hamartomas  developing  in  any  organ  of  the  body  are 
caused by  mutation  in  TSC1  and  TSC2  also  acting  upstream  of  mTOR  (Mak  and 
Yeung, 2004). Interestingly, mutations in or overexpression of mTOR have not been 
reported so far (Bjornsti and Houghton, 2004).  
Deregulation of downstream targets of mTOR has also been shown to play a role in 
malignant transformation. For example, overexpression of eIF4E leads to deregulated 
growth  and  malignant  transformation  of  cells  in  vitro.  Elevated  eIF4E  levels  are 
associated with solid tumor formation and can be found in breast, colon, head and neck 
cancers (DeBenedetti et al., 1999). On the other hand, the translation inhibitor 4E BP1 
has been found down regulated in some types of tumors, which is also associated with 
cancer progression (Jiang et al., 2003).  
These observations strongly indicate that the components of the translation initiation 
complex are important effectors of mTOR and their deregulation is involved in cancer 
formation.  As  shown  the  mTOR  signaling  pathway  is  also  required  for  cell cycle 
progression and inhibition of mTOR activity by rapamycin causes a G1 phase cell 
cycle arrest (Jacinto and Hall, 2003). For these reasons the mTOR pathway is thought 
to  be  a  valuable  target  for  anti cancer  therapy.  It  is  not  surprising  that  rapamycin 
inhibits tumor growth and has been used in clinical studies (Houghton and Huang, 
2004).  Despite  the  significant  antiproliferative  activity  of  rapamycin  it  can  not  be 
easily used for cancer therapy because of stability and solubility problems. Therefore, 
three  analogues  of  rapamycin  were  recently  synthesized  to  obtain  better 
pharmacokinetical  properties.  These  analogs,  CCI 779,  RAD001  and  AP23573  are 
inhibitors of mTOR and have similar growth inhibitory properties and are currently 
tested in clinical trials (Janus et al., 2005).  Introduction 
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1.5 The role of bHLH proteins in mammary gland development  
The development of the mammary gland is tightly controlled through the coordinated 
action of many signaling pathways that regulate the expression of genes involved in 
proliferation  and  differentiation.  However,  so  far  very  little  is  known  about  the 
molecular mechanisms that regulate the action of transcription factors involved in this 
process. One of the group of transcription factors identified to play such an important 
role in development is the bHLH (Basic Helix Loop Helix) super family. Generally, 
bHLH  proteins  are  transcriptional  regulators  involved  in  cell  proliferation  and 
differentiation during many important developmental processes (Massari and Murre, 
2000). The bHLH super family can be subdivided into four main groups, on the basis 
of the presence or absence of distinct functional domains like a DNA binding domain, 
LZ (leucine zipper) or PAS (Per Arnt Sim) domain (Figure 1.11). Alternatively, they 
can  be  grouped  into  seven  classes,  based  on  their  tissue  distribution,  dimerization 
capabilities and DNA binding specificity (Table 1.1) (Massari and Murre, 2000).  
 
Figure  1.11  Schematic  structure  of  different  bHLH  subfamilies.  The  bHLH  transcription  factor 
family can be divided into 4 groups based on their structure. The Idb class doesn’t contain the basic 
DNA binding domain (b) and therefore is not able to bind the DNA. HLH, helix loop helix. b, basic 
DNA binding domain. Per Arnt Sim homology (PAS) or leucine zipper (LZ) domain. Adapted from 
Norton J. D., 2000. 
 
The highly conserved helix loop helix domain enables bHLH transcription factors to 
form homo or hetero dimers. The dimerization of bHLH proteins is absolutely required 
to achieve transcriptional activity (Murre et al., 1994). The basic domain is a common 
sequence motif, which mediates the binding of dimerized proteins to the target DNA 
sequence.  They  can  bind  certain  sequence  motifs  in  promoters  such  as  E boxes 
(CANNTG) or E box like sequences as homo or heterodimers and are able to regulate 
the transcription of target genes.  Introduction 
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Tabele 1.1 Classification of the different members of bHLH Transcription Regulators Adapted 
from Desprez et al., 2003. 
 
 
Idb (Inhibitors of differentiation and DNA binding) proteins belong to the basic helix 
loop helix  (bHLH)  super family.  They  act  as  negative  regulators  of  bHLH  DNA 
binding  proteins  (Benezra  et  al.,  1990).  The  Idb  subclass  is  comprised  of  four 
members: Id1 to Id4. They have been shown to be implicated in the regulation of a 
variety of cellular processes including cell growth, proliferation and differentiation. All 
Idb  proteins  contain  a  HLH  domain,  allowing  the  formation  of  dimers  with  other 
bHLH proteins, but in contrast to other members of the bHLH super family they lack 
the basic DNA binding domain. In absence of Idb proteins the bHLH proteins form 
dimers, which can bind to specific DNA elements and activate the transcription of 
proliferation or differentiation associated genes. When Idb proteins are abundant the 
other bHLH proteins of class I and II preferentially form heterodimers with the Idb 
proteins. These heterodimers are not able to bind the DNA because the Idb proteins 
lack  the  DNA  binding  domain,  preventing  the  transcription  of  their  target  genes 
(Figure  1.12).  In  this  way  the  Idb  proteins  regulate  transcription  indirectly  by 
inhibiting the interaction of bHLH proteins with promoters of various target genes. 
Class  Protein families  Function  Characteristics 
 I  E12, E47, HEB, E2 2 
ITF 2 (E proteins) 
Myogenesis, lymphogenesis 
Neurogenesis,  sex  determination, 
lymphomagenesis 
Ubiquitous pattern of expression and capable 
of forming either homo or heterodimers 
II  Myo  D  ,  Myogenin, 
NeuroD/BETA2 
 
DHAND, eHAND 
Mash 
 
Twist 
 
Mist 
 
SCL/Tal1 
Myogenesis 
Neurogenic differentiation, 
pancreatic development 
Cardiac morphogenesis 
Positive regulator of neurogenesis 
Inhibition  of  myogenic  and  neurogenic 
differentiation 
Exocytosis of serous secretions 
Involved  in  functional  differentiation  of 
mammary gland 
Hematopoiesis 
Tissue restricted  pattern  of  expression  and 
incapable  of  forming  homodimers  and 
preferentially  heterodimerize  with  the  E 
proteins Class I or with Class II proteins and 
can bind both canonical and noncanonical E 
boxes 
III  Myc 
 
TFE 
Cell proliferation, differentiation 
Oncogenesis, apoptosis 
Transcription in immunoglobulin 
Heavy chain enhancer 
Presence  of  a  leucine  zipper  adjacent  to  the 
HLH motif 
IV  Mad, Max Mxi   Interaction  with  Myc  family  proteins, 
regulators of cell proliferation 
Dimerization  with  the  Myc  proteins  or  with 
each other 
V  Idb 
 
 
Id1 and Id2 
Inhibition of DNA binding, cell proliferation 
growth  and differentiation in  many  type  of 
cells. 
Regulators of growth invasion and terminal 
differentiation of mammary epithelial cells 
Lack the basic DNA bibding domain and act 
as dominant negative regulators of Class I and 
Class II bHLH proteins 
VI  HES, HESR1  Notch signaling pathway, cell proliferation  Presence of proline in their basic region 
VII   AHR, ARNT, Sim 
 
HIF 
Biological  responses  to  planar  aromatic 
hydrocarbons 
Regulator of oxygen homeostasis 
Presence of bHLH PAS domain Introduction 
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Figure 1.12 Schematic model of transcriptional regulation of bHLH transcription factors  by Idb 
proteins. (A) The bHLH proteins can form homodimers as well as heterodimers with other members of 
the bHLH family. As a dimers the bHLH proteins can bind the DNA containing the sequence CANNTG 
and activate the transcription of target genes. (B). During development the Idbs are able to preferentially 
form dimers with the bHLH proteins. Since Idbs lack the DNA binding domain these heterodimer are 
not able to bind the DNA and activate the transcription. Adapted from Sikder Hashmat  Cancer Cell 
2003. 
1.5.1 The role of Id1 in proliferation and invasion 
It is known that  Id1 is  important for the regulation of proliferation, differentiation 
motility  and  programmed  death  of  normal  as  well  as  of  transformed  mammary 
epithelial  cells.  Id1  mRNA  is  expressed  at  a  high  level  in  proliferating  mouse 
mammary  epithelial  cells  SCp2  in  vitro,  and  its  expression  declines  prior  to 
differentiation  or  in  quiescent  cells.  SCp2  cells  transfected  with  an  Id1  expressing 
vector grow more rapidly, whereas cells transfected with a vector leading to expression 
of Id1 anti sense sequence grow more slowly compared to control cells. In addition 
constitutive over expression of Id1 prevented the cells to functionally differentiate as 
measured by expression of β casein (Desprez et al., 1995). 
It is unclear how many genes are regulated by the Id1 protein, only a few targets have 
been described so far. A recent study reports cloning of a novel zinc finger protein, 
Zfp289,  the  expression  of  which  is  induced  by  Id1.  The  expression  of  Zfp289 
correlates  with proliferative  stages  of  mammary  epithelial  cells in  vitro  as  well  as 
during  mammary  gland  development  in  vivo.  Therefore,  Zfp289  is  potentially  an 
important mediator of the Id1 induced growth pathway in mammary epithelial cells 
(Singh et al., 2001). Other investigations showed that constitutive over expression of 
Id1  can  induce  an  invasive  and  migratory  phenotype  in  non transformed  and  non 
tumorigenic murine mammary epithelial cells (SCp2).  
Idb
Transcription NO Transcription
bHLH
bHLH bHLH
CANNTG
Idb
Transcription NO Transcription
bHLH
bHLH bHLH
CANNTGIntroduction 
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The  ability  of  Id1  over expressing  SCp2  cells  to  actively  invade  the  extra  cellular 
matrix  (ECM)  suggested  that  Id1  might  induce  the  expression  of  ECM  degrading 
proteases. Indeed a novel matrix metalloproteinase (MMP) was found to be secreted by 
Id1  over expressing  cells.  Experiments  with  MMP  inhibitors  showed  that  this  Id1 
related metalloproteinase is indeed essential for the invasive phenotype of SCp2 cells. 
This MMP is also expressed during involution of the mammary gland, correlating with 
the expression of Id1. During involution this Id1 associated MMP may then participate 
in the remodelling of the mammary gland. Interestingly, this MMP was also detected 
in the medium of invasive breast cancer cells which highly express Id1 suggesting that 
Id1 regulates the invasive phenotype of breast cancer cells at least in part through 
transcriptional activation of the MMP gene. This idea is supported by the fact that 
other breast cancer cell lines expressing Id1 at a high level are also more invasive than 
those in which the Id1 gene is silenced (Desprez et al., 1998). 
1.5.2 The role of Id2 during pregnancy and lactation  
The Id2 protein has been shown to be an important transcription factor involved in the 
maintenance  of  the  differentiated  phenotype  of  mammary  epithelial  cells.  This  is 
shown by the fact that Id2 is expressed at a high level in fully differentiated SCp2 cells 
that express milk proteins. Unlike Id1 the expression level of Id2 is undetectable in 
proliferating cells. Over expression of exogenous Id2 in undifferentiated SCp2 cells 
accelerates  differentiation  whereas  silencing  of  Id2  by  using  anti sense  sequence 
blocks the expression of milk protein also confirming a role of Id2 in the functional 
differentiation of mammary epithelial cells. These in vitro data are supported by in 
vivo  experiments.  The  mammary  gland  of  Id2  knock out  female  mice  develops 
normally during embryogenesis and virgin mice have normal ductal trees, similar to 
those  of  heterozygous  animals.  At  the  day  of  delivery,  however,  the  alveolar 
compartment  is  still  poorly  developed.  The  alveoli  are  small  without  clear  milk 
accumulation. The mammary gland of the Id2 /  female mice resembled the gland of 
wild type mice at early pregnancy (Mori et al. 2000). From these in vitro and in vivo 
data  it  can  be  concluded  that  Id2  is  involved  in  the  regulation  of  functional 
differentiation of mammary epithelial cells and it regulates the development of the 
secretory alveolar compartment during pregnancy.  Introduction 
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1.6  RNA  interference  as  a  tool  for  the  analysis  of  genes  involved  in 
mammary gland development 
Functional genomics and proteomics analysis help to uncover novel genes and proteins 
involved in the various steps of mammary gland development. To study the role of 
these  genes  more  specifically  and  in  more  detail  different  techniques  have  been 
established. One popular method is the use of siRNA. With short interfering RNA it is 
possible to silence gene expression in a sequence specific manner in a process called 
RNA interference (Dykxhoorn et al., 2003). 
RNA interference can be divided into two separate pathways (Figure 1.13). In the first 
case long double stranded RNA precursors are cut into typical short interfering RNA 
consisting of two 21 base pairs nucleotides, which form 19 base pairs duplexes, with 2 
nt overhangs at the 3' ends and 5' phosphates and 3' hydroxyl groups (Elbashir et al., 
2001) (Figure 1.13 A). This process is catalyzed by Dicer, which is a evolutionarily 
conserved member of the RNAse III enzyme family (Bernstein et al., 2001), and is an 
ATP  dependent  reaction  (Zamore  et  al.,  2000).  Dicer  guides  the  siRNA  to  a 
multiprotein RNA inducing silencing complex (RISC). Although uptake of siRNA by 
RISC  is  independent  of  ATP  the  unwinding  of  siRNA  duplexes  requires  ATP 
(Nykanen  et  al.,  2001).  The  antisense  strand  then  guides  the  RISC  complex  to  its 
homologous  target  mRNA  sequence  (Schwarz  et  al.,  2002).  The  target  mRNA  is 
endonucleolytically cleaved at a single site in the center of the duplex region between 
the  guiding  antisense  siRNA  and  sense  mRNA  strand.  Finally,  this  promotes  the 
degradation of the cleaved mRNA. (Elbashir et al., 2001). In the case of the micro 
RNA (miRNA) pathway, Dicer produces the short 22 nt miRNA by cleavage of longer 
RNA  precursors  of  70  nt  possessing  imperfect  hairpin  structures  (Figure  1.13C). 
Unlike  the  siRNAs  the  miRNAs  are  single  stranded  and  are  incorporated  into  the 
miRNA protein complex (miRNP) (Hutvagner et al., 2002). The miRNA are known to 
bind to sites that share complementarity in the 3' untranslated region (UTR) of the 
target mRNA, leading to suppression of mRNA translation and inhibition of protein 
synthesis  (Pasquinelli  and  Ruvkun,  2002).  In  case  of  perfect  pairing  the  miRNP 
complex is able to cleave the target mRNA (McManus and Sharp, 2002).  
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Figure 1.13 The RNA interference pathways. (A) Short interfering RNA 5'P ends and 19 nt duplex 
with  2 nt  unpaired  and  unphosphorylated  3'  ends.  (B).  The  siRNA  is  processed  by  Dicer  and  in 
corporated  to  the  siRNA protein  complex  (siRNP)  that  lead  to  activation  of  RISC  (RNA  inducing 
silencing complex) which is guided by antisense RNA strand to target mRNA and cleaves it. (C) The 
miRNA are processed by Dicer form hairpin precursors and incorporated to miRNP protein complex 
(miRNP) that can inhibit translation or cleavage the mRNA. 
1.6.1 Endogenous expression of siRNA 
The  siRNA  molecules  can  be  chemically  synthesized  and  directly  transfected  into 
cells. Such siRNAs are relatively resistant to degradation. Nevertheless, in this way the 
knock down of a gene is only transient, since with each cell division the siRNA is 
diluted. Soon the siRNA concentration is too low for effective inhibition of targeted 
gene expression. To achieve long lasting gene silencing the siRNA can be expressed 
from  DNA  vectors  containing  promoters  for  RNA  polymerases  for  intracellular 
synthesis of siRNA (Dykxhoorn et al., 2003). The transient transfection of vectors 
expressing siRNA also has some limitation. For example the transfection reagents have 
to be tested for any negative effects on the cells. The number of cells used for the 
transfections, the total amount of vector DNA as well as the ratio vector: carrier has to 
be optimized for each cell line. There are many cells that are refractory to transfection 
including the mammary epithelial HC11 cell line. Therefore, an alternative to achieve 
stable  siRNA  expression  in  mammary  epithelial  cells  is  of  interest  to  study  the 
function of genes found to be involved in mammary gland development. The retrovirus 
based siRNA delivery system could be of interest for this purpose (Naldini et al., 1996; 
Brummelkamp et al., 2002). Introduction 
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1.6.2  The  use  of  lentiviral  vectors  for  stable  siRNA  expression  in 
mammalian cells 
Lentiviral  vector  system  has  been  developed  for  stable  expression  of  sequences 
encoding siRNA. These vectors are delivered into many types of cells in vitro and in 
vivo, with transduction efficiencies of almost 100% (Rubinson et al., 2003; Naldini et 
al., 1996). Stable expression of siRNA enables to study the effects of mRNA silencing 
over an extended period of time. This is important for analysis of genes involved in 
functional differentiation of mammary epithelial cells, a process which takes 10 days 
in vitro. Long term siRNA expression is also required if proteins with a long half life 
are to be studied since in this case the effect of mRNA degradation on the protein level 
can be detected many hours even days after transduction with siRNA delivery vectors. 
Several members of the lentivirus family have been molecularly engineered for stable 
expression  of  a  certain  sequence  of  interest.  These  lentiviruses  have  a  highly 
manipulable genome and sequences up to 8 kbp long can be inserted. They have a very 
low level of pro inflammatory activity and most importantly they have the ability to 
stably  integrate  into  the  genome  of  dividing  as  well  as  non dividing  cells.  These 
vectors have been successfully used for gene delivery into primary cells, liver, muscle, 
cardiac, neuronal cells and immune system dendritic cells, in vitro as well as in vivo. 
Several lentiviral based gene therapies are now in phase I clinical studies although 
there is still much concern about the fact that these vectors integrate randomly in the 
genome  raising  the  probability  to  activate  proto oncogenes  (Lever  et  al.,  2004; 
Quinonez, 2002; Stewart et al., 2003).  
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1.7 Systems for cultivating mammary epithelial cells 
During organogenesis the mammary gland develops from a small epithelial mammary 
anlage present in the embryo into a highly organized ductal tree of polarized epithelial 
cells  in  a  mature  female  individual.  During  pregnancy  the  cells  start  to  form  the 
secretory compartment with alveoli. This process depends on the correct interaction 
between epithelial cells building the ducts and alveoli as well as the interaction of 
epithelial cells with surrounding adipocytes, fibroblasts and myoepithelial cells, which 
contribute to the mammary gland stroma. The role of genes involved in this process 
can be studied in vivo, but this method is time consuming and work intensive. Such 
studies  do  not  allow  simple  and  fast  analysis  of  genes  of  interest.  Therefore  two 
dimensional  cell  culture  conditions  have  been  developed  but  not  all  fullfill  the 
physiological  needs  of  mammary  epithelial  cells  necessary  for  development  of  the 
ductal tree and alveolar units. To solve such problems, many systems mimicking in 
vivo conditions have now been established over the years. The cells can be co cultured 
with  other  mammary  gland  cell  types,  they  can be  seeded  within  a  special  matrix 
(collagen, matrigel, hydrogel) or transplanted into specially prepared stroma tissue, 
cleared fat pad, or can be grown as whole organ culture in vitro.  
In three dimensional culture systems (3D culture) mammary epithelial cells are seeded 
within collagen type  I  gel or matrigel which serves  as an  extracellular matrix that 
allows  epithelial  cells  to  arrange  themselves  into  branching like  structures  that 
resemble  the  ductal  tree  of  the  mammary  gland.  The  cells  can  also  form  acinar 
structures similar to alveoli in vivo (Ip and Darcy, 1996).  
Co cultures  with  adipocytes  have  been  shown  to  enhance  the  proliferation  of 
mammary cells in vitro. For example primary epithelial isolated from pregnant mice 
and seeded together with adipocytes grew more rapidly than cells cultured alone on 
plastic  (Levine  and  Stockdale,  1984).  In  response  to  the  induction  with  lactogenic 
hormones  the  primary  mammary  cells  co cultured  with  fat  cells  were  able  to 
differentiate  and  to  synthesize  milk  proteins  (Levine  and  Stockdale,  1985).  The 
epithelial cells can be cultivated in an ex vivo system as transplants into cleared fat 
pads. The epithelial ductal tree can be entirely removed from gland number four of 
three weeks old mice resulting in a cleared (from endogenous mammary epithelial 
cells)  fat  pad,  which  can  be  used  as  a  transplantation  site  for  normal  and  tumour 
epithelial cells but also for cells in which certain genes are silenced or over expressed.  Introduction 
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The  epithelial  cells  can be  grown  and  would  respond  to  induction  with  lactogenic 
hormones in other than mammary fat tissue, for example they can be maintained in 
perenal, micrometrical and subcutaneous fat depots (Hoshino K. 1980). Other study 
has shown that mammary epithelial proliferation can also be supported by brown fat 
matrix (Hoshino, 1967).  
The  epithelial  tissues  are  structures  of  polarized  and  specialized  cells,  strictly 
organized by cell cell contact and attached to basement membrane. The disruption of 
the  epithelial  architecture  leads  to  deregulation  of  proliferation,  differentiation  and 
survival, resulting in tumour development. The 3D cultures have been used to study 
the  role  of  cancer  genes  and  pathways  in  disorganization  of  normal  epithelial 
architecture in biologically relevant environment (Debnath and Brugge, 2005).  
 
 
Figure 1.14 Schematic representation and comparison of mammary epithelial cell culture systems 
in vitro (A) Mammary epithelial cells cultivated on plastic dishes. The cells are grown in presence of 
insulin and EGF until they are confluent. After 2 4 days in medium containing only EGF the cells are 
competent  and  can  be  induced  for  functional  differentiation  with  lactogenic  hormone  mix 
(Dexamethasone, Insulin, Prolactin) After 4 days of lactogenic stimulation the cells express the milk 
protein β casein (indicator of terminal differentiation). (B) When cultivated in 3D context the cells can 
morphologically differentiate and form ducts and alveolar like structures that resemble branching and 
alveolar development in vivo. 
 
The described three dimensional system using collagen or matrigel will be used to 
study the influence of mTOR inhibition by rapamycin as well as silencing and/or over 
expressing  of  candidate  genes  using  lentiviral  vectors  on  the  morphological 
differentiation of mammary epithelial cells in vitro. 
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1.8 The aims of this work 
The mammary gland is a perfect model to study the molecular mechanisms that govern 
processes  like  organogenesis  and  organism  development.  The  proliferation  and 
differentiation of mammary epithelial cells, which lead to the formation of complicated 
glandular structure composed of ducts and secretory alveolar units are controlled by 
many pathways that activate transcription of hundreds of genes. Although the major 
pathways involved have been described, many aspects of the gene transcription profile 
regulation during mammary gland development are unknown. For this reason the aim 
of this work was the identification of novel signaling pathways, genes and proteins 
involved in proliferation and differentiation of mammary epithelial cells during the 
mammary gland development. This required the establishment of a system that allows 
the fast validation of candidate genes and proteins identified to play a possible role in 
this process. These candidate genes were identified in studies using the micro array 
technology. For these experiments the expression patterns between proliferating and 
differentiated mammary epithelial cells were compared. This led to the identification 
of genes and proteins involved in the process of proliferation and/or differentiation of 
mammary epithelial cells. Some interesting candidates were selected and characterized 
in  this  work.  As  shown  in  the  introduction  the  mTOR pathway  is  involved  in  the 
regulation of many important cellular processes influencing cell growth. The role of 
mTOR  in  mammary  epithelial  cell  proliferation  and  differentiation  as  well  as  in 
mammary gland development has not been investigated in detail. Therefore, in this 
study the potent drug  rapamycin, which is a very specific inhibitor of mTOR was 
applied  to  investigate  the  role  of  the  mTOR  pathway  during  proliferation  and 
differentiation of mammary epithelial cells.  
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2 MATERIALS AND METHODS  
2.1 MATERIALS 
2.1.1 Chemicals 
Acrylamid                 Roth 
Agarose                 PeqLab 
Albumin, bovine serum fraction V           Sigma 
Ampicillin                 AppliChem 
Aprotinin                 Sigma 
APS                   Sigma 
Beta mercaptoethanol             Roth 
Bradford Reagent               BIO RAD 
Bromophenol blue               Fluka 
CaCl2                  Sigma 
Chloroquine                Sigma 
Chloroform                 Roth 
DMSO (Dimethyl Sulfoxide)             Merck 
DTT (Dithiothreitol)              Sigma 
ECL reagent 1 and 2              AmershamPharma 
EDTA (Ethylene diamine tetraacetic acid)        Roth 
EGTA (Ethylene glycol tetraacetic acid)        Roth 
Ethanol                Roth 
Ethidium Bromide               Sigma 
Eosin                  Roth 
Formaldehyde               Roth 
Glycerol                 Roth 
HCl                  Roth 
HEPES                Sigma 
Isopropanol                Roth 
KCl                   Roth 
Leupeptin                 Sigma, Steinheim 
MgCl2                  Fluka 
Milk powder                AppliChem 
Na2HPO4                Sigma 
NaCl                   Roth 
NaOH                 AppliChem 
Pefabloc                 Sigma  
Pepstatin                 Sigma 
Polybrene                Sigma 
Polyethylenimine (PEI)            Sigma 
SDS (Sodium dodecyl sulfate)          Roth 
Sucrose                Roth 
TEMED                 Sigma 
Tris                   AppliChem 
Triton X 100                Fulka 
Tween 20                 Fluka  Materials and Methods 
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2.1.2 Commercial kits and reagents  
GeneAmp®   RNA PCR Core Kit         Applied Biosystems 
IQ
TM SYBR® Green Supermix        Bio Rad 
Lipofectamine
TM            Invitrogen 
Mammalian Transfection Kit         Stratagene 
mRNA Midi Kit             Qiagen  
NUCLEOBOND Plasmid Isolation Kit      Macherey Nagel 
NucleoSpin® Plasmid Isolataion Kit       Macherey Nagel 
NucleoSpin® RNA II Kit          Macherey Nagel 
peqGOLD TriFast
TM            peqLab 
Ponceau S Solution            Sigma 
Proliferation Kit II             Roche 
Protein Assay Dye Reagent Concentrate      Bio Rad 
RNeasy® Midi Kit            Qiagen 
QIAguick® Spin Kit            Qiagen 
Trizol®              Gibco   
2.1.3 Enzymes 
AmpliTaq®DNA Polymerase         Roche 
BglII, EcoRI, HincII, SacII, SnaBI, SmaI, XbaI, XhoI  New England Biolabs 
Calf Intestinal Phosphatase (CIP)        New England Biolabs 
RNaseOUT
TM Recombinant RNase Inhibitor      Invitrogen 
SuperScript
TM II Reverse Transcriptase       Invitrogen 
T4 DNA Ligase             New England Biolabs 
2.1.4 Material used in cell culture 
Actinomycin D              Sigma 
Collagen Type I from rat tail            BD Biosciences 
Collagenase                Roche 
Dexamethasone              Sigma 
DMEM with 4.5 g/l Glucose w/o L glutamine       BioWhittaker 
DMSO, cell culture tested            Sigma 
DPBS (1x) w/o Ca and Mg              PAA Labortories 
EGF (Epidermal Growth Factor)          Becton Dickinson 
F 12 (HAM) Nutrient Mixture with L Glutamine       Gibco 
FBS (Foetal Bovine Serum)             Gibco 
Fetuin                 Sigma 
Hydrocortisone              Sigma 
Insulin                 Sigma 
L Glutamine 200 mM (100X) in 0.85% NaCl Solution     BioWhittaker 
Matrigel
TM Basement Membrane Matrix         BD Biosciences 
Opti MEM Medium             Invitrogen 
PEN STREP (10.000U Penicillin/ml 10.000  g Streptomycin/ml)   BioWhittaker 
Prolactin (Luteotropic hormone)          Sigma 
Rapamycin                 Calbiochem 
RPMI 1640 w/o L Glutamine           BioWhittaker 
TRYPSIN EDTA(1x) in HBSS w/o Ca&Mg w/EDTA     Gibco Materials and Methods 
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2.1.5 Markers 
1 kb DNA Ladder             New England BioLabs 
100 bp DNA Ladder            New England BioLabs 
Precision Plus Protein Standards Dual Color       Bio Rad 
2.1.6 Plasmids 
Name  Specification  Reference 
pSuper  Mammalian  expression  vector  with  H1 
RNA gene promoter allowing intracellular 
synthesis  of  siRNA  transcript  by 
polymerase III 
Oligoengine 
pSuper A115  siRNA  sequence  A115  against  Id1  upon 
regulation  of H1 promoter 
This work 
pSuper B131  siRNA  sequence  B131  against  Id1  upon 
regulation  of H1 promoter 
This work 
pSuper C152  siRNA  sequence  C152  against  Id1  upon 
regulation  of H1 promoter 
This work 
pSuper 7  siRNA  sequence  7  against  Id2  upon 
regulation  of H1 promoter 
This work 
pSuper 9  siRNA  sequence  9  against  Id2  upon 
regulation  of H1 promoter 
This work 
pSEW  Lentiviral  vector  with  SFFV  promoter 
allowing stable intracellular expression of 
proteins of interest 
Grez, M. Frankfurt 
am Main 
pSEW A115  siRNA  sequence  A115  against  Id1  upon 
regulation of subcloned H1 promoter 
This work 
pSEW B131  siRNA  sequence  B131  against  Id1  upon 
regulation of subcloned H1 promoter 
This work 
pSEW C152  siRNA  sequence  C152  against  Id1  upon 
regulation of subcloned H1 promoter 
This work 
pSEW 7  siRNA  sequence  7  against  Id2  upon 
regulation of subcloned H1 promoter 
This work 
pSEW 9  siRNA  sequence  9  against  Id2  upon 
regulation of subcloned H1 promoter 
This work 
pCMVSport 6  Mammalian expression vector with CMV 
promoter allowing intracellular expression 
of proteins of interest 
Invitrogen 
pCMVSport6 Id1  Id1  protein  coding  sequence  upon 
regulation of CMV promoter 
This work 
pCMVSport6 Id2  Id2  protein  coding  sequence  upon 
regulation of CMV promoter 
This work 
pSiEW  Lentiviral  vector  with  SFFV  promoter 
allowing stable intracellular expression of 
proteins of interest 
Grez, M. Frankfurt 
am Main 
pSiEW Id1  Id1  protein  coding  sequence  upon 
regulation of SFFV promoter 
This work 
pSiEW Id2  Id2  protein  coding  sequence  upon 
regulation of SFFV promoter 
This work Materials and Methods 
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2.1.7 Antibodies 
Epitope  Dilution  Origin  Manufacturer 
β casein  1:1000  Rabbit, polyclonal  Kindly provided by Barash, I.  
β tubulin  1:1000  Mouse, monoclonal  Sigma (C 20) 
Id1  1:500  Rabbit, polyclonal  Santa Cruz (C 20) 
Id2  1:500  Rabbit, polyclonal  Santa Cruz (C 20)    
Phospho mTOR  1:1000  Rabbit, polyclonal  Cell Signaling (Ser2448) 
Phospho Stat5a/b  1:1000  Rabbit, polyclonal  UpState (Tyr694/699) 
Stat5a/b  1:1000  Rabbit, polyclonal  Santa Cruz (N 20) 
Anti mouse Ig HRP  1:5000  Sheep, polyclonal  Amersham Bioscience 
Anti rabbit Ig HRP  1:5000  Donkey, polyclonal  Amersham Bioscience  
2.1.8 Primers 
2.1.8.1 Primers used for generation of siRNA  
Name  Sequence 5' to 3' 
mId1_A_up  
 
GAT CCC CAA GGT GGA GAT CCT GCA GCA TTT CAA GAG  AAT GCT 
GCA GGA TCT CCA CCT TTT TTT GGA AA 
mId1_A_low  AGC TTT TCC AAA AAA AGG TGG AGA TCC TGC AGC ATT CTC TTG 
AAÀ TGC TGC AGG ATC TCC ACC TTG GG 
mId1_B_up  GAT CCC CAA CGG CGA GAT CAG TGC CTT GTT CAA GAG ACA AGG 
CAC TGA TCT CGC CGT TTT TTT GGA AA 
mId1_B_low  
 
AGC TTT TCC AAA AAA ACG GCG AGA TCA GTG CCT TGT CTC TTG 
AAC AAG GCA CTG ATC TCG CCG TTG GG 
mId1_C_up  GAT CCC CAA CGT CCT GCT CTA CGA CAT GTT CAA GAG ACA TGT 
CGT AGA GCA GGA CGT TTT TTT GGA AA 
mId1_C_low  AGC TTT TCC AAA AAA ACG TCC TGC TCT ACG ACA TGT CTC TTG AAC 
ATG TCG TAG AGC AGG ACG TTG GG 
Id2 7_up  
 
GAT CCC CGG ACT GTG ATA CCG TTA TTT TCA AGA GAA ATA ACG 
GTA TCA CAG TCC TTT TTG GAA A 
Id2 7_low  AGC  TTT TCC AAA AAG GAC TGT GAT ACC GTT ATT TCT CTT GAA 
AAT AAC GGT ATC ACA GTC CGG G 
Id2 9_up  GAT CCC CGT GAA CCT TGT GGA CTC TTT TCA AGA GAA AGA GTC 
CAC AAG GTT CAC TTT TTG GAA A 
Id2 9_low  AGC TTT TCC AAA AAG TGA ACC TTG TGG ACT CTT TCT CTT GAA AAG 
AGT CCA CAA GGT TCA CGG G 
 
2.1.8.2 Primers for amplification of Idb gene with SacII enzyme adaptor. 
Name  Sequence 5' to 3' 
Id1 SacII up  TCC CCG CGG ATG AAG GTC GCC AGT GGC AG 
Id1 SacII lp  TCC CCG CGG TCA GCG ACA CAA GAT GCG AT 
Id2 SacII up  TCC CCG CGG ATG AAA GCC TTC AGT CCG GT 
Id2 SacII lp  TCC CCG CGG TTA GCC ACA GAG TAC TTT GC 
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2.1.8.3 Primers used for Real Time PCR 
Name  Sequence 5' to 3' 
18S_up  CGT TGG TGT GGG GAG TGA ATG GTG 
18S_lp  GCG TGG GGG TTG GCG GAA AGA GAA 
β casein_up  TCA CTC CAG CAT CCA GTC ACA 
β casein_lp  GGC CCA AGA GAT GGC ACC A 
Id1_up  TGG TCT GTC GGA GCA AAG C 
Id1_lp  GCA GCC GTT CAT GTC GTA GAG 
Id2_up  ACT CGC ATC CCA CTA TCG TCA GC 
Id2_lp  TGA CCA CCC TGA ACA CGG ACA T 
Cited4_up  GGC CGA CCA CCT GAT GCT C 
Cited4_lp  ATG CCC GGG CCT GCG TAT 
Nedd8_up  CAG TGG CAA GCA AAT GAA TGA TGA 
Nedd8_lp  CACTGC CCA AGA CCA CCT C 
Ltf_up  ATG CTG GAG CCT TGA GGT GTC TGA 
Ltf_lp  GGT CCC TTT CGG CTT TAT TTG GTA 
Atp5l_up  CAA CCC CTG CTG AAA TCC CTA CA 
Atp5l_lp  GGC CAC CAA ACCATT CAG CAC AG 
Nkd2_up  GAG CAG GCC AGG CAA GAA CAT CAT 
Nkd2_lp  GTA TAG CGT GGG CAT CCG ACT CTT 
Hdac2_up  TCA ATT GGG CTG GAG GAC TAC A 
Hdac2_lp  TTC GAG GAT GGC AAG CAC AAT 
Sap30_up  GAA GGT GAA GAT CGA GCT GGA 
Sap30_lp  CCT TCT GTT CCG AAC GCT CT 
Esg1_up  GAG CCA GGC CAT GTT TGA GC 
Esg1_lp  TAG CCC GAA TCT TGT TGT TTT GAG 
Rae1_up  CAG CAA CCA GGC CAT TCA GA 
Rae1_lp  CAG CTC CCG GTC ATC ACA C 
Nap1l1_up  GGG CGT GGG ACA GTT CGT 
Nap1l1_up  CGC CTC AGC ATC ATC ATC CA 
Hsp105_up  CCA GGC TAA GCA GGC ATA CAT 
Hsp105_lp  ACA CTT TCG GTC GTT CCT CAG 
Pdlim1_up  CCC AAC TGG CCT CTA CTC ATC 
Pdlim1_lp  ACC ACG GGC CTG CTG TTT 
Nol5_up  TAG GCC AGT CAA GTC CCA AAC AC 
Nol5_lp  TTC ACC AAA AGC GTC GTA TCT G 
Biklk_up  TCA CCA ACC TAC GGG AAA ACA 
Biklk_lp  AAG AAG ACC AGC AGC ACC ATC 
Kpna2_up  GAT GGT TCA GCT TTC CGA GAC T 
Kpna2_lp  CCA CAT GCC AAG GTA GAC AGA 
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2.1.8.4 Primers used for RT PCR  
Name  Sequence 5' to 3' 
β casein up  ACT ACA TTT ACT GTA TCC TCT GA 
β casein lp  GTG CTA CTT GCT GCA GAA AGT ACA G 
GAPDH up  GTG AAG GTC GGT GTG AAC GGA TTT GGC CGT 
GAPDH lp  CCA CCA CCC TGT TGC TGT AG 
 
2.1.9 Labware 
Company  Item 
Abgene  Thermo Fast, 0.2 ml Semi Shirted 96 well PCR plate  
BD Biosciences  
Becton Dickinson 
Labware 
 
Falcon Polypropylene Conical Tube BLUE MAX 50 ml  
Falcon Polypropylene Conical Tube BLUE MAX Jr 15 ml  
Polypropylene Round Bottom Tube 14 ml 
Polypropylene Round Bottom Tube 5 ml 
Falcon ADVANTAGE
TM Serological Pipet 2, 5, 10, and 25 ml  
Microlance
TM 0.9 x 40 mm Sterile needle 
Plastipak
TM Sterile syringe 1 ml  
Bio Rad  Mini Protean Short Plates  
Mini Protean Long Plates 
ICycler iQ Optical Tape  
Brand  Plastibrand
TM 0.5 ml, 1.25 ml, 2.5 ml, and 5 ml dispenser tips 
B/Braun  Omnican®30  0.33 x 12 mm 0,3 ml syringe    
Corning 
Incorporated 
Costar 
STRIPETTE 5 ml, 10 ml, and 25 ml serological pipet  
Sterile Cell Lifter  
Sterile 12, 24 and 96 well cell culture flat bottom plate with lid   
Dahlhausen   2 ml sterile syringe  
Fujifilm  Fuji Medical X Ray Film 18 x 24 cm 100 NIF 
Greiner Bio One  CELLSTAR® Tissue Culture Dish 94,0/16 mm Vented, Sterile  
Millipore  Millex
TM (0.22  m pore size filter) 
Ratiolab  10  l, 20  l, 200  l and 1 ml Aeroject® xL tips 
Schleicher 
Schuell 
PROTRANBA83 Nitrocellulose membrane (0.2 m pore size) 
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2.1.10 Eukaryotic cell lines 
Cell line  Description  Ref/ATCC No. 
HC11  mouse  mammary  epithelial  cell  line 
established in vitro  
Ball et al., 1998 
PMEC  mouse primary mammary epithelial cells  Freshly Isolated 
HEK 293T  humane  embryonic  kidney  cells  transformed 
with SV40 large T antigen. 
CRL 11268 
 
2.1.11 Bacterial strains  
Strain  Genotype  Supplier 
TOP10  F   mcrA  (mrr hsdRMS mcrBC)  80lacZM15  lacX74 
recA1  ara139  (ara leu),7697  galU  galK  rpsL  (StrR) 
endA1 nupG 
Invitrogen 
Stbl2  F–  mcrA  (mcrBC hsdRMS mrr)  recA1  endA1  lon 
gyrA96 thi supE44 relA1– (lac proAB) 
Invitrogen 
XL 1 blue  SupE44, hsdR17, recA1, endA1, gryA46, thi, relA1, 
Lac
_, F´(proAB
+, lacI
q, lacZ,  M15, Tn110 (tet
r)) 
Invitrogen 
 
2.1.12 Culture media 
2.1.12.1 Media for cultivating bacterial cells  
Bacterial cells were grown in LB medium with addition of 100  g/ml ampicillin in a 
shaker at 200 rpm and 37˚C overnight. Bacterial strains are stored in –80˚C in LB 
medium with addition of 50% glycerol. 
 
LB medium  Bacto Trypton 10 g/l 
Bacto Yeast Extract 5 g/l  
NaCl 5g/l,  
pH 7.5 established with 5N NaOH, autoclave. 
SOC medium  
 
Bacto Trypton 20 g/l 
Bacto Yeast Extract 5 g/l 
NaCl 0,5 g/l 
KCl 2.5 mM 
pH 7.0 established with 5 N NaOH, autoclave 
 
2.1.12.2 Medium for cultivating HEK 293T cells 
DMEM growth medium  DMEM (Dulecco´s modified Eagle medium)  
10% FCS, deactivated 30 min in 56˚C, 
2 mM L Glutamine  
100 U/ml Penicillin  
100  g/ml Streptomycin 
 Materials and Methods 
  54 
2.1.12.3 Media for HC11 cells (mouse mammary epithelial cells) 
Growth medium  RPMI 1640 
10%  FCS, heat inactivated 
100 U/ml Penicillin 
100  g/ml Streptomycin 
2 mM L Glutamine 
10 ng/ml EGF 
5  g/ml Insulin 
Starvation medium  RPMI 1640 
10% FCS, heat inactivated 
100 U/ml Penicillin 
100  g/ml Streptomycin 
2 mM L Glutamine 
10 ng/ml EGF 
Induction medium  RPMI 1640 
10% FCS, heat inactivated 
100 U/ml Penicillin 
100  g/ml Streptomycin 
2 mM L Glutamine 
5  g/ml Prolactin 
5  g/ml Insulin 
10
 7M Dexamethasone 
 
2.1.12.4 Media required for isolation and cultivation of mouse primary mammary 
epithelial cells 
Digestion Medium:  DMEM/F12     1:1 (v:v) 
Collagenase     2 mg/ml 
Hyaluronidase    100 U/ml  
Gentamicin    50  g/ml 
Penicillin    100 U/ml 
Streptomycin    100  g/ml 
2x Plating Medium  F12 medium    
Insulin      10  g/ml  
Hydrocortisone                  2  g/ml 
EGF      10 ng/ml 
Gentamicin    100  g/ml 
Penicillin    200 U/ml 
Streptomycin    200  g/ml 
Growth Medium  F12 medium    
Insulin      5  g/ml  
Hydrocortisone                  1  g/ml 
EGF      5 ng/ml 
FCS, heat inactivated  5% 
Gentamicin    50  g/ml 
Penicillin    100 U/ml 
Streptomycin    100  g/ml 
Differentiation Medium  DMEM/F12    1:1 (v:v) 
Insulin      5  g/ml  
Hydrocortisone                 1  g/ml 
Prolactin    3  g/ml 
Gentamicin    50  g/ml 
Penicillin    100 U/ml 
Streptomycin    100  g/ml Materials and Methods 
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2.1.13 Buffers and solutions 
Anode Buffer I  300 mM Tris HCl pH 10.4, 20% (v/v) Methanol  
Anode Buffer II  25 mM Tris HCl pH 10.4, 20% (v/v) Methanol  
Blocking buffer  1  x  TBS  0.1%  Tween 20  with  5%  w/v  BSA  (Bovine 
Serum Albumin) 
Buffer A  
(Nuclear fractionation) 
 
10 mM HEPES, 0.5 M Sucrose, 50 mM NaCl, 0.25 mM 
EGTA, 1m M EDTA, 0.5 mM Spermidine, 0.5% Triton X 
100,  0.5  mM  PMSF,  0.5   g/ml  Leupeptin,  0.7   g/ml 
Pepstatin, 1  g/ml Aprotinin, 40  g/ml Bestatin, 1  g/ml 
Trypsin 
Buffer B  
(Nuclear fractionation) 
 
10 mM HEPES pH 8.0, 25% Glycerol, 500 mM NaCl, 0.1 
mM EDTA, 0.1 mM EGTA,  0.5  mM  Spermidine,  0.25 
mM DTT, 0.5 mM PMSF, 0.5  g/ml Leupeptin, 0.7  g/ml 
Pepstatin, 1  g/ml Aprotinin, 40  g/ml Bestatin, 1  g/ml 
Trypsin  
DNA  Gel  loading 
Buffer (6x): 
15% Ficoll, 25 mM EDTA, Bromphenolblue 
Formalin fixative  10% Fromaldehyde (40% stock solution),10% glacial acid, 
80% ethanol (70% stock solution)  
Kathode Buffer:  25 mM Tris HCl pH 10.4, 20% (v/v) Methanol, 40 mM ε 
Aminocapron saure 
Luciferase Lysis Buffer:  1% Trton X 100, 25 mM Glycylglycin, 15 mM MgSO4, 4 
mM EGTA, 1 mM DTT (added fresh before use) 
Luciferin Substrate  2,97 g Glycylglycin 2.7 g ATP add 50 mg Luciferin add 
900 ml sterile H2O adjust to pH 7.8, store in dark 
PBS (1x):  137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM 
KH2PO4 pH 7.4 
RIPA:  50 mM Tris pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM 
DTT, 1% Nonidet P40, 0.5% Na deoxycholate, 0.1% SDS. 
Add  fresh  before  use:  100   l/ml  Pefabloc,  1   g/ml 
Aprotinin,  1   g/ml  Leupeptin  1   g/ml  pepstatin,  1  mM 
Na3VO4, 1 mM NaF  
SDS PAGE  
Running Buffer 
25 mM Tris, 250 mM Glycin, 0,1% SDS 
SDS PAGE  
Loading Buffer (5x) 
100  mM  Tris  pH  6.8,  200  mM  DTT,  4%  SDS,  20% 
Glycerol, 0,2% Bromophenolblue 
Solution 1  
(preparation  of  bacterial 
competent cells) 
100  mM  RbCl2,  50  mM  MnCl2,  30  mM  KAc,  10  mM 
CaCl2,  15%  (v/v)Glycerol,  pH  5.8  (HCl),  sterilized  by  
filtration. 
Solution  2  (preparation 
of  bacterial  competent 
cells) 
10 mM MOPS pH 7.0, 10 mM RbCl2, 75 mM CaCl2, 15% 
Glycerol (v/v), pH 7.0 (NaOH), sterilized by filtration. 
TAE Buffer:  40 mM Tris (pH 8.0), 2 mM EDTA 
TBS (1x)  10 mM Tris (pH 7.5), 150 mM NaCl 
TBS T wash buffer  TBS with addition of 0,1% Tween 20 
Tris Buffer  Tris with different molar concentrations and pH Materials and Methods 
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2.2 METHODS  
The standard methods were described on the basis of Molecular Cloning (Sambrook et 
al 1989), if not indicated by other reference in the text. 
2.2.1 MOLECULAR BIOLOGY METHODS 
2.2.1.1 Preparation of transformation competent bacterial cells 
XL1 blue bacterial cells were incubated in 500 ml of LB medium and grown until the 
OD600 reached range 0.55 0.6. The bacterial culture was centrifuged at 2000 rpm for 10 
minutes at 4°C and the resulting supernatant was discarded. The bacterial cell pellet 
was  resuspended  in  200  ml  ice cold  solution  1.  The  obtained  cell  suspension  was 
incubated on ice for 1 hour. Then the bacterial cells were centrifuged at 2000 rpm for 5 
minutes at 4°C and the supernatant was discarded. The pellet was resuspended in 15 
ml ice cold solution 2. Aliquots of 200  l volume each were prepared, which were 
shock frozen in liquid nitrogen. The aliquots of competent bacterial cells were stored at 
–80°C until needed for transformation with plasmid DNA. 
2.2.1.2 Transformation of bacterial cells 
A frozen aliquot of competent bacterial cells (CaCl2 treated) was thawn on ice. For 
each transformation 100  l was transferred to a sterile cold 1.5 ml tube using chilled 
micropipette tip. For each transformation sample 50 ng of plasmid DNA (in a volume 
of 10  l or less) was added to the cells and the content of the tube was mixed by gently 
swirling.  The  tubes  were  incubated  on  ice  for  30  minutes.  Then  the  tubes  were 
transferred to a heat block preheated to 42°C and incubated for exactly 90 seconds. 
After  this  incubation,  the  tubes  were  immediately  transferred  to  an  ice  bath  and 
allowed to cool down for 1 2 min. Then 900  l LB medium without antibiotics was 
added  to  each  sample  tube  and  the  transformed  bacteria  were  incubated  in  a 
thermomixer with gentle mixing at 37°C for 1 h. Finally, 100  l (up to 200  l per 10 
cm plate can be used) of transformed bacterial cells was plated onto an LB agar plate 
containing the appropriate antibiotic (normally 100  g Amp per 1 ml LB medium). 
The plates were incubated at room temperature until the liquid had been absorbed. The 
plates were then inverted and incubated at 37°C for 12 16 hours.  
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The next day the colonies that were able to grow on the plates, were used to isolate the 
transformed plasmid DNA. 
2.2.1.3 Plasmid DNA Mini Preparation  
For  the  isolation  of  a  small  amount  (<10   g)  of  plasmid  DNA  the  NucleoSpin 
Plasmid Isolation Kit MACHEREY NAGEL was used. The bacterial cells transformed 
with plasmid were cultivated in 5 ml LB medium at 37°C with constant shaking (200 
250 rpm) overnight (>12h incubation is recommended). To pellet the cells, 1.5 ml of 
bacterial  culture  was  centrifuged  for  30  s  at  11000  x  g  in  a  standard  bench  top 
microcentrifuge. The resulting supernatant was removed and 250  l buffer A1 was 
added to the tube. The cell pellet was resuspended by vigorous vortexing. To lyse the 
cells 250  l buffer A2 was added and the tube content was mixed gently by inverting 
the tube 6 8 times. The sample was incubated at room temperature for 5 min. After 
incubation,  300   l  buffer  A3  was  added  and  the  contents  were  mixed  gently  by 
inverting it 6 to 8 times. The obtained lysate was centrifuged for 5 10 minutes at 11000 
x  g  at  room  temperature.  The  resulting  supernatant  was  loaded  on  a  column,  and 
placed in a 2 ml sterile collecting tube. The tube with the column was centrifuged for 1 
minute at 11000 x g at room temperature and the flow through was discarded. To wash 
the column 600  l buffer A4 was added and the column was centrifuged for 1 min at 
11000 x g at room temperature. The resulting flow through was discarded. To dry the 
silica membrane completely the column was centrifuged for an additional 2 minutes at 
11000 x g at room temperature. Finally to elute the plasmid DNA the column was 
placed in a sterile 1.5 ml microcentrifuge tube and 50  l buffer AE was added. The 
column was incubated for 1 min at room temperature and then centrifuged for 1 min at 
11000 x g at room temperature. The flow through containing the plasmid DNA was 
collected in a properly labeled sterile tube. The isolated plasmid DNA was stored at –
20°C until needed for future applications. 
2.2.1.4 Plasmid DNA Maxi Preparation 
For the isolation of large amount (>100  g) of plasmid DNA the NUCLEOBOND 
Plasmid  Isolation  Kit  MACHEREY NAGEL  was  used.  The  bacterial  cells  were 
cultivated in 500 ml of  LB medium at 37°C with constant shaking (200 250 rpm) 
overnight (>12h incubation is recommended).  Materials and Methods 
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The bacterial culture was harvested by centrifugation at 3000 x g for 5 10 min at 4°C. 
The  pellet  of  bacterial  cells  was  resuspended  in  12  ml  buffer  S1.  The  obtained 
suspension was transferred to a 50 ml conical tube. To lyse the cells 12 ml buffer S2 
was added and immediately after closing the tube, the suspension was mixed gently by 
inverting the tube 6 8 times and incubated at room temperature for 5 min. Then, 12 ml 
of buffer S3 was added and the sample was immediately mixed by gently inverting the 
tube 6 8 times until a homogeneous suspension was formed. To complete precipitation 
of proteins and genomics DNA the suspension was incubated on ice for 5 min. The 
lysate was loaded onto pre wetted Whatman filter and the flow through was collected. 
The clear filtrated lysate was loaded onto a collection column equilibrated with 6 ml 
buffer N2.  The  column  was  than  washed  twice  with  16  ml buffer N3.  Finally  the 
plasmid DNA was eluted with 15 ml of buffer N5. To reduce the volume  the purified 
plasmid DNA was precipitated by adding 5 ml isopropanol, pre equilibrated to room 
temperature. The tube was immediately centrifuged for 30 min at high speed (>15000 
x g at 4°C). The obtained plasmid DNA pellet was washed with 5 ml of ice cold 70% 
ethanol and centrifuged for 10 min at 15000 x g at 4°C. The DNA pellet was briefly 
dried for 5 minutes at room temperature and re dissolved in a 1 x TE buffer or sterile 
water before the plasmid DNA was stored at –20°C for further applications.  
2.2.1.5 DNA concentration measurement 
The DNA samples were unfrozen at room temperature and after that the tubes were 
immediately  transferred  on  ice  bath  to  prevent  any  DNA  degradation.  To  prepare 
dilution of DNA samples for each measurement the 995  l of DNase free water and 5 
 l of the sample DNA were added to properly labeled microcentrifuge tube (the final 
DNA dilution factor is 1 to 200). The tubes were closed and mixed by shaking on 
vortex  machine.  The  DNA  concentrations  were  measured  by  OD260  using 
spectrophotometer. The calculated concentrations were written down on the tubes with 
the DNA stock. The DNA samples were stored at  20°C for further applications. 
2.2.1.6 RNA concentration measurement  
RNase  free  laboratory  equipment  was  used  when  working  with  RNA.  To  prevent 
degradation of RNA and inhibit eventually action of RNase all measurement steps 
were done at low temperature.  Materials and Methods 
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RNA samples were incubated until they unfreeze completely on ice bath. To prepare 
RNA sample dilution for measurement 99  l of RNase free water and 1  l of isolated 
RNA were transferred to microcentrifuge tube. The tubes were closed and the diluted  
RNA  was  mixed  by  short  shaking  on  a  vortex  machine.  The  RNA  sample 
concentration was measured by OD260 with spectrophotometer. A water resistant pen 
was used to write on the tubes the calculated RNA concentrations. The RNA samples 
were stored at  80°C for further applications. 
2.2.1.7 Sequencing of nucleic acids 
The DNA sequencing was performed by LabGroup Dietrich at the Georg Speyer Haus 
with  Taq Man  Sequencing  System.  For  each  sample  around  50  ng  of  DNA  was 
transferred to a properly labeled 1.5 ml microcentrifuge tube using DNase free pipette 
tips. Additionally the primers for sequencing the DNA fragment of interest were added 
(final primer concentration 100 M). The tubes were filled with HLPC water to a final 
volume of 15  l. The obtained DNA sequences were analyzed manually or using a 
special computer program (DNA Star). 
2.2.1.8 Gel Electrophoresis of DNA 
The electrophoresis tank was filled with 1 x TAE electrophoresis buffer. The open 
ends of the plastic tray were sealed with adhesive tape to form a mold which was then 
set on even part of bench. Usually 1 2% (w/v) agarose was dissolved in electrophoresis 
buffer, depending on the particular size of the fragments expected in the separated 
DNA  samples.  The  agarose  suspension  was  boiled  in  a  microwave  oven  until  the 
agarose  was  completely  dissolved.  Ethidium  bromide  was  added  to  a  final 
concentration of 0.5  g/ml after cooling the agarose. The agarose solution was poured 
into the mold and an appropriate comb was putted to the mold to form sample slots. 
The gel was incubated for 30 45 minutes at room temperature until it was completely 
set. A small amount of electrophoresis buffer was poured on the top of gel to enhance 
easy removal of the comb. The prepared gel was mounted in the electrophoresis tank 
and was covered with the electrophoresis buffer. The DNA samples were mixed with 6 
x gel loading buffer. The size standards were loaded on both the right and left sides of 
the gel. The samples were loaded into the slots of the submerged gel. The lid of the gel 
tank was closed and the electrical leads were attached to power supply. The voltage of 
1 5V/cm was applied.  Materials and Methods 
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When the DNA samples or dyes had migrated a sufficient distance toward the anode, 
the electric current was turned off and the leads and lid were removed from the gel 
tank. The gel was examined and photographed under UV light.  
2.2.1.9 Extraction of DNA fragments from agarose gels 
For the isolation of DNA fragments from agarose gels the QIAquick Gel Extraction 
Kit (QIAGEN) was used. The DNA fragment of interest was cut out from the agarose 
gel with clean, sharp scalpel. To minimize the size of the gel slice any extra agarose 
was removed. The gel slice was transferred into a microcentrifuge tube and weighed. 
Then 3 volumes of QG buffer were added to 1 volume of gel (100 mg gel = 100  l 
buffer). The gel sample was incubated at 50°C for 10 minutes and mixed by vortexing 
every 3 minutes during incubation. When the gel slice had dissolved completely, one 
gel volume of isopropanol was added to the sample and mixed. The dissolved gel 
sample was applied onto the QIAquick spin column and centrifuged for 1 minute at 
room  temperature.  The  flow through  was  discarded  and  0.75  ml  of buffer  PE  was 
added to the QIAquick spin column and centrifuged at 13000 rpm for 1 minute at room 
temperature to wash the membrane. The flow through was discarded and the column 
was placed back in the same micro centrifuge collection tube and centrifuged at 13000 
rpm for 1 minute at room temperature to dry the membrane completely. Finally, the 
column was placed in fresh microcentrifuge 1.5 ml tube and the DNA was eluted by 
adding  50   l  of  buffer  EB  or  sterile  H2O  to  the  center  of  the  column  membrane 
followed by incubation of the sample for 1 minute at room temperature. The column 
was centrifuged at 13000 rpm for 1 minute at room temperature and the obtained DNA 
was stored the at –20°C for further applications. 
2.2.1.10 Digestion of DNA with restriction endonuclease enzymes 
Restriction enzymes and buffers were obtained from New England BioLabs. The DNA 
and  all  necessary  buffers  were  unfrozen  at  room  temperature.  To  a  sterile 
microcentrifuge an appropriate amount of plasmid DNA was added. Generally, 1/10 
volume of optimal restriction buffer (as required for the enzyme used), and 10 U of 
each enzyme per 1  g of plasmid DNA were also added to the tube. If necessary 1/100 
volume of BSA solution was included. The tube was full filled with sterile water to the 
required final volume of 100  l and incubated, depending on reaction, for 4 to 8 h at 
37°C.  Materials and Methods 
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To  deactivate  the  enzymes  the  sample  was  incubated  additionally  at  65°C  for  10 
minutes. An 5  l aliquot of digestion mix was taken and resolved on 1% agarose gel to 
check the extension of digestion. As a control non digested plasmid DNA sample was 
used. Properly digested DNA, was purified using special column based kit (Qiagen). 
The purified linear DNA was finally dissolved in sterile water. The concentration of 
DNA was estimated with spectrophotometer. The digested DNA sample was stored at 
–20°C for further applications. 
2.2.1.11 Dephosphorylation of 5' ends of DNA 
Removal of 5' phosphate groups prevents self ligation and circularization of linearized 
plasmids. The reasonable amount of plasmid DNA was digested and purified. The 
dephosphorylation  reaction  mixture  was  performed  by  adding  to  a  microcentrifuge 
tube 10  l of 10 x reaction buffer and 0.5 U of calf intestinal phosphatase (CIP, New 
England Biolabs) per 1  g of linearized plazmid DNA. The reaction was adjusted to 
100  l with sterile water. The samples were incubated at 37°C for 45 60 minutes. To 
inactivate the CIP enzyme, EDTA (pH 8.0) and EGTA to final concentration 5 mM 
and 10 mM respectively were added to tube. The sample was mixed and incubated at 
65°C for 30 minutes. After the reaction, the tube was cooled to room temperature for 5 
minutes.  The  DNA  was  cleaned  using  column  kit  (Qiagen).  The  dephosphorylated 
DNA was stored in small aliquots at –20°C. 
2.2.1.12 Ligation of DNA fragments into plasmids 
Dephosphorylated plasmid DNA and a DNA insert were mixed with a molar ratio of 
1:2 in a sterile 1.5 ml microcentrifuge tube. Additionally 40 U of T4 DNA Ligase 
(New England Biolabs) and 2  l of 10 x ligation buffer were added to the tube and 
finally, the reaction was adjusted to a total volume of 20  l with sterile water. The 
ligation reaction was incubated for 2 to 3 hours at 16°C or overnight at 4°C. After 
ligation the tube was briefly centrifuged to down the contents of the tube and the whole 
ligation mix was used for transformation of 100  l competent bacterial cells.  
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2.2.1.13 Fast total RNA purification from cultured cells.  
For fast isolation of total RNA from cell cultures the NucleoSpin RNA II isolation 
Kit (MACHEREY NAGEL) was used. The cells of interest were seeded in 10 cm dish 
and cultivated in CO2 incubator at 37°C with proper medium and growth regulators for 
the desired time. The medium was removed and 700  l buffer RA1 mixed with 7  l β 
mercaptoethanol was added to the plate. The cells were scraped from the plate with a 
cell lifter and the obtained cell lysate was transferred to a 2 ml tube. To reduce the 
viscosity the lysate was passed 5 10 times through a 0,9 mm needle (20 gauge) fitted 
to  a  1  ml  syringe.  To  clear  the  sample  by  filtration  the  lysate  was  applied  onto 
NucleoSpin Filter Unit and centrifuged for 1 min at 11000 x g. After centrifugation 
the NucleoSpin Filter unit was discarded and 700  l 70% ethanol was added to the 
homogenized lysate and the sample was mixed by vortexing and. transferred onto a 
NucleoSpin RNA II column placed in microcentrifuge 2 ml tube. The column was 
centrifuged for 30 s at 8000 x g at room temperature. Next 350  l of MDB (Desalting 
Buffer) was applied to the column and the tube was centrifuged at 11000 x g for 1 min 
to dry the membrane. To remove the DNA from the RNA sample a DNase reaction 
mixture was prepared in a sterile microcentrifuge tube according to the manual. 95  l 
DNase reaction mixture was directly applied onto center of the silica membrane of the 
column and the tube was incubated at room temperature for 15 min. After incubation 
the membrane was washed with 200  l RA2 and centrifuged for 30 seconds at 8000 x 
g. The column was placed into a new 2 ml collecting tube and 600  l buffer RA3 was 
added on the column. After centrifugation for 30 seconds at 8000 x g the flow through 
was discarded and again 250  l buffer RA3 was added to the column. To dry the silica 
membrane completely the column was centrifuged for 2 min at 8000 x g. To elute the 
RNA the column was placed into a nuclease free 1.5 ml microcentrifuge tube and 60 
 l RNase free H2O was added to the membrane. The column was centrifuged at 11000 
x  g  for  1  min.  The  obtained  total  RNA  sample  was  stored  at  –80°C  for  further 
applications.  
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2.2.1.14 Reverse Transcription of mRNA  
To analyze the level of gene expression in Real Time PCR the mRNA of interest has 
to  be  reverse transcribed  to  cDNA.  The  reaction  can  be  catalyzed  by  the  reverse 
transcriptase. For the preparation of reverse transcription reactions the SuperScript™ II 
Kit (Invitrogen) was used. To a 1.5 ml RNase free microcentrifuge tube 10  g of the 
mRNA sample and 1  l of 100 pM AncT primer (Anchored oligo dT primer) with the 
sequence 5' T(20)VN 3' (V can be any nucleotide except T, N can be any nucleotide) 
was added.  
The reaction was adjusted to a final volume of 10  l with RNase free water. The tube 
content was then gently mixed by pipetting up and down. To denaturate the mRNA the 
tube was incubated in a heating block at 70°C for 10 minutes and after that the sample 
was  placed  on  ice  to  cool  down  and  was  finally  centrifuged  briefly  in  a 
microcentrifuge. Then the following components were added: 4  l 5 x First Strand 
Reaction  buffer,  2   l  0.1  M  DTT,  1   l  10  mM  dNTP  mix,  1   l  RNaseOUT 
(Ribonuclease Inhibitor), 1  l SuperScript II RNase H
  Reverse Transcriptase and 1 
 l RNase free water. The final reaction volume is 20  l. The tube was then incubated 
in a heating block at 42°C for 1h. At this temperature the enzyme reverse transcribe the 
mRNA into cDNA. To  inactivate the reaction the tube was heated at  70°C for 15 
minutes. After the reaction had cooled down on ice, the tube was shortly spun in a 
microcentrifuge. Finally to prepare 1:10 dilution of obtained cDNA sample (used for 
Real Time PCR reactions) 80  l of DNase free water was added to the tube and the 
content  was  gently  mixed.  The  prepared  cDNA  dilution  was  stored  in  –20°C  for 
further applications. 
2.2.1.15 Real Time PCR  
Real Time PCR reaction is dependent on many factors that have to be optimized for 
before reliable results can be obtained. One of the most important factors is the design 
of a primer pair that anneals very specifically to its target sequence in the template 
cDNA. The following rules were used to design optimal primer pairs for successful 
amplification of target sequences in the cDNA of interest using Real Time PCR. The 
oligos should be between 18 and 25 bp in length, with a G+C content between 40 and 
60%. There should be an equal distribution of all four bases along the sequence. Long 
repeats of single bases should be avoided.  Materials and Methods 
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The difference between the amounts of oligo nucleotides in a primer pair should not 
exceed 3 bp. The amplification product should be around 90 110 base pairs. In this 
study the Real Time PCR reaction had been performed using the iCycler iQ Real 
Time  Detection  System  or  The  MyiQ  Single Color  Real Time  PCR  Detection 
System. Both were purchased from Bio Rad. The instruments allowed analysis of 96 
PCR  reactions  at  once.  A  ready to use  master  mix  from  Bio Rad  was  used  for 
preparing  Real Time  PCR  reactions.  This  iQSYBR  Green  Supermix  is  a  2  x 
solution that has been optimized for Real Time PCR applications.  
It contains all necessary reagents and only the cDNA sample and a primer pair have to 
be  added  to  tube.  The  cDNA  obtained  from  the  reverse  transcriptase  reaction  was 
diluted once more 1:5 and 1:50 in DNase free water. The PCR reaction was performed 
always in triplicate for each cDNA sample and primer pair. Also the control reaction 
that contains all reagents except the cDNA template was included. For each reaction 
following components were added to a microcentrifuge tube: 12.5  l 2 x Supermix, 0.5 
 l of each primer (final concentration should be 100 nM 500 nM), 8.5  l DNase free 
water and 3  l diluted cDNA (1:5 or 1:50). The prepared reactions were transferred 
into 96 plate and the dish was cover with optical tape. Finally the plate was carefully 
placed in the thermoblock of Real Time PCR machine. 
The Real Time PCR reactions were run according to the protocol: 
Cycle 1.  1x  95°C for 5 min.   
Cycle 2.  40x 
Step 1 
Step 2 
 
95°C for 30 sec. 
59°C for 30 sec. 
 
Cycle 3.  100x 
Step1 
Step2 
 
50°C for 10 sec. 
increase set point temperature after Step1 by 0.5 °C 
 
Cycle 4.  1x  4°C hold   
 
During  Real Time  PCR  reaction  the  amount  of  amplified  fragment  is  constantly 
measured with help of specific fluorescence dye SYBR Green. The SYBR Green binds 
to double stranded DNA and gives 100 fold brighter fluorescence than alone. This 
allows for non specific visualization of amplified products in real time while running 
the reaction. The fluorescence data are presented as amplification plot (Figure 2.1A). 
To  confirm  that  the  fluorescence  observed  comes  from  one  expected  amplification 
product, the number of amplified products can be visualized by displaying the melting 
curve. Multiple peaks would indicate the presence of multiple amplification products. Materials and Methods 
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In  this  case  the  primers  have  to  be  redesigned  and  tested  again  for  their  target 
specificity.  In  presented  example  presence  of  one  peak  indicates  that  primers  are 
specific for the target conforming that only one sequence is amplified (2.1B). The 
amplification plot displays the relative fluorescence values for each sample at every 
cycle. The reaction cycle number when the reaction start to come into the logarithmic 
phase of amplification curve is called the Ct value (threshold cycle). By comparing the 
Ct value of two samples (Ct1 and Ct2) it is possible to calculate the relative expression 
level of the investigated gene in the samples.  
For  example  one  cycle  difference  would  mean  a  2  fold  relative  increase  in  DNA 
concentration according to the following formula where Relative Fold Expression is 
2
 Ct  where  delta  Ct  is  the  difference  in  cycle  amplification  number  between  two 
compared samples ( Ct = Ct1 Ct2).  
 
Figure 2.1 Analysis of  Real Time PCR data obtained with primers amplifying the Id2 gene. The 
RNA samples isolated  from growing competent and induced HC11 cells were reversed transcribed. The 
cDNAs were used as templates for Real Time PCR reactions run with primer pairs specific for a region 
in the Idb2 gene. (A) Amplification plot (B) Calculated average Ct values for 3 tested stages. Each 
reaction is performed in triplicate. (C) Melting curve graph a single peak indicates amplification of only 
one sequence. (D) Calculation of delta Ct value between growing competent and induced cells. The 
Relative fold expression of candidate gene in compared stages are calculated than according to formula 
2
 Ct where delta Ct is the difference in cycle amplification number between two compared samples ( Ct 
= Ct1 Ct2).  
Ct of Induced is 19 cycle Ct of Growing is 23,1 cycle Ct of Competent is 20,6 cycle
B
A
C D
Ct Growing
Ct Competent
Ct Induced
 Ct  G/C  2.5 
 Ct  C/I   1.6 
 Ct  G/I   4,1 
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2..2.1.16 Addition of restriction sites to cloned sequence using PCR  
Primers were designed (with restriction sites for SacII) for the amplification of a DNA 
fragment encoding a sequence of the target protein. The following PCR mix for each 
amplified fragment was prepared: 1  l dNTPs (10 mM), 0.5  l Forward primer (100 
pmol),  0.5   l  reverse  primer    (100  pmol),  0.5   l  Native  AmpliTaq Polymerase 
(Invitrogen), 5  l 10x AmpliTaq Buffer, 1  l MgCl2 (50 mM) and 10 ng template 
DNA. Sterile water was added to final volume of 50  l. 
The PCR was run using following protocol and lid temperature was set to 95°C to 
prevent evaporation of water from the reaction 
Step 1. 95°C  3 minutes 
Step 2. 95°C   30 seconds  
Step 3. 62°C   30 seconds 
Step 4. 58°C   30 seconds  
Step 5. 54°C   30 seconds 
Step 6. 51°C   30 seconds 
Step 7. 72°C   1 minute  back to step 2 and repeat 30 40 times 
Step 8. 72°C   10 minutes 
Step 9. 4°C  hold  
The size of the product was determined by running 2  l of the PCR reaction on 1% 
agarose gel. The obtained product of the PCR reaction was purified using column kit 
(Qiagen). The purified fragments were eluted in water and store –20°C for further 
applications 
2.2.1.17 Extraction of total RNA from mammalian cell  
The cells were grown in 10 cm dish in CO2 incubator at 37°C in medium containing 
the appropriate regulators for the desired time. At the time point of interest the medium 
was completely removed and 1.5 ml of pegGOLD TriFast
TM  (Peqlab) reagent was 
added to each plate, which was then incubated at 37°C for 2 5 minutes. The cells were 
disrupted by pipetting them up and down with 1 ml tips. The cell lysate was collected 
in a 2 ml microcentrifuge tube and incubated for 5 minutes at room temperature. The 
tube was centrifuged at 12000 x g and 4°C for 10 minutes and the resulting supernatant 
was  transferred  to  a  new  2  ml  microcentrifuge  tube.  To  remove  proteins  300   l 
chloroform  was  added  to  the  sample  and  the  tube  was  shaken  vigorously  for  15 
seconds on a vortex. After a 3 minute incubation at room temperature the tubes were 
centrifuged at 12000 x g at room temperature for 5 minutes.  Materials and Methods 
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The  obtained  clear  upper  phase  was  transferred  to  a  new  1.5  ml  tube  and  750   l 
isopropanol  was  added  to  each  sample.  The  tubes  were  then  gently  shaken  and 
incubated  for  5  minutes  at  room  temperature.  After  the  tubes  were  centrifuged  at 
12000 x g at 4°C for 10 minutes, the supernatant was removed and the white RNA 
pellet was washed with 1 ml of 75% ethanol (for RNA the ethanol solution was diluted 
with RNase free water). The tube was centrifuged at 12000 x g and 4°C for 10 minutes 
and the washing step with ethanol was repeated once more. After the second wash the 
ethanol was carefully removed and the RNA pellet was dried at room temperature for 5 
minutes. Then 50  l of RNase free water was added to the pellet and the tubes were 
incubated for 5 minutes at 60°C or until the RNA pellet was completely dissolved. The 
isolated RNA samples were stored at  80°C for further applications.  
2.2.18 Isolation of RNA and proteins from tissues 
The mammary gland tissue samples were homogenized in Trizol Reagent (Gibco,   
1 ml per 50 100 mg of tissue) using a power homogenizer. The tissue volume did not 
exceed 10% of the volume of Trizol Reagent used for homogenization. The samples 
were  incubated  for  5  minutes  to permit  the  complete  dissociation  of  nucleoprotein 
complexes. Then 0.2 ml chloroform was added (per 1 ml Trizol Reagent) and the 
tubes were vigorously shaken by hand for 15 seconds and incubated for 5 min at room 
temperature. The samples were centrifuged at 12000 x g and 4°C for 15 minutes and 
the resulting colorless upper aqueous phase was transferred to fresh tube. The lower 
red organic phase and white interphase were stored if DNA or protein isolation was 
desired.  After  adding  0.5  ml  isopropyl  alcohol,  the  sample  was  incubated  for  10 
minutes at room temperature. The tubes were centrifuge at 12000 x g for 10 minutes at 
room temperature and the resulting supernatant was removed. The RNA pellet was 
washed by vortexing with 1 ml of 75% ethanol. The samples were centrifuged at 7500 
x g at 4°C for 5 minutes. Finally, the RNA pellet was briefly dried for 5 10 minutes at 
room temperature and dissolved in RNase free water by passing the solution a few 
times through pipette tip and incubating for 10 minutes at 55°C. The red organic and 
the  white  interphase  were  mixed  with  300   l  100%  ethanol  (per  1  ml  of  Trizol 
Reagent). The samples were incubated at 30°C for 2 3 minutes.  
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To sediment the DNA the tubes were centrifuged at 2000 x g at 4°C for 5 minutes. The 
resulting phenol ethanol supernatant contains proteins. To precipitate the proteins 1.5 
ml isopropyl alcohol was added to the phenol ethanol supernatant and the samples 
were incubated for 10 minutes at room temperature. The resulting protein precipitate 
was sedimented by centrifugation at 12000 x g at 4°C for 10 minutes. The supernatant 
was removed and the protein pellet was washed 3 times in 2 ml of a wash solution (0.3 
M guanidine hydrochloride in 95% ethanol).  
The  protein  pellet  was  incubated  in  the  wash  solution  for  20  minutes  at  room 
temperature and centrifuged at 7500 x g and 4°C for 5 minutes. After a final wash, 2 
ml 95% ethanol was added and mixed with the samples by vortexing. The protein 
suspension in ethanol was stored for 20 minutes at room temperature and centrifuged 
at 7500 x g and 4°C for 5 minutes. The protein pellet was dried for 5 10 minutes at 
room temperature and dissolved in 1% SDS by pipetting. The remaining insoluble 
material was sedimented by centrifugation at 10000 x g for 10 minutes at 4°C. The 
obtained  supernatant  containing  proteins  was  transferred  to  fresh  micro  centrifuge 
tube. The protein samples were stored at –20°C for further applications.  
2.2.2 VIROLOGY METHODS 
2.2.2.1 Generation of viral particles 
5 x 10
6 HEK 293T cells were seeded in a 10 cm culture dish and 10 ml DMEM growth 
medium was added to each dish and the cells were cultivate in CO2 incubator at 37°C 
over  night  so  that  at  the  time  of  transfection  the  monolayer  of  cells  were  80% 
confluent. All steps from now were performed in the L2 lab. The HEK 293T were 
transfected  with  three  lentiviral  plasmid  using  the  calcium  phosphate  transfection 
Method. Per 10 cm plate the following plasmids were used: 10  g of pSiEW or pSEW) 
construct, 6.5  g of the packaging construct pCMVR 8.91 as well as 3.5  g of the 
envelope  construct  pMD2G.VSVG.  The  transfected  cells  were  incubate  in  CO2 
incubator  at  37°C  for  16  hours.  The  transfection  efficiency  was  verified  under 
fluorescence microscope. The transfected cells expressed the GFP protein encoded by 
pSEW or pSiEW. After successful transfection (50 to 70% GFP positive cells) the 
plate was used to collect the lentiviral particles. The medium was carefully aspirated 
off and discarded as infectious material. Next, 5 ml of fresh medium was added to each 
culture dish and the cells were incubated in CO2 incubator at 37°C for 16 24 h.  Materials and Methods 
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The next day the culture medium was collected in 50 ml conical tubes and centrifuged 
at 1000 rpm for 5 minutes at room temperature to remove the cell contaminations. The 
obtained supernatant was filtered through a nitrocellulose filter (0,22  m pore size). 
Finally,  1  ml  aliquots  of  filtrated  supernatant  containing  lentiviral  particles  were 
prepared and stored at  80°C for further applications. 
2.2.2.2 Titration of lentiviral particles containing supernatants 
The one day before titration 1 x 10
5 293T cells were seeded in each well of a 24 well 
plate in a DMEM growth medium and were cultivated in CO2 incubator at 37°C over 
night. All steps from now were performed in a laboratory suitable for working with 
infectious  material  under  laminar  flow  hood  (L2  lab).  Serial  dilutions  (1:10  to 
1:10000) of the obtained viral supernatants in the growth medium were prepared. The 
culture medium was carefully aspirated from the 24 well plate and 250  l fresh growth 
medium containing polybrene to final concentration 16  g/ml was immediately added 
to each well. Next 250  l of the prepared serial dilutions were added to each well 
changing  the  tips  each  time  between  adding  different  dilutions.  The  plate  was 
centrifuged at 2500 rpm for 90 minutes at 32°C and incubated for 2.5 hours in CO2 
incubator at 37°C. Then the medium was slowly aspirated and replaced carefully with 
fresh growth medium. The cells were cultured for next 24 to 48h in CO2 incubator at 
37°C. The next day the medium was removed and the cells were washed with 500  l 
1x PBS. The PBS was completely removed and 50  l Trypsin EDTA solution was 
added to each well and the plate was incubated for 3 minutes on a thermoplate at 37°C 
to detach the cells from the plate bottom. Then 500 l of PBS was added to each well 
and  the  cells  suspension  was  collected  into  5  ml  round  bottom  tubes  (Becton 
Dickinson). The tubes were centrifuge at 1000 rpm for 5 minutes at room temperature. 
The  resulting  supernatant  was  removed  and  250   l  of  fixative  solution  (4% 
formaldehyde in 1x PBS) was added to each cell pellet and the tubes were vortexed. 
Samples can be stored at 4°C up to 2 weeks. The samples were analyzed using FACS. 
For proper calculation only values corresponding to less than 20% of positive cells 
were taken for account. The viral titer was calculated using the following formula: 
Transducing Units/ml (TU/ml) = (%positive cells/100%) x Nb of cells x dilution.  
Nb of cells is a number of cells at the day of fixation.  
The MOI (multiplicity of infection) was calculated using the following formula: 
MOI= TU/ml divided by number of transduced cells. Materials and Methods 
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2.2.2.3 Transduction of epithelial cells with lentiviral particles 
10
5 cells were seeded per well of 6 well multi dish so that the plate reached 70% 
confluency at the time of transduction with lentiviral particles. 3 ml of growth medium 
was added to each well and the cultures were incubated in a CO2 incubator at 37°C 
over  night.  All  steps  from  now  on  were  performed  under  laminar  flow  hood  in 
laboratory  suitable  for  working  with  infectious  material  (L2  lab).  To  each  well 
following components were added: 1 ml of supernatant containing proper amount of 
lentiviral particles, 2 ml of medium without antibiotics, 30  l polybrene (stock 400 
 g/ml). The plate was centrifuged at 2500 rpm for 30 minutes at 32°C.  
The cells were then incubated with the lentiviral particles in a CO2 incubator at 37°C 
for the following 8 hours. The medium was discarded (infectious material) and fresh 
growth medium was added to each well. After 24 hours incubation in CO2 incubator at 
37°C the medium was removed again and the fresh growth medium was added to the 
transduced cells. The cells were grown in CO2 incubator at 37°C for another 24 hours. 
Next day the medium was aspirated and the cells were washed with 1x PBS. Finally 3 
ml of warm growth medium was added to each well. The cells can be manipulated 
under L1 cell culture condition. 
2.2.3 PROTEIN BIOCHEMISTRY METHODS 
2.2.3.1 Isolation of proteins using RIPA Buffer  
Mammalian cells were cultivated in a 10 cm dish in a CO2 incubator at 37°C in proper 
medium  and  regulators  for  the  desired  time.  The  medium  was  aspirated  and  the 
adherent cells were washed twice with ice cold 1 x PBS. After the last washing the 
PBS solution was completely removed. The cells were lysed by adding 500  l ice cold 
RIPA buffer and immediately scraped from the plate with a cell lifter. Then the cell 
extract  was  transferred  to  1.5  ml  microcentrifuge  tube.  The  suspension  was  gently 
mixed and incubated on ice for 15 minutes. After centrifugating the cell lysate for 15 
minutes at 14000 x g at 4°C, the resulting supernatant was immediately transferred to a 
fresh  1.5  ml  microcentrifuge  tube.  The  isolated  proteins  were  stored  at  –80°C  for 
further applications.  Materials and Methods 
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2.2.3.2 Determination of the protein concentration 
To prevent degradation of the proteins samples were unfrozen on ice. A commercially 
available  solution  (Protein  Assay  Dye  Reagent  Concentrate,  Bio Rad)  for 
determination of the protein concentration was used. This solution was diluted 1:5 in 
water. To measure the protein concentration a dilution of each sample was prepared by 
adding  5   l  of  protein  extract  and  995   l  of  diluted  reagent.  The  mixtures  were 
incubated  for  3  minutes  at  room  temperature.  The  protein  concentrations  were 
measured at wave length of 260 nm using a spectrophotometer (Bio Rad). The protein 
concentrations were calculated according to a BSA standard. 
2.2.3.3 SDS polyacrylamid gel electrophorese  
Two glass plates were assembled according to the instruction of the manufacturers 
(Bio Rad). A separating gel was prepared with an acrylamide concentration necessary 
for optimal separation of the proteins of interest. The acrylamide solution was poured 
between the assembled glass plates and immediately covered with isopropanol. The gel 
polymerized at room temperature for approximately 30 minutes. The isopropanol was 
removed and the top of the gel was dried with a strip of Whatmann paper. The stacking 
gel was prepare and poured on top of the separating gel. A comb was inserted and the 
stacking  gel  polymerized  for  approximately  30  minutes  at  room  temperature.  The 
comb was removed and the polymerized gel was place into the electrophoresis tank. 
The  tank  was  filled  with  SDS PAGE  running  buffer  until  the  wells  of  gel  were 
submerged. The isolated proteins (40–80  g) were diluted in a proper volume of 4 x 
loading buffer in a 1.5 ml microcentrifuge tube. The samples were heated to 95 100°C 
for 5 minutes and centrifuged for 30 seconds. Then they were carefully loaded on the 
gel using a long thin pipette tip. The chamber was closed with a lid and electrodes 
were connected to the power supply. The gel was run with 50 mA at room temperature 
until the tracking dye had reached 0.5 cm from the bottom of the gel.  The power 
supply was turned off and the gel was removed form glass plates with the help of a 
spatula. The unnecessary stacking gel was cut off with a scalpel. Subsequently, the gel 
was used for western blotting or Coomassie brilliant blue staining. Materials and Methods 
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2.2.3.4 Electro transfer of proteins onto nitrocellulose membranes 
To analyze the proteins separated by SDS electrophoresis they were electro transferred 
onto  a  nitrocellulose  membrane  (Schleicher&Schuell)  using  the  Semi Dry Blotting 
apparatus  (BIO RAD).  Therefore  a  “sandwich”  construction  was  prepared  in  the 
following way. Four filter papers cut in the size of the gel (3 MM Whatmann paper) 
were soaked in anode buffer I and were placed on the anode. Two filter papers (3 MM 
Whatmann) were soaked in anode buffer II and placed on the top pf the first papers. A 
piece of nitrocellulose membrane (0.2  m pore) was wetted in water, washed in anode 
buffer II and placed on top of the paper Stack. Then the separating gel was rinsed in 
cathode buffer and placed on the top of the membrane. 
Finally, four filter (3 MM Whatmann) papers soaked in cathode buffer were placed on 
the top of the gel. The blotting chamber was closed and the proteins were transferred 
for 1 h with 1 mA per cm
2 membrane. Proper transfer was determined by staining the 
membrane with Ponceau S solution (Sigma). 
2.2.3.5 Verification of protein transfer on nitrocellulose membranes  
The nitrocellulose membrane was transferred from the blotting chamber to a flat dish 
containing 10 ml Ponceau S solution (Sigma). The membrane was incubated for 5 
minutes on an orbital shaker or until the proteins bands became visible. Finally, the 
membrane  was  washed  twice  with  15  ml  of  distillated  water  and  analyzed  before 
processing for immuno blotting. 
2.2.3.6 Detection of proteins on a western blot 
After the transfer of proteins from gel to a nitrocellulose membrane, the membrane 
was washed with 10 ml of TBS T wash buffer for 5 minutes at room temperature and 
then incubated in 10 ml of blocking buffer (5% BSA in TBS T) for 30 minutes at room 
temperature. Then it was washed three times with 15 ml of TBS T for 5 minutes each 
and the membrane was incubated with primary antibody (1:1000 dilution in 10 ml 
blocking buffer) with gentle agitation overnight at 4°C. The next day the membrane 
was washed three times with 15 ml of TBS T for 5 minutes each and incubated with 
HRP conjugated secondary antibody (1:5000 dilution in 10 ml of blocking buffer) with 
gentle agitation for 1 hour at room temperature.  
 Materials and Methods 
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The membrane was then washed three times with 15 ml of TBS T for 5 minutes each 
and finally incubated with 1 ml of ECL solution (Amersham) for 1 minute at room 
temperature. The developing solution was removed and the membrane (do not let it dry 
completely) was placed into a plastic cover and exposured to an X ray film. The film 
was developed using an automated developing machine. 
2.2.3.7 Stripping of nitrocellulose membranes 
To remove primary and secondary antibodies bound to a western blot the membrane 
was put into 50 ml conical tube and washed once with 1x TBS T for 5 minutes to 
remove the ECL solution. The TBS T wash buffer was completely removed and 10 ml 
stripping buffer was added. Than the tube was securely closed and the membrane was 
incubated at 55°C in rotating oven for 30 minutes.  
The stripping solution was discarded and the membrane was washed two times with 20 
ml sterile H2O for 10 minutes. Finally, the membrane was washed in 10 ml of TBS T 
for 10 minutes. Subsequently, the membrane can be blocked with blocking buffer and 
used again for detection of another protein of interest.  
2.2.3.8 Preparation of nuclear protein extracts 
The cells of interest were washed 5 ml 1x PBS containing 1 mM EDTA and the wash 
solution was completely aspirated. Then 1 ml of PBS containing 1 mM EDTA was 
added to the dish and the cells were carefully scraped from the plate with cell lifter 
cells. The obtained cell suspension was transferred to 1.5 ml microcentrifuge tube and 
centrifuged at 1000 rpm for 10 minutes at room temperature. The cell pellet was re 
suspended in ice cold buffer A (800  l per 10 cm dish, or 10 volumes of buffer per 1 
volume of cell pellet) to disrupt the cell membranes. The nuclei were collected by 
centrifugation  at  4000  rpm  for  5  minutes  at  4°C.  The  supernatant  containing  the 
cytoplasmic fraction was stored at  80°C. To wash the nuclear fraction 800  l fresh ice 
cold  buffer  A  was  added  to  the  pellet  and  the  nuclei  were  collected  again  by 
centrifugation at 4000 rpm for 5 minutes at 4°C. The resulting nuclear pellet was re 
suspended by adding 300  l of buffer B (per 10cm dish or 1x10
8cells) and vortexing. 
Then  the  nuclear  suspension  was  incubated  for  30  minutes  at  4°C.  Finally,  the 
disrupted nuclei were centrifuged at 12000 rpm for 10 minutes at 4°C and the obtained 
supernatant containing nuclear proteins was stored at –80°C for future applications. Materials and Methods 
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2.2.4 CELL CULTURE METHODS 
2.2.4.1 In vitro differentiation of mammary epithelial cells 
HC11 is a mammary epithelial cell line that can differentiate in vitro. When induced 
with  lactogenic  hormones  the  cells  can  functionally  differentiate  and  express  milk 
proteins for example β casein. The cells were seeded into 10 cm sterile plastic dish and 
cultivated in RPMI 1640 growth medium in the 5% CO2 incubator (98% humidity) at 
37°C  for  2  days  or  until  the  plate  was  confluent.  Then  the  growth  medium  was 
aspirated from the plate and the cells were washed with warm 1 x PBS. The starvation 
medium was added to the dish and the cells were incubated for the next 2 4 days. After 
4 days the starvation medium was removed from the plate and the cells were washed 
twice  with  warm  1  x  PBS.  Finally,  the  cells  were  induced  for  differentiation  with 
induction  medium  with  lactogenic  hormones  and  cultured  for  the  next  4  days. 
Accumulation of β casein mRNA was detected using Real Time PCR after 8 24 h of 
lactogenic stimulation and expression of β casein protein was observed after 4 days of 
induction with lactogenic hormones. 
2.2.4.2 Splitting mammalian adherent cells 
The medium as well as 1 x trypsin EDTA and 1 x DPBS solutions were pre warmed to 
37°C in water bath. One 10 cm plate containing a confluent monolayer of adherent 
cells was chosen and placed under a laminar flow hood. All manipulations with cells 
(open plate)  were performed  under  sterile  condition preventing  contamination  with 
bacteria, fungi and mycoplasm. The growth medium was aspirated from the plate and 
the  cells  were  washed  with  1x  DPBS  by  agitating  the  plate  carefully.  The  wash 
solution was completely removed and 1 ml 1x trypsin EDTA solution was added to the 
plate making sure that the entire surface of the cell monolayer was covered. The dish 
was then incubated on a 37°C thermo plate for 3 5 minutes. In the meantime it was 
checked  if  the  cells  started  to  detach  from  the  bottom  of  the  plate  under  a  phase 
contrast microscope. Then 9 ml of warm growth medium containing 10% FCS (it will 
neutralize activity of trypsin) was added to the plate and the content was mixed by 
pipetting up and down with serological pipette. The cell suspension was transferred to 
15 ml conical tube and centrifuged at 1000 rpm for 3 minutes at room temperature. 
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The resulting supernatant was aspirated and the obtained cells pellet was resuspended 
in 10 ml fresh growth medium. 1 ml of the cell suspension was added to a 10 cm plate 
containing 9 ml of fresh warm growth medium (1:10 dilution). The cells were then 
distributed  evenly  over  entire  plate  surface  by  gently  steering.  The  cells  were 
cultivated in the 5% CO2 incubator (98% humidity) at 37°C until the plate was 90% 
confluent, than the cells were split again.  
2.2.4.3  Isolation  and  culture  of  primary  mammary  epithelial  cells 
from mice 
The isolation of primary mammary epithelial cells was performed in a sterile laminar 
flow hood to prevent the cells from contamination with bacterial or fungi. The mouse 
was anesthetized by an overdose of chloroform. The skin of the animal was sterilized 
by washing its body with 70% ethanol. The mouse was pinned out on sterile dissection 
board. The thoracic (number 2 and number 3), abdominal (number 4) and inguinal 
(number  5)  mammary  glands  were  removed  using  sterile  dissection  tools  and  the 
glands  were  transferred  into  25  ml  DMEM/F12  (100  U/ml  Penicillin  100   g/ml 
Streptomycin 50  g/ml Gentamicin) to keep them moist until all glands from the mice 
were collected. Under sterile condition the isolated glands were placed on a glass slide 
and  all  muscles  and  lymph  nodes  were  carefully  removed.  The  gland  tissue  was 
chopped into very small pieces using sterile scalpel blades. The minced tissue was 
transferred into a round bottom Erlenmeyer flask containing digestion medium and the 
tissue  suspension  was  incubated  for  1 3  hours  or  until  the  tissue  was  thoroughly 
digested at 37°C on a shaker set to 125 rpm. When the tissue was completely digested 
it  appeared  as  a  cloudy  homogeneous  solution.  The  digested  tissue  mixture  was 
transferred into a 50 ml conical tube and centrifuged at 1000 rpm (200 x g) for 5 
minutes. The resulting supernatant was removed and the cells were resuspended in 
cold F 12 medium (containing 50  g/ml Gentamicin) and centrifuged again at 1000 
rpm for 5 minutes. The obtained cell pellet was than resuspended in 5 ml of 2 x plating 
medium. Finally, around 2.5 5.0 x 10
5 cells per cm
2 of the plate were seeded on the 10 
cm dish containing 5 ml serum fetuin mix (20% fetal calf serum, 1 mg/ml fetuin in F 
12 medium). After 24 h incubation in 37°C the culture medium was aspirated and 
replaced with fresh warm growth medium. Materials and Methods 
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For proper growth and differentiation of primary mammary epithelial cells in vitro the 
cells  require  the  addition  of  extracellular  matrix.  Rat  Tail  Collagen  Type  I  and 
Matrigel used in this study were purchased from Becton Dickinson Biosciences. To 
coat the plastic 10 cm dishes with a thin collagen layer the gel was diluted in ice cold 1 
x DPBS to a final concentration 80  g gel/ml. 100  l of prepared collagen dilution was 
used to cover 1 cm
2 of the dish surface. The gel was allowed to polymerize overnight 
at 4°C.  
The next day the gel was washed two times with ice cold 1 x DPBS and once with F 
12 medium and finally the collagen layer was covered with 5 ml serum fetuin mix 
(20% fetal calf serum, 1 mg/ml fetuin in F 12 medium). Plates were then ready for use. 
To cover plastic dish with a thin layer of Matrigel, the stock of Matrigel had to be 
thawed at 2 8°C overnight. Matrigel gels rapidly at room temperature so pre cooled 
plates and pipettes tips were used and the gel stock was always kept on ice. The gel 
stock was initially diluted 1:2 in serum free F 12 medium. 50  l of prepared matrigel 
dilution was used to cover 1 cm
2 of plastic dish. The plates coated with the matrigel 
dilution were then incubated at 37°C for 30 minutes. The plate was then ready and was 
used immediately.  
To induce functional differentiation of the primary epithelial cells they were cultivated 
on the plates  coated  with extracellular matrix in primary mammary epithelial cells 
growth  medium  until  they  reached  confluency.  Then  the  cells  were  induced  for 
functional differentiation by adding a lactogenic hormone mix containing prolactin (5 
 g/ml), insulin (5  g/ml), hydrocortisone (1  g/ml). The increase in β casein mRNA 
was measured after 8 h and the expression β casein protein 4 days after stimulation 
with lactogenic hormones. 
2.2.4.4 Freezing and thawing mammalian cells 
The medium as well as 1 x trypsin EDTA and 1 x DPBS solutions were pre warmed in 
a water bath set to 37°C. All subsequent steps were performed in a laminar flow hood. 
One 10 cm plate containing a confluent monolayer of adherent cells was used to make 
frozen cell stocks. The medium was removed from the plate and the cells were washed 
with  warm  1  x  DPBS.  The  washing  solution  was  completely  aspirated  and  1  ml 
trypsin EDTA solution was added to the plate making sure that entire surface of the 
cell monolayer was covered.  Materials and Methods 
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The dish was incubated on a thermo plate at 37°C for 3 5 minutes or until the cells 
started to detach from the plate (if cells are not adherent the trypsin is not needed).To 
inactivate the trypsin 9 ml medium containing 10% FCS was added to the plate and the 
plate content was mixed by gentle pipetting up and down. The cell suspension was 
then transferred to a 15 ml conical tube, and centrifuged at no more than 1000 rpm for 
3 minutes at room temperature. The resulting supernatant was removed and the cell 
pellet was resuspended in 1 ml freezing buffer (5% DMSO 95% FCS). Finally, the 
cells were transferred to 2 ml labeled cryo tubes and were stored at  80°C. For long 
term storage of stocks the cells were frozen in liquid nitrogen.  
To cultivate the cells from frozen stocks the frozen cells were treated according to the 
following protocol. The frozen cells were melted quickly by incubating the vial in a 
water bath set to 37°C. The cell aliquot was transfer to 15 ml conical tube and 9 ml of 
growth medium was added drop by drop to the cells, preventing osmotic shock. To 
remove  the  DMSO  the  tube  was  centrifuged  at  1000  rpm  for  5  minutes  and  the 
supernatant was removed. The obtained cell pellet was resuspended in 10 ml of warm 
growth medium and seeded into culture dish. 
2.2.4.5 Three dimensional culture of mammary epithelial cells 
The cells were cultured in a CO2 incubator at 37°C in sterile 10 cm dish with 10 ml of 
growth medium. When the plate reached 90% confluency the cells were detached with 
trypsin solution and the cell suspension was transferred in a 15 ml conical tube and 
spun down using microcentrifuge at 1000 rpm for 3 min at RT. The cell number per ml 
was then estimated using a special cell counter chamber (Marienfeld). After counting 
the cells suspension was diluted in RPMI 1640 medium containing 10% FCS to a cell 
density of 5 x 10
4 cells/ml in a sterile 15 ml conical tube. 100  l of this cell suspension 
was transferred into fresh sterile 1.5 ml microcentrifuge tubes and mixed with an equal 
volume (100  l) of ice cold collagen (Becton Dickinson). The cells were mixed with 
the collagen by gently pipetting up and down, very carefully without generating air 
bubbles. Quickly 100  l of the performed collagen/cells suspension was dispensed as a 
drop into the center of each well of a 12 well plate without leaving air bubbles on the 
top of the gels. The collagen was then let to polymerize at room temperature for 10 
min  (the  gel  turns  milky)  without  shaking  or  moving  as  leading  to  homogenous 
polymerization.  Materials and Methods 
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The plate was then placed in the incubator (37°C) for at least 30 min to let the gel 
completely  polymerize.  After  the  polymerization  was  completed  500   l  of  growth 
medium was  carefully and slowly  added to  each well. The medium should not be 
blown onto the gel as this might detach or destroy it. The medium was refreshed every 
other  day.  Three  dimensional  growth  was  observed  using  a  contrast  phase  or 
fluorescence microscope. 
2.2.4.6 Proliferation assay 
For this assay the XTT based proliferation kit II (Roche) was used. 5 x 10
3 mammalian 
cells were seeded in a flat 96 well plate. For each sample drug concentration and time 
point triplicates were prepared. To each well 100  l of warm growth medium was 
added and the cells were cultivated in CO2 incubator at 37°C for desired time. At the 
time point of interest the XTT reagent solution and the activation solution (Roche) 
were defrosted immediately prior to use in a 37°C bath and swirled gently until clear 
solutions were obtained. To prepare the reaction solution, 100  l of activation solution 
were  mixed  with  5  ml  XTT  reagent.  The  reagent  solution  allows  for  detection  of 
metabolic active cells. 50  l of the freshly prepared reaction solution was than added 
to each well and the plate was incubated in the CO2 incubator for 2 5 hours at 37°C. 
After this incubation the plate was gently shaken to equally distribute the dye in the 
wells. The absorbance of the samples was measured with a spectrophotometer (ELISA 
reader, Molecular Devices Corporation) at a wavelength of 490 nm. 
2.2.4.7 Luciferase Assay 
The  cells  were  cultivated  in  10  cm  dish  in  a  CO2 incubator  at  37°C  with  proper 
medium and regulators. At the time point of interest the medium was removed and the 
cells were washed two times with ice cold 1x PBS. After the second wash the PBS 
solution  was  completely  aspirated.  Just  before  use  the  luciferase  lysis  buffer  was 
prepared by adding 1/1000 volume of 1M DTT. Then, 300  l of ice cold luciferase 
lysis  was  added  to  the  plate.  The  cells  were  scraped  off  and  transferred  to  a  1.5 
microcentrifuge tube. The sample was stored on ice for 10 min and mixed from time to 
time during the incubation.  
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The sample was centrifuged for 10 minutes at full speed at 4°C in a microcentrifuge 
and the resulting supernatants were transferred to a new 1.5 ml microcentrifuge tube. 
10   l  of  supernatant  was  dropped  into  well  of  a  96 well  plate,  for  each  sample 
triplicates were prepared. Then, luciferase substrate was added to each sample and the 
luminescence was immediately measured with an integration time of 10 15 seconds in 
a microplate luminometer (Berthold Technologies). 
2.2.4.8 Transfection of mammalian cells with Lipofectamine  
To transfect the HC11 cells with plasmid DNA the commercially available transfection 
reagent  Lipofectamine
TM  (Invitrogen)  was  used.  The  day  before  transfection  the 
adherent HC11 cells were plated in a 12 well plate in 1 ml of growth medium without 
antibiotics so that at time of transfection the plate would be 90% confluent. The cells 
were than cultivated in a CO2 incubator over night at 37°C. The next day 1.6  g of 
plasmid DNA and 100  l of Opti MEM Medium (Invitrogen) or other serum free 
medium was gently mixed by pipetting up and down in a 1.5 ml microcentrifuge tube. 
Next, 4  l of Lipofectamine
TM was diluted in 100  l of Opti MEM Medium (or other 
medium  without  serum)  and  the  suspension  was  incubated  for  5  minutes  at  room 
temperature.  
The diluted DNA sample was combined with the diluted Lipofectamine
TM and the tube 
was  incubated  for  20  minutes  at  room  temperature  to  allow  DNA Lipofectamine 
complexes to form. Finally, 100  l of DNA Lipofecamine complexes were spread into 
each well drop by drop and then mixed with the medium by gently rocking the plate 
back  and  forth.  The  transfected  cells  were  placed  in  the  5%  CO2  incubator  (98% 
humidity) at 37°C and incubated for 24 48 hours until they were ready to be analyzed 
for expression of the transfected gene.  
2.2.4.9 Transfection with Polyethylenimine  
To  test  the  different  transfection  reagents  in  mammary  epithelial  cells  the  PEI 
(Polyethylenimine, Sigma) was used. One day before transfection the HC11 cells were 
seeded in 10 cm plate so that the plate should be 80% confluent the next day. To 
prepare the DNA PEI suspension mix for 10 cm dish Solution A containing 16  g 
DNA dissolved in 240  l 1x PBS was mixed with Solution B containing 45  l 10 mM 
PEI in 240  l 1x PBS and vortexed.  Materials and Methods 
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The suspension was incubated for 15 minutes at room temperature. In the meantime 
the medium was aspirated from the plate and the cells were washed with 5 ml of 1 x 
PBS and finally 5 ml of fresh growth medium was added to the plate. The prepared 
DNA PEI suspension was very carefully added drop by drop around the whole surface 
of the cells monolayer. The transfected cells were incubated in the 5% CO2 incubator 
(98% humidity) at 37°C for 3 hours. The medium was then aspirated from the plate 
and replaced with 10 ml fresh and warm growth medium. After 24 48 h of incubation 
the transfection efficiency (the percent of GFP positive cells) was monitored under the 
fluorescence microscope. 
2.2.4.10 Transfection with Calcium Phosphate 
To transfect lentiviral plasmids mostly the calcium phosphate transfection method was 
used. The day before transfection 5x10
6 adherent HEK 293T cells were seeded per 10 
cm plate, so at the time of transfection the plate is 80% confluent. 10 ml DMEM 
growth medium was added to the plate and the cells were cultivated in CO2 incubator 
at 37°C over night. Two hours before transfection the medium was aspirated from the 
plate and replaced with 5 ml fresh DMEM growth medium. For the production of viral 
particles a transfection mix was prepared containing, 10  g of vector pSiEW or pSEW 
encoding siRNA or gene of interest, and 6.5  g of core packaging plasmid pCMVR  
8.91 as well as 3,5  g of plasmid pMD2 VSVG encoding envelope components. All 
plasmids were added to 450  l of dpH2O (Sigma) in a 10 ml sterile round bottom 
conical tube. Finally, 50  l of 2.5M CaCl2 were added to the tube. To precipitate the 
plasmid DNA 500  l of 2 x HBS solution, were added drop by drop (one drop per 
sec.)  while  blowing  air  through  the  prepared  DNA CaCl2  suspension  with  a  2  ml 
serological sterile pipette mounted in automatic air pipettor. After adding of 500  l 2x 
HBS solution, the obtained 1 ml transfection mix was bubbled for additional 1 minute 
and than incubated for 15 min at room temperature. In the meantime 1  l of 100 mM 
chloroquine was added to the HEK 293T cells cultured in the 5 ml of medium. The 
precipitated DNA solution (1 ml) was slowly added to the cells. The transfected HEK 
293T cells were incubated in CO2 incubator at 37°C over nigh but no longer than 16 h. 
The  next  day  the  medium  was  aspirated  and  replaced  with  fresh  DMEM  growth 
medium. The transfection efficiency was monitored by checking the expression of the 
GFP protein under fluorescence microscope.  Materials and Methods 
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The culture medium containing the lentiviral particles was collected for following 48 
hours.  After  filtration  and  virus  titration  the  medium  was  used  for  transduction  of 
mammary epithelial cells.  
2.2.5 HISTOCHEMICAL METHODS 
2.2.5.1 Preparation of mammary gland whole mounts 
For  staining  of  mammary  glands,  abdominal  gland  (number  4)  was  removed  from 
treated and control mice. The glass slides were labeled with specimen code using a 
diamond tipped pencil. The isolated mammary glands were spread on labeled glass 
slides making sure that the edges of the glands were completely stretched. The glands 
were dried for 10 min at room temperature so they attached the glass. The slides with 
the mammary gland were then fixed for 16 to 24 hours in formalin fixative. The next 
day to re hydrate the gland tissue the slides were washed in the 70% ethanol for 15 
minutes  and  after  that,  transferred  to  50%  ethanol  and  incubated  for  15  minutes. 
Finally, the slides were washed in 25% ethanol for 15 minutes. The glands tissue was 
stained with Hematoxylin solution (colors basophilic structures with blue purple hue) 
over night and than eosin (colors eosinophilic structures bright pink) for 2 hours. After 
staining the slides were washed in 70%, and then 95% ethanol for 15 minutes in each 
concentration.  The  glands  were  mounted  and  covered  with  cover slip.  The  gland 
structure were analyzed under light microscope. 
 
. 
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2.3 INSTRUMENTATION  
Manufactures  Instrument name 
Beckman  GPKR Centrifuge  
Avanti
TM J 20  Megacentrifuge 
L8 80M Ultracentrifuge  
Berthold Technologies  MICROLUMAT LB96P luminometer  
Bio Rad 
 
ICycler iQ
TM Thermal Cycler  
My iQ
TM Thermal Cycler Single 
SmartSpec
TM 3000 spectrophotometer 
SmartSpec
TMPlus spectrophotometer 
GelDoc2000 gel scan system 
TRANS BLOT® Semi dry transfer cell 
Molecular Imager®FX western blot scanner  
Brand  Handy Step Electronic automatic dispenser 
Eppendorf  
 
Thermomixer 5436 
Thermomixer Compact 
Centrifuge 5417C 
Centrifuge 5417R 
Gilsion  1000 l, 200 l, 20 l,10 l and 2 l pipetmans  
Heidolph  Polymax 2040 shaking plate 
Heraeus Instruments  Heraeus SEPATECH Megafuge 1.0  
Heraeus SEPATECH Megafuge 1.0R 
HERA Safe Typ HS 12/2 cell culture hood 
CO2 Incubator Typ BB6220CU  
Heraeus  80°C freezer Model No 75007693 
Herolab  TRANSILLUMINATOR UVP Model: TM 20  
Hettich   UNIVERSAL 16R centrifuge  
Janke&Kunkel IKA® 
Labortechnik 
ULTRA TURRAX T25 ultramixer for tissue 
IKA COMBIMAG RET magnetic mixer 
VIBROFIX UF1 ELECTRONIC vortex 
Julabo Labortechnik   JULABO VC Typ VC/3 CIBA heater for water bath 
JULABO 12B Typ VC/3 BRUE.12/20B water bath  
Las Laborapparate  PRÄZITHERM Typ PZ60 thermoplate in cell culture 
Marienfeld   Cell counter chamber 0.100 mm x 0.0025 mm
2 
Mettler Toledo   METTLER PM4800 DeltaRange® balance  
METTLER AE 240 balance  
Molecular Devices 
Corporation 
SPECTRAmax
TM Microplate Spectrophotometer System 
MS Laborgeräte 
 
Optimax Typ TR film developing machine 
ΦpH Meter  
New Brunswick 
Scientific  
Incubator shaker G25 
Nikon 
 
Super High pressure mercury lamp power supply HB 10104 AF  
Power Supply white light  TE PSE100  
Nikon ECLIPSE TE300 fluorescent microscope 
Nikon DIAPHOT PHASE CONTRAST ELWD 0.3 No.133819  
Perkin Elmer   Gene Amp PCR System 9600  
Prutscher  Laboratory hood 
Revco Scientific Inc.   80°C Freezer ULT1786 5 V14 
Scotsman  Ice machine 
Sony®  Progressive 3CCD Color Video Camera DXC 91100P 
Whatman Biometra®  T3 Thermocycler  Advanced Multi Block Thermocycler 
Oven chamber used for stripping of cellulose membranes  
WILL WETZLAR  
GELMAN 
INSTRUMENT 
Wilovert® No.96792 microscope  
GELAIRE Laminar air flow Class100 cell culture hood 
GELAIRE® FLOW LaboratoriesTyp BSB 6A cell culture hood  
WTB Labortechnik   CO2  Incubators for cell culture, controller version E045.06.984 Results 
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3. RESULTS 
The  proper  development  of  the  mammary  gland  requires  a  tight  coordination  of 
expression of many genes involved in proliferation and differentiation. The aim of this 
work was to identify novel genes and proteins as well as signaling pathways involved 
in the development of the mouse mammary gland and to find a possible correlation 
between  the  pathway  components  and  their  downstream  targets  that  are  activated 
during proliferation and/or differentiation of mammary epithelial cells. In this study 
rapamycin has been used to specifically inhibit the mTOR pathway to analyze its role 
in mammary gland proliferation and differentiation (Chapter 3.1 to 3.3). Furthermore, 
a  genomic  approach was used to identify novel genes differently  expressed during 
mouse mammary epithelial cells proliferation and differentiation (Chapter 3.4).  
3.1 The role of mTOR signaling in mammary epithelial cells 
During  development  of  the  mammary  gland  the  epithelial  cells  first  extensively 
proliferate  in  order  to  form  ducts  and  alveoli.  Finally  the  cells  differentiate,  they 
become functional and start to secrete milk proteins. The mTOR signaling pathway has 
been  shown  to  be  implicated  in  the  regulation  of  many  crucial  cellular  processes. 
However, the role of the mTOR pathway in mammary gland development has not been 
studied  before.  In  order  to  study  the  role  of  the  mTOR  pathway  in  growth  and 
functional differentiation of mammary epithelial cells in vitro HC11 cells were used. 
This is an established mammary epithelial cell line able to proliferate and differentiate 
in vitro. These cells were originally isolated from a mid pregnant mouse and have been 
optimized for in vitro cultivation. The HC11 cells proliferate well on plastic dishes and 
when they are induced with a mix of lactogenic hormones (Dexamethasone, Insulin 
and Prolactin) they are able to express the milk protein β casein. This indicates that 
these cells are able to terminally differentiate in vitro.  
To study the role of mTOR signaling during proliferation, morphological and terminal 
differentiation of mammary epithelial cells in vitro, the HC11 cells were treated with 
rapamycin. This is a very specific inhibitor of mTOR, which can prevent the activation 
of downstream targets by mTOR.  
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3.1.1 Activation of mTOR in proliferating and differentiating HC11 cells 
To  study  the  role  of  mTOR  signaling  during  proliferation  and  differentiation  of 
mammary epithelial cells, the amount of phosphorylated mTOR in HC11 cells was 
analyzed. Therefore, the HC11 cells were cultivated in growth medium for 2 days, then 
the  medium  was  changed  to  starvation  medium  and  the  cells  were  cultivated  for 
additional 4 days. At this stage the cells reach the competent stage and can be induced 
with lactogenic hormones (DIP) for the next 4 days. This will lead to the functional 
differentiation of HC11 cells. Every day and from all three stages protein extracts were 
prepared  with  RIPA  buffer  (growing  (proliferation)  stage,  competent  stage,  and 
induced stage). The total protein extracts were than used for western blot analysis with 
an  anti mTOR  antibody  specific  for  mTOR  phosphorylated  at  Ser2488.  To  verify 
proper differentiation of the mammary epithelial cells the blots were also incubated 
with an antibody specific for β casein. High expression of the milk protein β casein 
indicates that the induction of terminal differentiation was successful. To check equal 
loading of the samples, the membrane was stripped and re probed with anti β tubulin 
antibody.  
 
Figure 3.1 Phosphorylation of mTOR in mammary epithelial cells. The HC11 cells were grown for 
2 days, brought to competency for 4 days and than induced for differentiation with lactogenic hormones 
(DIP). Protein extracts from each stage (growing, starvation (competent), and induced) were isolated 
and  western  immuno blotted  with  anti  Phospho  Ser2488 mTOR  antibody.  To  confirm  functional 
differentiation of the treated cells, blots were also incubated with β casein antibody. To confirm equal 
loading of the samples the blots were stripped and reprobed with anti β–tubulin antibody. 
 
The western blot (Figure 3.1) shows that the described treatment of the cells indeed 
induces  the  expression  of  β casein.  This  shows  that  it  is  possible  to  mimic  the 
differentiation  of  mammary  epithelial  cells  by  using  HC11  cells  and  lactogenic 
hormones. It also shows that mTOR is active at a low level in proliferating (growing) 
and competent cells (days 1 4).  
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However, during induction with lactogenic hormones the amount of phosphorylated 
mTOR increases. This experiment indicates that mTOR signaling is mainly involved in 
the regulation of differentiation of mammary epithelial cells.  
3.1.2 Influence of mTOR on expression of β β β β casein during differentiation 
of mammary epithelial cells 
As shown above, HC11 is a mammary epithelial cell line which is able differentiate 
upon stimulation with lactogenic hormones. As shown in Figure 3.1 the successful 
induction of differentiation can be monitored by checking the expression of the milk 
protein  β casein.  It  is  commonly  used  as  a  marker  of  functionally  differentiated 
mammary epithelial cells in vitro. The previous experiments showed that mTOR is 
strongly activated upon induction with lactogenic hormones and therefore, may play an 
important role during differentiation of HC11 cells. To confirm this idea the activity of 
mTOR was inhibited by the addition of rapamycin (1 or 10 nM) during starvation 
and/or DIP induction. As a control equivalent amounts of DMSO (drug solvent) were 
added. Protein extracts of HC11 cells in different stages were analyzed in a western 
blot for the presence of β casein protein.  
The first 3 lanes Figure 3.2A show that β casein expression is induced if cells are 
treated  with  DIP.  However,  if  cells  are  treated  with  rapamycin  and  induced  with 
lactogenic hormones they are not able to synthesize β casein protein and therefore are 
not  functionally  differentiated.  Rapamycin  treatment  prevents  the  expression  of  β 
casein if the drug was added 4 days before induction of differentiation (lane 8) or just 
before  activation with lactogenic hormones (lane 6). The control cells treated with 
DMSO  (lanes  7  and  9)  expressed  β casein  at  a  level  comparable  with  untreated 
differentiated  cells  (lane  3).  This  experiment  was  performed  using  1  or  10  nM 
rapamycin and both treatments gave the same results.  
The  western blot  experiment  with  extracts  from  rapamycin  treated  HC11  cells  has 
shown that mTOR influences the amount of β casein on the protein level. Although 
mTOR is known to regulate the activity of components of the translation machinery it 
was of interest to investigate if rapamycin treatment also influences the transcription of 
the milk gene by reducing the level of β casein mRNA synthesis. Therefore, total RNA 
was isolated from the same HC11 cells as described in figure 3.2A.  
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A semi quantitative reverse transcription PCR reaction was performed with primers 
specific for β casein. Primers amplifying GAPDH were used as an internal control to 
verify the use of equal amounts of mRNA in each reaction. 
The PCR products were analyzed on an agarose gel and  as shown in  Figure 3.2B 
rapamycin treatment  (lanes 6 and 8)  clearly prevents the  accumulation of β casein 
mRNA during induction of HC11 cells for differentiation. From mRNA extracts of 
untreated and induced HC11 cells (lane 3) or control cells treated with DMSO (lanes 7 
and 9) it was possible to amplify the β casein cDNA. The reverse transcription PCR 
experiment  shows  that  inhibition  of  mTOR  down  regulates  the  transcription  or 
influences  mRNA  stability  of  the  β casein  gene.  The  results  confirm  that  mTOR 
signaling  is  essential  for  functional  differentiation  of  HC11  cells  as  shown  by  the 
expression of β casein.  
 
Figure  3.2  Rapamycin  blocks  the  expression  of  the  milk  protein  β β β β casein  during  induction  of 
differentiation  in  HC11.  (A)  Total  protein  was  extracted  from  growing  (proliferating)  (lane1) 
competent (lanes 2,4,5) and differentiated (lanes 3,6,7,8,9) HC11 cells treated with rapamycin or as a 
negative  control  DMSO.  As  indicated  the  HC11  were  treated  with  rapamycin  4  days  before  the 
induction (lane 8) or the drug was added just before activation with the lactogenic hormones (lane 6) 
The protein concentration  were estimated by  spectrophotomerty. 40   g of each protein extract  was 
loaded and separated on 12% SDS PAGE gel. The gel was blotted on a nitro celulose membrane which 
in turn was incubated with anti β casein antibody. To control equal loading of the sample the membrane 
was stripped and reprobed with an antibody specific for β tubulin. (B) The RNA was isolated from 
growing competent and cells induced for differentiation treated with rapamycin or DMSO. The RNA 
samples were used in reverse transcription PCR run with primers specific for β casein or GAPDH as a 
control. The reaction products were separated on 1.2% agarose gel and visualized by EtBr staining. 
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3.1.3 Effect of rapamycin on β casein mRNA stability  
The inhibition of mTOR with rapamycin has a clear effect on the β casein expression. 
The  down regulation  of  β casein  mRNA  could  be  caused  by  the  fact  that  mTOR 
influences the post transcriptional processing of mRNA making it less stable. To test 
this theory the effect of rapamycin on β casein mRNA stability was studied in HC11 
cells. To block transcription of mRNA a potent inhibitor of transcription actinomycin 
D,  was used in the following experiment. HC11 cells were grown to competent stage 
and were than induced for differentiation with lactogenic hormones. After 16 hours of 
stimulation a mixture of actinomycin D and rapamycin or actinomycin D and DMSO 
was added to the medium. The control cells were treated with a mixture of ethanol 
(solvent  for  actinomycin  D)  and  rapamycin  or  equivalent  mixture  of  ethanol  and 
DMSO, so the inhibitory effects of actinomycin D could be compared to the control. 
The  addition  of  actinomycin  D  blocks  the  transcription  process  and  the  gradual 
degradation of mRNA can be measured over time. Therefore total RNA was isolated at 
several  time  points  after  drugs  treatment.  The  amount  of  β casein  transcripts  was 
analyzed using Real Time PCR at each time point. 
 
Figure 3.3 The influence of mTOR on the stability of β casein mRNA The HC11 cells were induced 
for differentiation in presence of combinations of rapamycin (10 nM) and Actinomycin D (1 g/ml) and 
their solvents ethanol and DMSO. Total RNA was isolated at indicated time points after treatment. The 
reverse transcription of mRNA was followed by a Real Time PCR performed with primers specific for 
β casein cDNA.  
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The obtained cDNA samples were used in a Real Time PCR reaction performed with a 
primer  pair  specific  for  β casein.  The  results  obtained  in  these  Real Time  PCR 
reactions  were  normalized  against  18S  ribosomal  mRNA.  The  obtained  data  are 
presented  as  graph  in  Figure  3.3.  The  actinomycin  D  effectively  inhibited  the 
transcription of the β casein gene as seen in treated cells (yellow and light blue curve 
on  the  graph).  Rapamycin  had  no  de stabilizing  effect  on  β casein  mRNA  in 
actinomycin treated cells (light blue curve) when compared with cells treated with 
Actinomycin D and DMSO (yellow curve). An effect of rapamycin was only visible 
when transcription was active (dark blue and pink). After around 1h the cells treated 
with rapamycin (pink curve) stopped accumulating β casein mRNA when compared 
with control (dark blue curve). These results indicate that mTOR has no influence on 
the stability of the β casein mRNA, since the inhibition of mTOR by using rapamycin 
did not change the amount of β casein mRNA. The question why β casein mRNA is 
reduced upon mTOR inhibition is therefore still open.  
 
3.1.4 Influence of mTOR on the morphology of mammary epithelial cells  
Several  mammary  epithelial  cell  lines  have  been  shown  to  differentiate 
morphologically  when  seeded  in  three  dimensional  (3D)  culture  systems.  Upon 
hormonal stimulation, the cells form structures similar to the glandular organization of 
the mammary gland in vivo. To test the influence of mTOR on the morphology of 
differentiated  mammary  epithelial  cells  it  was  necessary  to  investigate  the  normal 
morphology of HC11 cells in 2D and 3D culture systems.  
3.1.4.1 The morphology of HC11 cells in 2D and 3D cultures 
To study morphological changes during differentiation the HC11 cells were seeded 
either on plastic dishes (2D) or in a collagen gel (3D). Collagen served as a three 
dimensional matrix for cell growth.  
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Figure 3.4 Comparison of HC11 cultured on plastic and in collagen gel. (A) HC11 cells growing for 
24  h  on  plastic  dish.  (B)  HC11  cells  in  confluent  stage  after  4  days.  (C)  HC11  cells  induced  for 
differentiation with lactogenic hormones for 4 days, a mammosphere (arrow) present in the middle of 
picture. (D) HC11 cells growing three dimensionally for 4 days in collagen. (E) Branching structures 
formed by HC11 cells induced for morphological differentiation in collagen after 8 days. 
 
The  cultures  on  plastic  and  in  collagen  gels  were  analyzed  in  a  phase  contrast 
microscope at several time points (Figure 3.4). In dishes, the cells proliferate (A) until 
they fill all available space and the plate become confluent (B). The HC11 cells are 
very  compact,  forming  a  tight  monolayer.  When  induced  for  differentiation  with 
lactogenic  hormones  the  HC11  cells  occasionally  form  “domes”  also  called 
mammospheres. In 3D cultures the growing cells first clumped together and formed 
globular structures (D). When induced for differentiation the cells formed branch like 
structures (E). These branches resemble thin ducts seen in the mammary gland. 
3.1.4.2 Influence of mTOR on the morphology of HC11 cells in 3D culture 
The previous experiment showed that HC11 cells, like other mammary epithelial cell 
lines, when seeded in a three dimensional matrix are able to build structures that are 
similar  to  ductal  structures  formed  by  epithelial  cells  during  mammary  gland 
development. As matrix for 3D cell culture the rat tail collagen type I or matrigel® are 
commonly used. To test the effect of mTOR on the formation of branch like structures 
the  HC11  cells  were  seeded  within  collagen  or  matrigel.  After  2  days  the  growth 
medium was changed to starvation medium and cells were cultured for next 4 days to 
obtain competent cells. Then, induction medium with fresh lactogenic hormones were 
added to the cells for next 8 days of culture with or without rapamycin. After the 
incubation the gels were analyzed under the light microscope.  
mammosphere 
A  B 
C  D 
E Results 
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Untreated HC11 cells are able to form duct like structures in collagen and matrigel. 
The  morphology  resembles  that  of  the  ductal  tree  in  mammary  gland.  In  contrast, 
HC11 cells treated with Rapamycin were not able to form any structures neither in 
collagen nor in matrigel. These results indicate that mTOR plays an important role in 
the morphological differentiation of mammary epithelial cells.  
 
Figure 3.5 Rapamycin inhibits the morphological differentiation of HC11 cells in 3D cultures. 
Around  2000  cells  were  seeded  in  collagen  or  matrigel  in  12 well  plate  and  were  stimulated  for 
differentiation with lactogenic hormones in the absence (DMSO control) or presence of rapamycin (10 
nM). After 8 days of stimulation the gels were analyzed under the phase contrast microscope. 
  
3.1.5 Influence of mTOR inhibition on the proliferation of HC11 cells 
The analysis of HC11 cells in 3D cultures indicated that mTOR plays an important role 
in  the  regulation  of  morphological  differentiation  of  mammary  epithelial  cells. 
Inhibition  of  mTOR  signaling  in  HC11  cells  by  rapamycin  evidently  reduced  the 
formation of branch like structures in collagen as well as in matrigel®. The rapamycin 
treated cells possibly proliferate slower than controls and therefore the effect of mTOR 
inhibition  on  the  proliferation  of  HC11  cells  was  analyzed.  Possibly,  the  lack  of 
branch like  structures  is  due  to  the  negative  effect  of  rapamycin  on  the  ability  of 
mammary epithelial cells to proliferate. Therefore, HC11 cells were seeded in 96 well 
plates in growth medium. After overnight incubation rapamycin or DMSO (control) 
was added to the culture medium and the cells were incubated for the next 96 hours.  
Collagen                                   Matrigel 
+Rap 
   Rap Results 
  91 
The amount of proliferating cells was measured every 24 hours starting from the time 
point when the drug was added (0 h). For this, an XTT assay was used, which detects 
metabolically active cells.  
 
Figure 3.6 Rapamycin reduces proliferation of mammary epithelial cells.  Around 5000 cells were 
seeded  per  one  well  of  96 well  plate  in  growth  medium  and  cultivated  in  presence  of  Rapamycin 
(10nM)  or  DMSO  (control)  for  96  hours.  The  amounts  of  living  and  metabolic  active  cells  were 
measured at indicated time points with XTT proliferation assay.  
 
As shown in Figure 3.6 the inhibition of mTOR by rapamycin has a negative effect on 
the proliferation of mammary epithelial cells. The control cells were able to proliferate 
much faster so the difference between the amounts of proliferating control and treated 
cells  visibly  increased  with  time.  The  obtained  results  indicated  that  the  observed 
reduction  in  the  development  of  branch like  structures  in  3D  cultures  was  at  least 
partly due to the inhibition of cell proliferation. The next question to be answered was, 
which downstream targets of mTOR are involved in the regulation of proliferation and 
differentiation. 
3.1.6 The influence of mTOR on the Stat5 signaling pathway 
The  HC11  cells  treated  with  rapamycin  were  not  able  to  express  milk  proteins 
indicating that mTOR is essential for the activation of pathways allowing the terminal 
differentiation of mammary epithelial cells. It was therefore interesting to investigate 
how mTOR controls these pathways. The prolactin pathway has been shown to be 
essential  for  the  transcriptional  activation  of  the  milk  protein  genes  (Rosen  and 
Wyszomierski  1999).  The  prolactin  hormone  binds  to  the  prolactin  receptor  (PR), 
which  leads  to  the  activation  of  the  associated  Jak2  kinase  and  in  turn  to  the 
phosphorylation of Stat5.  
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Phosphorylated Stat5 proteins dimerize and translocate to the nucleus. Stat5 binds to 
GAS elements  in  the  promoter  of  various  targets  genes  and  activates  their 
transcription. The promoter of the β casein gene contains such GAS elements and it 
has been shown that Stat5 binding is essential for its transcriptional activation. To test 
if mTOR influences the Stat5 signaling pathway the phosphorylation, translocation and 
transactivation  activity  of  Stat5  upon  rapamycin  treatment  were  investigated.  The 
results are summarized in chapter 3.1.6.1 3.1.6.3. 
3.1.6.1 The influence of mTOR on the phosphorylation of Stat5 
To study the role of mTOR on the Stat5 signaling pathway the phosphorylation of 
Stat5 was investigated in HC11 cells. The HC11 cells were cultivated to the competent 
stage and were than induced for differentiation with lactogenic hormones including 
prolactin  in  presence  or  absence  of  rapamycin.  The  proteins  were  isolated  after 
different  time  points  of  lactogenic  stimulation.  The  isolated  protein  samples  were 
analyzed in a western blot with an antibody specific for the phosphorylated form of 
Stat5.  To  verify  equal  loading  of  the  samples  the  membranes  were  stripped  and 
reprobed with an antibody specific for total Stat5. 
 
Figure 3.7 Phosphorylation of Stat5 is not influenced by rapamycin treatment. The HC11 cells 
were grown to the competent stage and were than induced with lactogenic hormones (DIP) in presence 
of  rapamycin  or  DMSO  (control).  The  protein  extracts  were  isolated  at  indicated  time  points  after 
lactogenic stimulation and western blotted and incubated with an anti phospho Stat5 antibody. To verify 
even protein loading the membranes were stripped and reprobed with an antibody specific for total Stat5 
protein. 
 
The  western  blot  analysis  in  Figure  3.7  shows  that  phosphorylation  of  Stat5  is 
successfully induced by the addition of lactogenic hormones to the culture medium. 
Accordingly, in the non induced cells (time point 0, competent stage) phosphorylated 
Stat5 was undetectable. 
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Comparison of the phosphorylation pattern of Stat5 of rapamycin treated cells with 
untreated cells did not show any differences. The kinetics as well as the amount of 
Stat5 phosphorylation is not influenced by rapamycin treatment. In both rapamycin 
treated and control cells phosphorylated Stat5 is present within 5 minutes after DIP 
induction and phosphorylation lasts over 30 minutes. After that the activation of Stat5 
is gradually lost over time. Therefore it was concluded that mTOR does not influence 
the prolactin pathway on the level of Stat5 phosphorylation.  
 
3.1.6.2 Influence on nuclear translocation of Stat5  
Although mTOR has no influence on the activation of the Stat5 signaling pathway, it 
was possible that mTOR effects dimer formation preventing translocation of the Stat5 
into  the  nucleus.  Because  only  total  protein  extracts  were  used  in  the  previous 
experiment such a translocation effect would be undetectable. Therefore, it was crucial 
to separate the nuclear and cytoplasmic cell fractions and investigate the translocation 
kinetics of Stat5 upon rapamycin treatment. To perform the experiment the HC11 cells 
were  again  cultivated  to  reach  the  competent  stage  and  were  than  induced  for 
differentiation with lactogenic hormones (DIP) in presence or absence of rapamycin 
(10  nM).  Nuclear  and  cytoplasmic  proteins  were  separated  using  a  nuclear 
fractionation method described in Material and Methods (chapter 2.2). Proteins were 
isolated  at  several  time  points  after  lactogenic  induction.  The  obtained  cellular 
fractions were analyzed on a western blot with an anti Stat5 antibody.  
 
 
Figure 3.8 Rapamycin has no effect on the translocation of Stat5 into the nucleus. The HC11 cells 
were grown to reach competency and than induced for differentiation with lactogenic hormones (DIP). 
Nuclear and cytoplasmic proteins were isolated at indicated time points after induction. The blots of 
nuclear and cytoplasmic proteins were incubated with an anti Stat5 antibody. CF cytoplasmic fraction; 
NF  nuclear fraction. 
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As seen in Figure 3.8 upon induction of control cells with lactogenic hormones Stat5 
translocated into the nucleus. There were no differences observed between rapamycin 
and non treated cells. After 15 minutes the amount of protein in the nuclear fraction 
clearly increased. As seen for Stat5 phosphorylation (Figure 3.7) this translocation last 
30 minutes and then slowly returns to level before DIP stimulation. The small amount 
of Stat5 detected at time point 0 in the nuclear fraction may be due to a contamination 
of cytoplasmic proteins in the nuclear fraction. These results indicate that mTOR has 
no influence on the phosphorylation or nuclear translocation of Stat5.  
3.1.6.3 Influence on transcriptional activation of Stat5  
Since mTOR has no effect on the phosphorylation nor on the dimerization and nuclear 
translocation of Stat5, the mTOR could affect the transcriptional activity of Stat5. The 
promoter  of  β casein  contains  GAS  elements,  a  sequence  region  required  for  the 
binding of Stat5 dimers. The activation of this promoter by Stat5 leads to transcription 
of the  β casein gene. We surmised that the mTOR signaling pathway could influence 
the  binding  of  Stat5  on  the  β casein  promoter.  This  would  explain  the  reduced 
expression  of  β casein  after  rapamycin  treatment.  Therefore  the  binding  and 
transactivator activity of Stat5 was studied using a reporter construct. In the previously 
established HC11 β casein luc cells a luciferase gene under control of β casein gene 
promoter is stably integrated into the genome. With the help of such a reporter system 
it is possible to estimate the binding and transactivation activity of Stat5 by measuring 
the enzymatic activity of luciferase. The HC11 β casein luc cells were cultivated to 
reach the competent stage and were induced for 16 hours with lactogenic hormones 
(DIP) with addition of rapamycin or DMSO. Finally the cells were lysed in a special 
luciferase assay buffer (see Material and Methods, chapter 2.2). The luciferase activity 
in  the  cell  extracts  was  measured  in  a  luminometer  by  addition  of  the  luciferin 
substrate. The obtained data were normalized against the protein concentration in each 
sample and plotted in a diagram (see Figure 3.9). 
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Figure 3.9 Rapamycin has no effect on the activation of the β β β β casein promoter by Stat5. HC11 β β β β 
casein luc  were  grown  to  reach  competency  and  than  induced  for  differentiation  with  lactogenic 
hormones (DIP) with addition of rapamycin or DMSO as a control. After 16 h the level of luciferase 
activity  was  measured  in  luminometer.  The  activity  was  normalized  against  the  total  protein 
concentration in each sample. 
 
As  can be  seen  (Figure  3.9)  the  transcriptional  activity  of  Stat5  was  induced  with 
lactogenic  hormones  (DIP)  when  the  activity  of  luciferase  between  non induced 
(column  6)  and  induced  control  cells  (column  5)  were  compared.  There  was  no 
significant difference between the induced cells treated with rapamycin (column 3) or 
DMSO (column 1). In both cases Stat5 binding was stimulated upon addition of DIP to 
the medium.  
 
Figure 3.10 Rapamycin reduces expression of β β β β casein mRNA in HC11 luc cells. The HC11 luc 
cells were cultivated to reach competent stage and were stimulated for 16 with lactogenic hormones. 
The total RNA was isolated and reverse transcribed. The cDNA was used in real time PCR reaction run 
with primers specific for β casein gene. The data were normalized against the 18S ribosomal subunit 
mRNA that serve as internal standard. 
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Because  there  was  no  effect  of  mTOR  on  Stat5  signaling,  it  was  important  to 
investigate whether β casein expression in the HC11 luc cells is the same as in normal 
HC11 cells. Therefore the amount of β casein mRNA and protein was also analyzed in 
these  cells.  To  confirm  that  mTOR  also  affects  the  endogenous  β casein  mRNA 
accumulation in the HC11 luc cells, total mRNA was isolated from the HC11 luc cells 
after 16h of stimulation with lactogenic hormones. The mRNA was reverse transcribed 
into  cDNA,  which  was  then  used  for  a  quantitative  Real Time  PCR  reaction  with 
primers specific for the β casein gene. As an internal control, also primers amplifying 
the 18S ribosomal unit were used. β casein mRNA was then normalized against the 
amount of 18S mRNA. The PCR data (Figure 3.10) showed a clear increase of mRNA 
expression in cells stimulated with DIP (column 2) when compared with non induced 
cells  (column  1).  Treatment  with  rapamycin  (column  3)  significantly  reduced  the 
accumulation of mRNA as compared with control cells treated with DMSO (column 
4). This is in agreement with data shown in figure 3.2B. 
To  further  confirm  that  induction  of  functional  differentiation  with  lactogenic 
hormones on the protein level, the HC11 luc cells were stimulated with DIP for 4 days. 
The isolated protein extracts were analyzed in a western blot with an antibody specific 
for β casein protein (Figure 3.11).  
 
Figure 3.11 Rapamycin inhibits the expression of β β β β casein in HC11 luc cells. The HC11 luc cells 
were cultivated to reach competency and than stimulated for 4 days with lactogenic hormones (DIP) in 
presence of Rapamycin or DMSO (drug solvent). To compare the lactogenic stimulation one sample 
was left untreated and non stimulated. Total proteins were isolated and western immuno blotted with an 
antibody specific for β casein. To verify the equal loading of the sample the membrane was stripped and 
reprobed with anti β tubulin. 
 
The  western  blot  analysis  in  Figure  3.11  confirms  the  induction  of  functional 
differentiation with DIP in HC11 luc cells (lane 2). The differentiation marker β casein 
is expressed, as compared to non stimulated cells (lane 1). Also in the HC11 luc cells 
rapamycin (lane 3) inhibits β casein expression when compared with cells treated only 
with the drug solvent DMSO (lane 4).  Results 
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The results showed that mTOR has no influence on the prolactin pathway. Treatment 
of mammary epithelial cells with rapamycin, inhibiting mTOR, had no effect on the 
Stat5 phosphorylation status, nor on its nuclear translocation or binding ability to the 
β casein promoter. Moreover, the results showed that although Stat5 binds to the β 
casein promoter upon rapamycin treatment there was no full activation of the β casein 
gene transcription. The level of β casein mRNA was clearly reduced in treated HC11 
luc cells. As a result the β casein protein expression was inhibited, indicating that cells 
were not functionally differentiated. This was also not caused by mRNA instability of 
β casein as shown in Figure 3.3. Therefore, other factors important for the expression 
of β casein must be influenced by mTOR.  
3.1.7 The Influence of mTOR on the expression of Idb proteins  
The mTOR protein is one of the down stream targets of the insulin signaling pathway 
(Wang et al., 2006). Several studies have shown that activation of the insulin pathway 
is required for the expression of milk proteins (Rosen et al., 1999). Insulin signaling 
was also shown to regulate the activity of Idb proteins (Belletti el al., 2002; Navarro et 
al.,  2001).  These  observations  suggest,  that  there  might  be  a  correlation:  possibly 
mTOR  is  a  mediator  of  insulin by  influencing  the  action  of  Idb proteins.  Another 
observation supports this idea: if mTOR is inhibited by treatment with rapamycin the 
HC11 cells proliferate slower. This is in agreement with the observation that the down 
regulation of Id1 also reduces cell proliferation. In the following chapter the possible 
link between mTOR and Idb proteins was studied in more detail.  
3.1.7.1 Regulation of Id1 by mTOR 
If insulin regulates the activity of mTOR and if mTOR affects Idb proteins several 
experiments can be performed to test this hypothesis. To test the influence of mTOR 
on Id1 expression the HC11 cells were seeded at low density to allow proliferation and 
were treated for 24 hours with rapamycin (+) or as negative control with an equivalent 
dilution of DMSO ( ) or left untreated (0). The proteins and total mRNA were than 
isolated and the mRNA was reverse transcribed. The obtained cDNA samples were 
used as templates for Real Time PCR reactions, which were performed with primers 
specific for Id1. The PCR data were normalized to 18S ribosomal subunit mRNA.  Results 
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In parallel,  the  isolated  protein  extracts  were  analyzed  on  a  western blot  using  an 
antibody  specific  for  Id1.  To  control  equal  loading  of  the  samples  on  the  gel,  the 
membrane was re probed with anti β tubulin antibody. 
 
Figure 3.12  mTOR  influences the expression level of Id1. The HC11 cells  were proliferating  in 
presence of rapamycin (+) or DMSO as negative control ( ) or were left untreated (0). The total RNA 
and proteins were isolated after 24h of treatment. (A) The isolated mRNA was reverse transcribed to 
cDNA. The Real Time PCR reaction was performed with primers specific for Id1 and for normalization 
with primers specific for 18S ribosomal subunit mRNA. The data were normalized and plotted in a 
diagram. (B)  Protein extracts were western blotted with an antibody specific for Id1. To control the 
equal loading of the samples, the membrane was re probed with anti β tubulin antibody. 
 
The Real Time PCR analysis (Figure 3.12A) showed that rapamycin treatment clearly 
down regulates the expression of Id1 (the relative expression level is reduced 30 times) 
when  compared  with  control  or  untreated  cells.  This  result  indicated  that  mTOR 
controls the expression of Id1 on the transcriptional level. The western blot (Figure 
3.12B) showed also the down regulation of Id1 on the protein level upon treatment 
with rapamycin and confirmed the Real Time PCR data. These experiments indicated 
that mTOR might control the proliferation of HC11 cells by influencing the expression 
level of Id1. Since Id1 has also been shown to be involved in the regulation of cell 
invasiveness it is well possible that inhibition of its expression with rapamycin not 
only reduces the cellular proliferation rate, but is also responsible for reduced ability of 
the rapamycin treated cells to migrate in the surrounding matrix during morphological 
differentiation in 3D cultures (Figure 3.5). 
3.1.7.2. Regulation of Id2 expression by mTOR. 
The HC11 cells induced for differentiation with lactogenic hormones were not able to 
express β casein in presence of rapamycin (Figure 3.2 and 3.11).  
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Studies  with  an  epithelial  cell  line  showed  that  Id2  is  required  for  functional 
differentiation  and  that  inhibition  of  Id2  was  followed  by  a  decrease  in  β casein 
expression  (Parrinello  et  al.,  2001).  It  is  therefore  possible  that  mTOR  regulates 
differentiation  by  controlling  the  expression  of  Id2.  To  study  the  effect  of  mTOR 
inhibition on Id2 expression, HC11 cells were grown to the competent stage and than 
induced  with  lactogenic  hormones  in  the  presence  of  rapamycin  (+DIP+Rap)  or 
DMSO (+DIP Rap) or were left unstimulated ( DIP). After lactogenic stimulation for 
16 hours the total RNA was isolated and reverse transcribed. The obtained cDNA 
samples were used as a template in Real Time PCR reactions, which were run with 
primers specific for β casein or Id2. Again a primer pair for amplification of ribosomal 
subunit 18S mRNA was used as internal standard for the normalization of obtained Id2 
PCR data.  
 
 
Figure 3.13 mTOR regulates the expression of Id2. The HC11 cells were cultivated to the competent 
stage and than induced for terminal differentiation with lactogenic hormones (+DIP) in presence of 
rapamycin (+Rap) or DMSO ( Rap) or were left unstimulated ( DIP) or were induced but  not treated 
(0). (A) The isolated total RNA was reverse transcribed and the obtained cDNA used as template in a 
Real Time PCR reaction with primers specific for β casein or Id2. The results were normalized against 
18S mRNA. (B) The protein extracts were western blotted with an antibody specific for Id2. To control 
equal loading of the samples the membrane was reprobed with anti β tubulin antibody. 
 
As can be seen in Figure 3.13A treatment with DIP induced the expression of Id2 and 
as expected also of β casein. In HC11 cells treated with rapamycin the expression of 
Id2  was  significantly  reduced  and  reflects  the  decrease  in  mRNA  observed  for  β 
casein.  
Also, proteins were isolated after 16 h of lactogenic stimulation from induced and 
untreated cells (0) as well as cells induced in presence or absence of rapamycin.  
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The protein extracts were western blotted with an antibody specific for Id2. To verify 
equal  loading  of  the  samples  the  membrane  was  reprobed  with  an  anti  β tubulin 
antibody. The western blot analysis (Figure 3.13B) showed that the protein level of Id2 
in cells induced with DIP in presence of rapamycin is strongly reduced in comparison 
to control cells. These western blot data correlate with the obtained Real Time PCR 
data (Figure 3.13A). These results confirm the hypothesis that mTOR is involved in 
the regulation of functional differentiation of mammary epithelial cells by controlling 
the expression of Id2 on the transcriptional level.  
3.1.8 The influence of rapamycin on primary mammary epithelial cells  
HC11 treated with rapamycin were not able to proliferate and to form branch like 
structures when cultured in a 3D matrix. Inhibition of mTOR signaling also had a 
negative  effect  on  the  functional  differentiation  of  these  mammary  epithelial  cells. 
Furthermore, HC11 cells induced for differentiation with lactogenic hormones (DIP) in 
the  presence  of  rapamycin  were  not  able  to  express  β casein,  which  additionally 
indicates a lack of terminal differentiation. To confirm that the obtained result from 
these studies with HC11 cells are not only true for this in vitro established epithelial 
cell  line,  the  influence  of  rapamycin  on  the  morphological  and  functional 
differentiation was also investigated in primary mammary epithelial cells, since the 
behavior of primary cells in vitro resembles the response of cell in an in vivo situation 
more closely. Primary epithelial cells were freshly isolated from mammary glands of 
virgin mice and transferred into culture dishes. To investigate the effect of rapamycin 
on  the  morphological  differentiation  of  the  primary  cells  the  isolated  primary 
mammary epithelial cells were seeded in collagen gels and induced for morphological 
differentiation in the presence of rapamycin or DMSO (negative control). After 4 days 
of incubation the cells grown in the gels were analyzed under the microscope (Figure 
3.14A).  The  control  primary  cells  formed  well  developed  tree like  structures.  In 
contrast, the primary  epithelial cells treated with rapamycin were not  able to form 
branch like structures. Their morphology resembled that of rapamycin treated HC11 
cells. These results indicate that like for the HC11 cells the ability of murine primary 
mammary epithelial cells to differentiate in 3D cultures depends on an intact mTOR 
signaling pathway. It also shows that the HC11 cells responses are still comparable to 
those of primary cells and confirms that HC11 cells are a usefull model system for 
these studies. Results 
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To  study  the  role  of  mTOR  on  functional  differentiation  of  primary  mammary 
epithelial  cells  the  isolated  cells  were  induced  for  functional  differentiation  with 
lactogenic hormones in the presence of rapamycin. The control cells were stimulated in 
the presence of DMSO. After 4 days of lactogenic stimulation proteins were extracted 
with RIPA buffer. The obtained protein samples were analyzed in a western blot with 
an antibody specific for the milk protein β casein.  
 
Figure 3.14 The role of mTOR in the morphological and functional differentiation of primary 
mammary epithelial cells. (A) Freshly isolated primary epithelial cells were seeded in collagen gel and 
induced  for  differentiation  in  presence  of  rapamycin  (+Rap)  or  DMSO  ( Rap).  (B)  The  primary 
mammary epithelial cells were grown (Growing) and than induced for functional differentiation with 
lactogenic hormones in presence of rapamycin (+) or DMSO ( ) or were left untreated (0). The total 
protein extracts were western blotted with an anti β casein antibody. To verify equal loading of the 
samples the membrane was stripped and reprobed with an anti β tubulin antibody. 
 
The western blot analysis (Figure 3.14) showed that the control primary cells induced 
with  lactogenic  hormones  in  presence  of  DMSO  (lane  4)  as  well  as  the  induced 
primary  cells  without  any  treatment  (lane  2)  expressed  the  milk  protein  β casein 
compared to non induced cells (lane 1). This indicated successful induction of terminal 
differentiation of primary cells. In contrast the primary cells induced in presence of 
rapamycin were not able to functionally differentiate as indicated by absence of β 
casein  protein  (lane  3).  The  studies  indicate  that mTOR  signaling  is  important  for 
morphological and functional differentiation of primary mammary epithelial cells in 
vitro and confirm the data obtained with our established HC11 cell line.  
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3.2 The role of mTOR during development of the mammary gland 
The in vitro studies with the established mammary epithelia HC11 cell line as well as 
with  the  freshly  isolated  primary  epithelial  cells  showed  that  mTOR  signaling  is 
essential  for  the  formation  of  branch like  structures  if  cells  are  seeded  in  a  three 
dimensional  culture  system.  More  importantly,  mTOR  signaling  is  crucial  for  the 
terminal differentiation of these cells. Inhibition of mTOR by rapamycin leads to an 
inhibition of the milk protein β casein expression, which is a marker used as indicator 
to determine the differentiation status of mammary epithelial cells. To support these in 
vitro studies, it was essential to analyze the role of mTOR signaling in vivo. Therefore, 
the effect of rapamycin treatment on mammary gland development was investigated in 
mice.  
3.2.1 Role of mTOR during pregnancy 
During  pregnancy  epithelial  cells  start  to  proliferate  extensively  (see  Introduction 
chapter 1.1). This process leads to the extension of ducts and finally to the formation of 
the secretory compartment, which almost completely fills the mammary gland stroma 
at the end of pregnancy. In vitro studies showed that mTOR signaling is required for 
the  proliferation  of  mammary  epithelial  cells  and  the  formation  of  branch like 
structures in gels (see Figures 3.5 and 3.6). To study the role of mTOR in vivo mid 
pregnant (10 days postcoitum) wild type NMRI mice were treated i.p. up to the day of 
delivery with daily doses of 1.5 mg/kg of rapamycin (Kind gift of Dr. K. Brinck Wyeth 
Pharma). The group of control animals was treated with the drug solvent alone (N,N 
Dimethylacetamid, Polysorbat 80, Polyethylenglycol 400 (in ratio 2:1:7)) at the same 
time points as the rapamycin treated mice. At the day of delivery the treated and the 
control animals were anesthetized and sacrificed. The mammary glands from treated 
and control animals were isolated and analyzed. Also the embryos of the mice were 
investigated.  Rapamycin  totally  blocked  the  development  of  the  embryos  (Figure 
3.15B).  In  comparison,  the  embryos  of  the  control  animals  were  fully  developed 
(Figure 3.15A). Since abortion of pregnancy reduces the level of pregnancy hormones, 
which directly influence the development of the mammary gland, it was not possible to 
define the cause of the observed changes. They could be caused by the direct inhibition 
of proliferation and differentiation of mammary epithelial cells by rapamycin. Another 
possibility is that the reduction of mammary gland development is caused indirectly by 
the inhibition of embryonic development by rapamycin. Results 
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If the embryos are not able to develop, this results in a decreased level of lactogenic 
hormones  which  normally  stimulate  mammary  gland  development  in  treated  mice. 
Intact mTOR signaling is required for embryonic development.  
 
Figure 3.15 Treatment with rapamycin inhibits the development of mouse embryos. Pregnant mice 
were treated with rapamycin or drug solvent as a control from mid pregnancy (10 day postcoitum) up to 
the day of delivery. (A) Fully developed embryos of a mouse treated with placebo (left) in comparison 
with new born pups (right). (B) Uterus of rapamycin treated mice with undeveloped and dead embryos.  
 
3.2.2  The role of mTOR during lactation 
The experiments with HC11 cells indicate that intact mTOR signaling is required for 
the morphological differentiation of mammary epithelial cells. The untreated HC11 
cells when seeded in collagen gel or martigel® formed three dimensional structures 
that  resembled  their  glandular  organization  in  vivo.  This  process  was  significantly 
inhibited by the addition of rapamycin in the culture medium. Furthermore, mTOR 
signaling  was  extremely  important  for  the  functional  differentiation  of  mammary 
epithelial cells in vitro. Blocking mTOR activity with rapamycin during the induction 
of HC11 cells with lactogenic hormones caused a total inhibition of β casein protein 
expression. Induction of the insulin signaling pathway is essential for lactation, and 
mTOR is one of the downstream targets of the insulin pathway. Therefore the role of 
the mTOR pathway during lactation of mammary epithelial cells was analyzed in vivo. 
Mammary epithelial cells reach their peak of functional differentiation during lactation 
where they are part of alveolar compartment secreting high amounts of milk proteins. 
To  study  the  role  of  mTOR  during  this  developmental  stage,  pregnant  mice  were 
treated with rapamycin or placebo starting from 19 days postcoitum until day 10 of 
lactation. During this 12 day treatment the development of the mammary gland of the 
mothers as well as the development of their new born pups was monitored.  Results 
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3.2.2.1 The influence of rapamycin on the development of pups 
New born mice are naked with closed ears and eyes. Pups start to eat solid food around 
14 16 days later when their eyes become fully functional. During the first two weeks 
after  birth  they  are  fully  dependent  on  the  mother.  The  most  important  factor 
influencing growth of the pups is milk produced in the lactating mammary glands of 
the  mother.  The  quality  and  quantity  of  milk  has  therefore  a  direct  impact  on  the 
development of the  growing pups. During the  first 10 days after birth infant mice 
usually triple their weight. Therefore the growth curve of pups can be used as indicator 
for milk availability and quality. The weight of pups of mothers treated with inhibitor 
of  mTOR  and  of  mothers  treated  with  drug  solvent  was  determined  daily.  The 
measurement was continued up to 10 days after birth and the data were plotted into a 
graph  (Figure  3.16).  As  can  be  seen,  the  pups  from  the  mothers  injected  with 
rapamycin gain weight more slowly, when compared with pups of control mice treated 
with  drug  solvent.  This  indicates  the  possibility  that  differentiation  and  as  a 
consequence milk expression is reduced in rapamycin treated glands. 
 
Figure 3.16 Inhibition on mTOR reduces the growth of new born mice. Mothers were injected daily 
with  rapamycin  (1.5  mg/kg  i.p.)  or  placebo  for  10  days  after  birth.  The  weight  of  the  pups  (12 
pups/mother) of treated and control mothers was measured daily. The average litter weight is plotted in 
the graph. 
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3.2.2.2 Effect of mTOR inhibition on gland weight and milk production 
During the first days of life the newborn pups are fully dependent on their mothers 
milk. The milk proteins and fatty acids are the only source of nutrition and are required 
for proper growth. Small changes in milk quality or quantity have a direct impact on 
development of the pups. The observed reduced growth of the pups of mothers treated 
with rapamycin might be caused by the drug inhibiting the terminal development of 
the mammary gland and milk production.  Another possibility is that rapamycin is 
secreted with the milk influencing growth of the pups directly.  To investigate this 
question the lactating mice were sacrificed after 10 days of lactation and the mammary 
glands were isolated. The first difference observed was the weight of the glands of 
control and treated mice. Mice treated with rapamycin had significantly flatter glands 
in comparison to non treated mice indicating that there is either less milk production or 
less  developed  gland  tissue  when  mTOR  is  inhibited.  Their  average  weight  was 
reduced from 1.5 gram to 0.6 gram upon rapamycin treatment (Figure 3.17). 
 
Figure 3.17 Rapamycin treatment reduced the wet weight of the mammary gland in vivo. Mice 
were treated with rapamycin intra p. (1.5 mg/kg) or placebo up 10 days of lactation. Than the animals 
were  anesthetized  and  sacrificed. The  mammary  glands  number  4  were  carefully  isolated. The  wet 
weight of treated and control glands was measured immediately after dissection. The obtained data are 
averaged in the diagram.  
 
 
To investigate the idea that there is a reduction in milk protein synthesis influencing 
the body weight of the pups, the mammary glands of treated and non treated animals 
were used for isolation of the milk and the concentration was measured. As can be 
seen in Figure 3.18 mice treated with the drug have significantly less milk proteins. 
The  expression  of  milk  proteins  is  reduced  around  60%  (Figure  3.18)  and  is 
comparable to the average decrease in mass of the treated pups (Figure 3.16). 
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These results indicate that the inhibited growth of the pups was at least partly due to a 
reduction in the amount of produced milk.  
 
Figure  3.18  Milk  protein  concentration  is  lower  in  mice  treated  with  Rapamycin  Mice  were 
injected with rapamycin or as a control placebo. Glands number 4 has been removed by surgery from 
mice and store in 60% EtOH for 48h. The obtained milk protein pellets were resuspended in RIPA 
buffer and the suspensions were spin again and protein concentrations were determined using Bradford 
solution for measurement.  
3.2.2.3 Morphology of the mammary gland of rapamycin treated mice  
During lactation, the mammary epithelial cells that contribute to alveoli, are terminally 
differentiated  and  secrete  milk.  The  decrease  in  milk  protein  expression  in  treated 
animals could be due to a reduced development of the alveolar compartment since 
rapamycin  clearly  inhibited  terminal  differentiation  of  mammary  epithelial  cells  in 
vitro. To test if rapamycin reduced the differentiation of alveolar cells in vivo, the 
histology  of  the  control  and  rapamycin  treated  glands  was  studied.  Initially,  the 
isolated glands were investigated as whole mounts spread on a glass slide. As can be 
seen in Figure 3.19A the control glands are fully developed. They are bigger and the 
well developed  secretory  units  are  visible.  In  comparison,  glands  isolated  from 
rapamycin treated animals are visibly thinner and the alveolar compartment is clearly 
less  developed.  Between  the  alveolar  units  there  was  still  a  lot  of  stroma  tissue 
compared  with  the  control  glands,  where  no  stroma  was  observed  in  the  alveolar 
compartment. To analyze the secretory compartment in more detail glands isolated 
from treated and control mice were cut into thin slices and stained with a combination 
of  two  dyes:  hematoxylin  and  eosin.  The  gland  slices  were  analyzed  under  the 
microscope. As can be seen in Figure 3.19B the alveolar compartment of the control 
was filled with milk. The alveoli are big and open and the epithelial cells form a thin 
layer around the alveolar space.  Results 
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In comparison the alveolar compartment of the treated gland is clearly affected by 
rapamycin.  The  single  alveoli  were  smaller  and  less  extended  indicating  that  the 
epithelial cells secreted less milk and do not completely fill the alveoli lumen.  
 
Figure  3.19  The  mammary  gland  of  mice  treated  with  rapamycin  are  filled  with  less  milk  in 
comparison to the controls. Mice were treated with rapamycin or drug solvent up to the 10 days of 
lactation. (A) The whole mounts of isolated glands were photographed. (B) The isolated glands were 
fixed and cut into thin slices and stained with hematoxylin eosin. 
3.2.2.4 The effect of rapamycin on expression of Id2 and β casein. 
Inhibition of mTOR with rapamycin during differentiation of mammary epithelial cells 
in vitro leads to a block of β casein expression and simultaneously reduces the level of 
Id2 protein which is involved in regulation of mammary gland development. Id2 has 
been shown to be expressed in parallel to β casein in vivo. Both proteins accumulate 
during lactation (Parrinello et al., 2001). The reduced growth of pups was probably due 
to  a  reduction  in  milk  synthesis.  In  rapamycin  treated  mothers  the  drug  evidently  
affected proper differentiation of the alveolar compartment. To confirm that rapamycin 
inhibits the terminal differentiation of mammary epithelial cells in vivo, the β casein 
expression (marker of functional differentiation) was investigated. The expression of 
β casein  in vitro was shown to be regulated by mTOR through Id2. It can be expected 
that the same mechanism plays a role in vivo. Thus, a reduction in expression of the β 
casein should be accompanied by a reduction in the expression of Id2.  
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To confirm this hypothesis total RNA and proteins were extracted from isolated glands 
of rapamycin treated and control mice at 10 day of lactation. The RNA was reverse 
transcribed to cDNA, which was used as template in a Real Time PCR reaction run 
with primers specific for β casein or Id2. The obtained results were normalized against 
data from reactions run with primers for 18S ribosomal subunit and plotted into a 
diagram (Figure 3.20A). As expected the β casein as well as Id2 mRNA levels were 
reduced by 3.5 fold and 4.2 fold, respectively, in the rapamycin treated glands. The 
western  blot  analysis  (Figure  3.20B)  confirmed  the decrease  in  β casein  in  treated 
animals which is accompanied by a reduced in expression of Id2. 
 
Figure  3.20  Rapamycin  reduces  expression  of  β casein  and  Idb2  in  mammary  glands  of  mice 
during lactation (A) Total RNA was extracted from three glands at 10 day of lactation and reverse 
transcribed into cDNA. The PCR reactions were run with primers specific for β casein or Idb2. Data 
were normalized against 18S ribosomal unit mRNA. (B) Total proteins isolated from 3 glands of treated 
(+Rap) and non treated ( Rap) mice were western blotted with anti β casein or Idb2. To control equal 
sample loading, the membrane was stripped and reprobed with an anti β tubulin antibody. 
 
Treatment of induced HC11 cells with rapamycin down regulated the expression of 
Id2 on the mRNA and the protein level. This correlated with a decrease in milk protein 
β casein expression (Figure 3.20). The in vitro experiments are thus in agreement with 
the results obtained in vivo.  
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3.3 The effect of rapamycin on mammary epithelial cells over expressing 
Id proteins.  
The in vitro and in vivo experiments indicate that treatment of mammary epithelial 
cells with rapamycin reduces the level of Id1 and Id2 proteins. The Ids inhibit DNA 
binding of bHLH transcription factors and were shown to be important regulators of 
proliferation and differentiation of mammary epithelial cells in vitro. Previously, it was 
proposed  that  mTOR  regulates  the  growth  and  functional  differentiation  of  the 
mammary  epithelial  cells  through  Idb  proteins.  To  confirm  this,  the  effect  of 
rapamycin on HC11 cells over expressing Id1 or Id2 was investigated. If there is a 
direct connection, over expression of Id1 or Id2 would bypass the negative effect of 
rapamycin.  To  over express  the  genes  in  HC11  cells,  transient  transfection  can  be 
used. However, several methods of transient transfection were tested and usually only 
low transfection efficiencies (10 15% positive cells) were obtained (see Figure 3.4.3). 
Therefore, a lentiviral vector system was used for the stable transduction of HC11 
cells. The coding sequences of Id1 or Id2 were cloned in a lentiviral vector pSiEW, 
which  is  schematically  shown  in  Figure  3.21.  The  long  terminal  repeat  sequences 
(LTRs) are required for integration in the host genome. The SFFV promoter allows 
stable  over expression  of  the  transgene  and  of  EGFP.  The  internal  ribosome  entry 
sequence (IRES) allows that a single Id EGFP mRNA is translated into two proteins. 
EGFP, serves as marker for the identification of positively transduced cells and for a 
fast estimation of the transduction efficiency under a fluorescence microscope or by 
FACS analysis. The HC11 cells stably over expressing Id1 or Id2 protein were treated 
with rapamycin and the effect on proliferation and differentiation was studied. 
 
Figure 3.21 Schematic representation of the pSiEW vector. LTR (long terminal repeat) sequences 
are  required  for  target  cell  integration.  SFFV  (spleen  focus  forming  virus)  promoter  allow  for 
amplification of Idb proteins. IRES (internal ribosome entry sequence) allows for co expression of Id1 
(or Id2) and GFP from one mRNA. The EGFP (enhanced green fluorescence protein) serves as marker 
of transduced cells. 
pSiEW
LTR LTR Id1 (465bp)  EGFP SFFV IRES
LTR LTR Id2 (423bp)  EGFP SFFV IRES
SacII SacII pSiEW
LTR LTR Id1 (465bp)  EGFP SFFV IRES
LTR LTR Id2 (423bp)  EGFP SFFV IRES
SacII SacIIResults 
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3.3.1 Preparation of plasmids for the production of lentiviruses 
The  plasmids  pCMV Sport6 Id1  or  pCMV Sport6 Id2  (obtained  from  RZPD, 
Germany), which contained the cDNA sequence of Id1 or Id2 respectively, were used 
as template in PCR reactions run with specially designed primer pairs. The primers 
contain  restriction  sites  for  Sac  II  and  only  allow  the  amplification  of  the  protein 
coding  region  of  Id1  or  Id2  (Figure  3.22A).  The  amplified  DNA  fragments  were 
purified using the QIAquick PCR Purification Kit (Qiagen). To obtain sticky ends the 
amplified fragments were cut with Sac II. The digestion products were again purified 
and  cloned  into  pSiEW,  which  was  also  linearized  with  Sac  II.  After  ligation  the 
plasmids were transfected to TOP10 cells and to select the insert positive clones the 
isolated plasmid DNA samples were digested with Sac II. The positive clones showed 
a band of 465 bp (in cease of Id1 insert) or 423 bp (in cease of Id2 insert) in addition to 
9.6 kbp vector band (Figure 3.22B).  
 
Figure 3.22 Cloning of Id1 and Id2 in the pSiEW lentiviral vector. (A) The Id1 and Id2 coding 
sequence was amplified in a PCR reaction. 1 kb marker  (lane 1), Id1 PCR product (lane2), 100bp 
marker  (lane 3) Id2 PCR product (lane 4). Thin bands show pCMVSport6 template. (B) Plasmids from 
several bacterial clones were isolated (mini prep) and digested with Sac II. Products of digestion were 
separated on a 1.2% agarose gel. The pSiEW clones containing Id1 or Id2 insert could be identified on 
the basis of presence of 465 bp (in cease of Id1) or 423 bp (in cease of Id2) digestion products. M–100 
bp DNA ladder.  
 
The pSiEW Id1 and pSiEW Id2 plasmids were purified in large scale (maxi preps). 
The obtained plasmid DNA was sequenced and the presence of the sequence coding of 
Id1 or Id2 was confirmed. The plasmids were also digested with Xba I and Xho I 
enzymes  to  verify  the  presence  of  the  LTRs  required  for  integration  of  the  viral 
genome into the host genome. Both pSiEW Id1 and pSiEW Id2 vectors contained the 
LTRs.  The  prepared  lentiviral  plasmids  were  used  for  the  transfections  of  293T 
packaging cells to obtain virus particles. 
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3.3.2  Transfection  of  293T  cells  for  the  generation  of  the  lentiviral 
particles  
To  produce  lentivirial  particles,  a  cell  line  is  used  which  is  easy  to  cultivate  (fast 
proliferation) and to transfect with high efficiency. The human cell line 293T fulfills 
these requirements and is commonly used for packaging of viral constructs. The 293T 
cells were transfected using the calcium phosphate method with the prepared lentiviral 
plasmids pSiEW Id1 or pSiEW Id2, as a control the empty pSiEW plasmid was used. 
Additionally, the two packaging plasmids pMD2.VSVG and pCMV R8.91 were co 
transfected.  One  day  after  transfection  the  293T  cells  were  analyzed  under  the 
fluorescence  microscope.  A  high  presentage  of  EGFP  positive  293T  cells  was 
observed indicating efficient transfection of these cells (Figure 3.23). This is important 
to obtain a high virus titer in the medium.  
 
Figure  3.23  High  efficiency  of  transfection  of  293T  cells  with  plasmids.  The  293  cells  were 
transfected  with  plasmids  for  production  of  lentiviruses.  Cells  were  transfected  with  pSiEW Id1 
(middle) pSiEW Id2 (right) or empty pSiEW plasmid (left) in combination with packaging plasmids. 
Green cells are the transfected cells expressing EGFP encoded on the pSiEW vector. If the packaging 
plasmids were co transfected the cells will produce viral particles within 48h after transfection. 
 
The culture medium of the transfected 293T containing the lentiviruses was collected 
every 24h for the next following 2 days. The viral titer in the medium was determined 
as described in Material and Methods (see 2.2.2.2). The lentiviruses were subsequently 
used for stable transduction of the mammary epithelial cell line HC11.  
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3.3.3 Viral transduction of HC11 cells and over expression of Idb proteins 
It  has  been  shown  that  the  HC11  cells  are  hard  to  transfect  using  many  different 
transfection  methods  (see  chapter  3.4.3).  To  improve  this,  the  HC11  cells  were 
transduced with the prepared lentiviral particles. Generally, MOI 5 or 10 was used for 
this  experiments.  The  efficiency  of  infection  was  checked  the  next  day  under  the 
fluorescence  microscope.  EGFP  served  as  a  marker  for  positively  transduced 
mammary  epithelial  cells  (Figure  3.24).  The  transduction  with  lentiviral  particles 
resulted in a high percentage (95 97%) of positive cells. 
 
 
Figure 3.24 Transduction of HC11 with lentiviral particles. HC11 cells were seeded in a 6 well plate 
and transduced with lentiviral vectors using an MOI 5 or 10. The efficiency of infection with virus was 
determined under the fluorescence microscope by estimating the presentage of EGFP. Green staining of 
cells correlate with over expression of Id1 or Id2.  
 
To confirm that the lentiviral genome was inserted into the host genome leading to the 
over expression of Id1 or Id2 and not only to the expression of EGFP a western blot 
analysis was performed. The HC11 cells transduced with lentiviral particles SiEW Id1 
(HC11 Id1), or SiEW Id2 (HC11 Id2), or empty SiEW (HC11 vector) were seeded in 
10 cm dishes and cultivated in growth medium for 2 days. Also non transduced HC11 
cells were used as a control. Total proteins extracts were isolated and a western blot 
with antibodies specific for Id1 or Id2 was performed.  
As shown, (Figure 3.25) the HC11 cells transduced with lentiviral particles SiEW Id1 
(lane 1) or SiEW Id2 (lane 2) over expressed either Id1 or Id2 protein when compared 
with the level of Id proteins in the controls (lanes 3 and 4). 
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The HC11 cells transduced with empty lentiviral vector over expressing only EGFP 
(lane 3) and the non transduced HC11 cells (lane 4) had the same level of Id1 and Id2 
expression indicating that insertion of the lentiviral construct or EGFP expression did 
not influence the expression of the  Id  endogenous proteins. The HC11  cells stably 
over expressing Id1 or Id2 proteins were used in functional assays described below.  
 
Figure 3.25 The HC11 cells infected with lentiviral vectors stably express Idb proteins. HC11 cells 
positive for EGFP were seeded in 10 cm dishes and cultivated in growth medium for 48h. Total proteins 
extracts were isolated and western immuno blotted with an antibody against Id1 or Id2 protein. To 
verify the equal loading of the samples the membranes were reprobed with an anti β tubulin antibody. 
 
3.3.4 The effect of Id1 over expression on proliferation and differentiation 
of HC11 cells 
As discussed in the introduction, Id1 plays a key role in the proliferation of epithelial 
cells in culture as well as in vivo (Chapter 1.4). The Id1 protein level is high during 
puberty when cells extensively divide to build ducts as well as during early pregnancy 
when cells proliferate to form the secretory  compartment.  Inhibition of the mTOR 
kinase by treatment with rapamycin was shown in the previous chapter (3.1) to inhibit 
the  proliferation  and  also  to  decrease  the  expression  of  Id1.  Therefore,  it  was 
interesting to investigate if the effect of rapamycin on proliferation depends on the 
down regulation of Id1.  
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Figure  3.26  Lentiviral  over expression  of  Id1  in  HC11 Id1  cells  is  insensitive  to  the  down 
regulating effect of rapamycin. The HC11 cells transduced with lentiviral particles SiEW Id1 (HC11 
Id1)  or  with  empty  lentiviral    SiEW  vector  (HC11 vector)  were  grown  in  presence  or  absence  of 
rapamycin (10 nM). After 24 h incubation total proteins were isolated and the obtained extracts were 
western blotted with an anti Idb1 antibody. To confirm equal loading of the samples the membrane was 
reprobed with an anti β tubulin antibody. 
 
The initial experiment where growing HC11 vector and HC11 Id1 cells were treated 
with rapamycin or DMSO showed (Figure 3.26) that the HC11 Id1 cells expressed 
high  levels  of  Id1  protein  and  were  resistant  against  the  down regulating  effect  of 
rapamycin on Id1 protein expression. To test the effect of this rapamycin insensivity 
on proliferation the HC11 Id1 cells stably over expressing Id1 protein were seeded in a 
96 well titration plate and were treated with rapamycin or DMSO for 96 hours. As a 
control, HC11 vector cells transduced with empty vector and expressing only EGFP 
were grown under the same conditions. The number of living cells was estimated every 
24  h  by  using  the  XTT  proliferation  assay  (Roche  Molecular  Biochemicals).  The 
obtained data were averaged and are presented as growth curves (Figure 3.27).  
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Figure 3.27 Rapamycin does not inhibit the proliferation of HC11 cells over expressing Idb1. The 
HC11 Id1 cells were seeded per well of 96 well micro titration plate and cultivated in 100  l of growing 
medium in presence or absence of rapamycin (10nM) for 96 hours. The control cells HC11 vector 
transduced with empty lentiviral vectors were incubated under the same condition. The number of living 
cells  was  counted  every  24h  at  indicated  time  points  of  rapamycin  treatment  with  help  of  XTT 
proliferation assay. 
 
As shown (Figure 3.27) the growth of the HC11 cells treated with rapamycin was 
clearly affected compared with the DMSO ( Rap) treated cells. The HC11 cells over 
expressing  Id1  were  proliferating  much  faster  compared  to  the  control  cells.  The 
growth of HC11 Id1 was not influenced by the inhibitory effect of rapamycin. These 
data confirm that Id1 controls the proliferation potential of HC11 cells and indicate 
that mTOR regulates the proliferation of mammary epithelial cells by influencing the 
expression level of Id1. 
It  was  also  interesting  to  investigate  how  over  expression  of  Id1  influences  the 
differentiation of the HC11 cells. Normally Id1 protein is expressed at high level in 
proliferating cells and is down regulated during confluency. That is a prerequisite for 
differentiation. Interestingly, western blot analysis (Figure 3.28) of HC11 cells induced 
for  differentiation  with  DIP  showed  that  over expression  of  Id1  prevents  the 
expression of Id2 as well as the induction of β casein by lactogenic hormones. This 
result indicate that Id1 is responsible for holding the cells in a proliferation stage and 
prevents pre mature differentiation by blocking the proteins involved in activation of 
differentiation including Id2. 
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Figure 3.28 Over expression of Id1 in HC11 cells prevents the expression of Id2 and β casein after 
stimulation with DIP. The HC11 Id1 and HC11 vector cells were induced for differentiation with DIP 
in presence or absence of rapamycin (10 nM). After 4 days of incubation the proteins were isolated and 
the  obtained  protein  extracts  were  western  blotted  with  an  anti  Id2  antibody  as  well  as  β casein 
antibody. To confirm the equal loading of the samples the membrane was stripped and reprobed with an 
anti β tubulin antibody. 
 
3.3.5 Branching of HC11 cells over expressing Id1 
HC11 cells seeded in a three dimensional environment are able to form structures that 
resemble  ducts  of  the  mammary  gland.  Treatment  with  rapamycin  inhibits  the 
development of duct like structure in collagen and matrigel (Figure 3.5). A similar 
effect was observed in the case of HC11 cells expressing siRNA silencing the Id1 
expression (Figure 3.38). Rapamycin was shown to down regulate the Id1 protein level 
and as a consequence cell proliferation. It was interesting to test, if the HC11 cells 
over expressing  Id1,  in  which  growth  is  insensitive  to  the  inhibitory  effect  of 
rapamycin, are also able to differentiate morphologically in 3D culture when treated 
with the drug.  
The HC11 Id1 over expressing Id1 protein and the HC11 vector cells transduced with 
empty lentiviral vector were seeded in collagen gel and cultured in the presence of 
rapamycin or DMSO. The expression of EGFP by HC11 Id1 and HC11 vector allowed 
the detection of the duct like structures in the gels analyzed under the fluorescence 
microscope (Figure 3.29).  
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Figure 3.29 Branching morphogenesis is not blocked by rapamycin in HC11 over expressing Id1. 
Around 2000 HC11 Id1 or HC11 vector cells were seeded within 100  l of collagen gel and cultivated 
in presence of rapamycin (10 nM) or DMSO as a control. The medium was replaced every day. After 4 
days the cells were analyzed under the fluorescence microscope. Because the cells also expressed GFP 
due to the lentiviral transduction the green branch like structures can be observed. 
 
Without addition of rapamycin the HC11 Id1 over expressing Id1 protein formed tree 
like structures already after 4 days of stimulation. Furthermore, the branches were far 
more developed in comparison to control HC11 vector transduced only with empty 
vector. Normal HC11 cells needed around 8 10 days to form such structures. This 
accelerated growth was not surprising, since we already observed that the HC11 Id1 
cells  proliferate  faster  than  the  control  cells  (Figure  3.27).  More  importantly,  the 
treatment with rapamycin did not block the morphological differentiation of HC11 
cells  over expressing  Id1.  This  was  in  clear  contrast  to  the  control  cells,  which 
proliferate  only  weakly  and  could  not  invade  the  surrounding  gels.  These  results 
strongly  indicate  that  mTOR  controls  morphological  differentiation  of  mammary 
epithelial cells in the 3D cultures through the regulation of Id1. This is in agreement 
with previously published data showing that Id1 directly regulates proliferation and the 
invasive potential of mammary epithelial cells. 
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3.3.6 Effect of Rapamycin on the functional differentiation of HC11 over 
expressing Id2  
Not only Id1, but also Id2 was shown to play an important role in the development of 
the mammary gland. Knock down of Id2 caused a block of functional differentiation of 
epithelial cells and a reduction of milk protein expression (Mori et al., 2000). HC11 
Id2 cells over expressing Id2 and HC11 vector cells were seeded in 10 cm plates and 
cultivated in growth medium for 2 days. During the next 2 days the cells were brought 
into the competent stage in starvation medium and finally induced for differentiation 
with lactogenic hormones (DIP) in the presence of rapamycin or DMSO. After 4 days 
of stimulation the total proteins were extracted with RIPA buffer and western immuno 
blotted with an antibody specific for β casein. Detection of the milk protein serves as a 
marker  for  functionally  differentiated  mammary  epithelial  cells.  To  verify  equal 
loading of the samples the membrane was stripped and reprobed with an anti β tubulin 
antibody. 
 
Figure 3.30 Rapamycin has no effect on the terminal differentiation of HC11 over expressing Id2. 
HC11 Id2 and HC11 vector cells were seeded in 10 cm dishes grown and induced for differentiation 
with DIP in presence of rapamycin or DMSO as control. After 4 days of stimulation with lactogenic 
hormones total proteins were isolated with RIPA buffer and western blotted with an antibody against β 
casein. To confirm the even loading of the samples the membrane was stripped and reprobed with anti 
β casein antibody. 
 
The western blot analysis (Figure 3.30) showed that HC11 vector cells transduced with 
empty lentiviral vector and treated with rapamycin are not expressing milk protein β 
casein (lane 2) indicating that they are not terminally differentiated in contrast to the 
control cells treated with DMSO (lane 1). The HC11 Id2 cells over expressing Id2 
were  still  able  to  differentiate  under  treatment  of  rapamycin  as  indicated  by  the 
presence  of  milk  protein  β casein  (lane  4).  These  experiments  together  with  the 
previous  results  provide  evidence  that  mTOR  influences  terminal  differentiation  of 
mammary epithelial cells through the regulation of Id2 expression.  
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3.4 Identification of genes involved in proliferation and differentiation of 
mouse mammary epithelial cells 
During mammary gland development several hormones are able to activate signaling 
pathways, which in turn activate transcription of hundreds of genes involved in the 
formation  of  a  functional  gland.  Although  some  important  signaling  pathways  and 
their activators have been studied in detail, little is known about the regulation of the 
various target genes during mammary epithelial cell proliferation and differentiation. 
Development of the micro array technology has provided a novel tool to study the 
transcription profile of thousands of genes in one experiment. In this work this method 
was  used  to  identify  genes  differently  expressed  during  proliferation  and 
differentiation of HC11 cells. Another aim of this work was to establish a fast and easy 
in  vitro  system  that  allows  testing  the  role  of  the  identified  candidate  genes  in 
proliferation and differentiation of the mammary gland. 
3.4.1  Micro array  analysis  of  gene  expression  during  differentiation  of 
mammary epithelial cells 
To  identify  genes  that  are  regulated  during  proliferation  and  differentiation  of 
mammary epithelial cells, the HC11 cell line was used as a model. The HC11 were 
originally isolated from mid pregnant mice. This cell line is able to proliferate well in 
vitro and can be induced for differentiation. The addition of the lactogenic hormones 
dexamethasone, insulin and prolactin (DIP) in the medium leads to the expression of 
the milk protein β casein which is used as indicator for functional differentiation of the 
mammary epithelial cells.  
 
Figure 3.31 The gene expression pattern in three different stages of HC11 cells was compared. The 
HC11 cells can be grown in plastic dishes. They proliferate until they reach confluency and can be 
brought  to  competency  and  than  induced  with  lactogenic  hormone  mix  (DIP)  for  terminal 
differentiation. The gene expression patterns of the three stages of culture were compared to each other: 
growing (proliferating) cells were compared to competent cells (G to C), growing cells were compared 
with cells induced for 1h with lactogenic hormones (G to C), competent cells were compared with cells 
induced  for  1h  with  lactogenic  hormones.  This  allowed  for  identification  of  genes  involved  in 
proliferation and/or early stages of differentiation. 
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To  compare  the  gene  expression  pattern  between  the  differentiated  and  non 
differentiated (proliferating) stage the HC11 cells were grown until they reached the 
competent stage and were than induced for differentiation (Figure 3.31). Total RNA 
was isolated from three different stages of cultures of growing cells which proliferate 
extensively, from competent cells, which are not able to divide because the plates are 
confluent,  and  from  cells  stimulated  for  1h  with  lactogenic  hormones  (DIP).  This 
allowed the identification of genes that are expressed at high level in proliferating cells 
as well genes specifically activated during early  stages of mammary epithelial cell 
differentiation.  The  isolated  RNA  was  reverse  transcribed  to  cDNA.  Micro array 
analyse was performed in cooperation with the lab of Dr. Peter Angel (German Cancer 
Research Center, Heidelberg). They hybridized the obtained cDNAs with the NIA 
Chip, which is a PCR based cDNA micro array containing 15,000 unique genes (78% 
are novel, 22% are known). The selected genes are known to be expressed during 
mouse  embryonic  development  (Tanaka  et  al.,  2000).  We  could  initially  detect 
expression of around 3000 genes in our HC11 samples. We have identified around 
1800 replicates after the color switch (60% of the total detected genes). We identified 
false positives (7%) which showed an inconsistent regulation pattern after the color 
switch. Around 397 proliferation associated and 639 differentiation associated genes 
were initially selected as candidates involved in these processes. Several genes, found 
to be regulated during proliferation and differentiation of HC11 cells, were picked and 
analyzed in this work in more detail.  
3.4.2 Confirmation of micro array data by Real Time PCR analysis. 
The expression patterns of target genes obtained from the micro array analysis were 
verified by PCR. By reverse transcription of mRNA of HC11 cells in combination with 
Real Time PCR it is possible to verify regulation of the mRNA level for particular 
gene  in  the  investigated  samples.  Therefore  the  HC11  cells  were  grown  to  reach 
competency and were induced with lactogenic hormones (DIP) for one hour. The total 
RNA  was  isolated  from  growing  (proliferating),  competent  (confluent  plate)  and 
induced HC11 cells. The extracted RNA samples were reveres transcribed ito cDNA. 
The obtained cDNAs were use as templates for in Real Time PCR reactions run with 
primers specific for the selected candidate genes. An example of the data obtained in a 
Real Time PCR reaction performed with primers specific for Id2 gene is shown in 
chapter 2.2.1.15.  Results 
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All data obtained form Real Time PCR reactions was analyzed as in the Id2 example. 
The  fold  difference  in  gene  expression  levels,  between  growing,  competent  and 
induced  cells  were  calculated  as   Ct  values  and  were  compared  with  micro array 
results  (Table  3.1).  Only  genes,  which  expression  pattern  was  confirmed  were 
considered for further analysis in functional assays. 
 
Gene Name  Type of analysis 
Growing vs. 
competent  
( Ct value) 
Competent vs.  
Induced 
( Ct value) 
Growing vs. 
Induced 
( Ct value) 
M A Data  2.6   3.9   3.1 
Idb1  Real Time PCR  3,1  1.1  4.2 
M A Data   2.6    0.4    3.2  
Idb2  PCR PCR   2.5   1.6   4.1 
M A Data   2.8    1.5     
Cited4  RealTime PCR   1.7   0.4   2.3 
M A Data   0.9    0.4    0.5  
Nedd8  RealTime PCR  0.3   0.1  0.2 
M A Data   2.1    1.0    1.0  
Ltf  RealTime PCR   6.6   1   7.6 
M A Data   1.9   1.2   1.6 
Atp5l  RealTime PCR   0.1   0.2   0.3 
M A Data   2.2  0.6   1.1 
Nkd2  RealTime PCR   2.6   1.1   3.7 
M A Data     1.6     
Hdac2  RealTime PCR  1.9   0.5  1.6 
M A Data     1.4     
Sap30  RealTime PCR   0.8   1.7   2.5 
M A Data     2.1     
Esg1  RealTime PCR   0.8  1.6  0.8 
M A Data  1.8   2.2   1.5  
Rae1  RealTime PCR   0.6   0.4   1 
M A Data  1.5   2.1   1.5  
Nap1l1  RealTime PCR  1.5   0.3  1.2 
M A Data  2.8      1.9  
Hsp105  RealTime PCR  1.8  0.3  2.1 
M A Data  2.8      1.8  
Pdlim1  RealTime PCR   2.2  0.1   2.1 
M A Data  1.5  0.8  2.5 
Nol5  RealTime PCR  3.3   0.4  2.9 
M A Data  1.2   0.5   2.3  
Biklk  RealTime PCR   4.8   1.1   5.9 
M A Data  1.4   0.9   1.6  
Kpna2  RealTime PCR  3.6  0.3  3.4 
 
Table 3.1 Comparison of results obtained from micro array and Real Time PCR analysis.  The 
data obtained from  micro array and PCR were plotted as delta Ct values of compared stages of  HC11 
cell differentiation (Growing, Competent, Induced). The Relative fold induction of target gene  can be 
calculated according to  formula 2
 Ct  where delta Ct is difference in the  Ct (threshold amplification 
cycle) between two compared stages ( Ct = Ct1 Ct2).  
 Results 
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3.4.3 Silencing of candidate genes by RNA interference 
Over expression or down regulation of candidate genes can be used to investigate the 
role of these  genes during differentiation of mammary  epithelial  cells.  The siRNA 
technology has become a potent tool in functional genomics to silence the expression 
of  genes  of  interest.  There  are  several  methods  to  introduce  vectors  leading  to 
expression of siRNA. Transient transfection and stable transduction are widely used. 
Before the effect of siRNA on the proliferation and differentiation of HC11 can be 
analyzed,  the  newly  designed  siRNA  has  to  be  tested  for  its  silencing  potential. 
Therefore transient tansfection was used, since this is an easy and fast method for 
validation  of  the  siRNA  silencing  power.  To  select  the  most  efficient  transfection 
method  for  mammary  epithelial  cells,  several  different  reagents  were  tested  for 
transfection of HC11 cells with pSuper vectors containing siRNAs. The results are 
shown in Figure 3.32.  
 
Figure  3.32  Mammary  epithelial  cell  HC11  are  difficult  to  transfect.  Mammary  epithelial  cells 
HC11 were transfected using different methods and kits for transient transfection. As control the 293T 
cells were transfected using calcium phosphate. GFP Green Fluorescence Protein is used as marker for 
transfected cells. Results 
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All transient transfection methods tested resulted in a very low transfection efficiency 
(5 15%) indicated by the low fraction of cells expressing GFP. The experiment showed 
that  HC11  cells  are  not  efficiently  transfected  compared  to  293T  cells  although 
different reagents and protocols were used. Therefore we decided to use the lentiviral 
vector  system,  which  requires  more  time  and  work,  but  gives  high  transduction 
efficiencies (95 100%). Moreover, lentiviral transduction results in stable expression 
of siRNA, which is required for subsequent functional analysis. 
3.4.3.1 Preparation of lentiviral vectors with siRNA targeting Id1 and 
Id2 mRNA 
To optimize the siRNA silencing system, it was important to analyze siRNA knock 
down on a gene, whose function is known. In this way it is possible to compare the 
obtained  phenotype  with  previous  results.  As  shown  in  this  work  the  Id1  and  Id2 
proteins  are  essential  for  proper  development  of  mammary  gland  as  well  as  for 
proliferation and differentiation of mammary epithelial cells in vitro. They were also 
detected in our micro array analysis and their differential expression pattern during 
proliferation and differentiation of HC11 was confirmed by Real Time PCR analysis. 
Therefore, the Id proteins were chosen as a model for the establishment of the siRNA 
knock down technique. The siRNA sequences for silencing the expression of Ids were 
delivered  in  pSuper  vectors  downstream  of  a  H1  promoter.  The  H1  promoter  and 
siRNA were than cloned into lentiviral vector pSEW. The final vector is schematically 
presented in Figure 3.33.  
 
Figure  3.33  Schematic  presentation  of  pSEW  vector  containing  the  cloned  H1  promoter  and 
siRNA sequences. The siRNA sequence with H1 promoter was subcloned from a pSuper plasmid and 
was inserted between  LTR (long terminal repeat)of lentiviral plasmid pSEW. RRE (Rev responsive 
element) as nuclear export and encapsidation permissive element. SFFV (spleen focus forming virus) 
promoter for stable expression of GFP. WPRE (woodchuck hepatitis virus posttranscription response 
element) enhancer for transgene expression in target cells. EGFP (enhanced green fluorescence protein). 
H1 (inducible Pol III) promoter, allowing expression of si (short interfering ) RNA. 
 
The LTR allows the stable insertion of the construct into the host genome. The siRNA 
sequence is under the control of the H1 promoter required for stable expression.  
pSEW siRNA
LTR LTR siRNA EGFP SFFV WPRE H1 RRE
pSEW siRNA
LTR LTR siRNA EGFP SFFV WPRE H1 RREResults 
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The expression of GFP is controlled separately by the SFFV promoter, and is used for 
identification  of  positively  transduced  cells  and  fast  estimation  of  transduction 
efficiency using fluorescence microscopy or FACS analysis.  
For silencing the Id1 gene, three siRNA sequences were selected: A115, B131, C152. 
For  silencing  Id2  gene,  two  siRNA  sequences  were  selected  7  and  9.  The  pSuper 
vectors  containing  siRNA  were  used  to  transform  TOP10  cells.  On  the  next  day, 
several colonies were picked up from plates and used to perform Mini Prep isolation of 
plasmid DNA (NucleoSpin® Macherey Nagel). To select the siRNA insert positive 
clones,  the  isolated  pSuper  plasmid  samples  were  digested  with  Bgl  II  and  EcoRI 
enzymes. The Bgl II restriction site is eliminated after insertion of siRNA into pSuper. 
The  digestion  of  positive  clones  gives  only  one  band  while  digestion  of  negative 
clones yields two bands after digestion and resolution on the 1.2% agarose gel. The 
selected pSuper siRNA insert positive vectors were sequenced. The bacterial clones 
containing  pSuper  vectors  with  the  proper  siRNA  sequences  were  used  for  the 
preparation  of  Maxi  Preps  of  plasmid  DNA  (Nucleobond®  Macherey Nagel).  The 
fragments containing the H1 promoter and the siRNA sequence were cut from the 
pSuper  plasmids  with  Sma  I  and  Hinc  II  (blunt  ends).  Products  of  digestion  were 
solved on 1.2% agarose gels. The expected 300 bp fragment containing H1 promoter 
and siRNA sequence could be recognized and was cut out from the gel with a sterile 
scalpel and than purified. (QIAquick, Qiagen). The pSEW vector was digested with 
Sna BI. To increase the insertion efficiency of ligated fragment and to prevent the 
circularisation  of  open  pSEW  plazmid,  the  blunt  ends  of  the  vector  obtained  after 
digestion reaction were dephosphorylated. After purification the open pSEW vector 
were ligated with isolated 300 bp fragment (H1 promoter+siRNA). The ligation mix 
was  used  for  transformation  of  TOP10  cells.  After  overnight  incubation,  several 
bacterial  clones  were  used  for  mini  plazmid  isolation.  The  positive  clones  were 
selected in digestion step with EcoRI enzyme. The insert positive vectors gave 2 kb 
band after digestion reaction products resolution on the 1.2% agarose gel. The positive 
clones with the proper orientated insert H1 promoter  siRNA were used for Maxi Prep 
preparation. The obtained vectors were than sequenced and the correct insertion of 
siRNA sequences in pSEW was verified. The prepared vector pSEW A115, pSEW 
B131, pSEW C152, pSEW 7, pSEW 9 were used for transfection of 293T packaging 
cells together with packaging vectors pMD2.G and pCMVR 8.91.  
 Results 
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3.4.3.2 Transfection of packaging cells with lentiviral vectors 
For expression of lentiviral particles, human 293T cells are commonly used. cell. The 
293T cells were seeded in 10 cm plate and transfected using calcium phosphate as 
described in material and methods, with the lentiviral plasmids pSEW siRNA Id1 or 
pSEW siRNA Id2 or as a control with an empty lentiviral plasmid (pSEW without the 
H1 promoter siRNA  insert).  Two  additional  plasmids  pMD2.G  and  pCMVR 8.91 
were co transfected for expression of viral proteins required for virus replication and 
packaging. The next day the transfected cells were examined under the fluorescence 
microscope. A high amount of GFP expressing 293T cells were detected (Figure 3.34). 
The transfection efficiency was estimated to be 60 80%. 
 
 
Figure 3.34 Transfection of 293T cells with vectors for production of lentiviral particles. The 293T 
were  seeded  in  10  cm  plates  and  transfected  with  lentiviral  plasmids  using  the  calcium  phosphate 
method. The GFP indicates cells expressing viral proteins. 293T cells transfected with pSEW siRNA 
Id1 A115 construct (middle). 293T cells transfected with pSEW siRNA Id2 7 construct (right). 293T 
cells transfected with empty pSEW plasmid (left). The cells were also co transfected with evenlope 
plasmid pMD2.G and packaging plasmid pCMVR 8.9. 
 
The transfection medium was changed to fresh medium and after 16 h the medium was 
aspirated and stored after filtration. The medium containing lentiviral particles was 
used  for  stable  transduction  of  the  mammary  epithelial  cells  in  the  following 
experiments.  
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3.4.3.3 Stable transduction of HC11 cells with lentiviral vectors  
To  investigate  the  role  Id  proteins  during  proliferation  and  differentiation  of  the 
mammary  epithelium,  the  HC11  cells  were  transduced  with  lentiviral  particles  to 
obtain stable expression of different siRNA sequences targeting Id1 and Id2 proteins. 
As a control the cells were transduced with empty vector to monitor the influence of 
transfection  procedures  and  expression  of  the  green  fluorescent  protein  on  normal 
HC11  proliferation,  morphology  and  differentiation.  The  efficiency  of  transduction 
was investigated 24 hours after transduction under the fluorescence microscope. As 
can be seen, almost all cells expressed GFP indicating high transduction efficiency 
(Figure 3.35). The high efficiency of viral transduction allowed to perform functional 
analyses  using  almost  a  homogenous  HC11  population  stably  expressing  siRNA 
targeting Id1 or Id2. 
 
 
Figure 3.35 High lentiviral transduction efficiency of mammary epithelial cells. The HC11 cells 
were transduced with lentiviral particles containing the siRNA targeting Id1 or Id2. The control cells 
were transduced with empty lentiviral vectors. GFP green fluorescence protein was used as a marker for 
viral uptake. The viral genome integrates in the host genome ensuring stable expression of siRNA. 
 
The  silencing  potency  of  the  cloned  siRNA  sequences  was  investigated  before 
functional  experiments  were  performed.  The  total  RNA  and  proteins  were  isolated 
form  HC11  cells  transduced  with  lentiviral  vectors,  stably  expressing  siRNA.  The 
extracted RNA was reverse transcribed into cDNA. The obtained cDNA samples were 
used as templates in Real Time PCR reactions, run with primers amplifying a specific 
sequence of Id1 or Id2. To verify equal loading of the samples in the reaction the 
obtained data were normalized using primers amplifying the 18S ribosomal subunit.  
HC11 siRNA Id1   HC11 empty vector  HC11 siRNA Id2  
Phase  
contrast 
EGFP Results 
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Figure 3.36 The expressed siRNA down regulates the expression of targeted mRNA. HC11 cells 
stably expressing siRNA against Id1 or Id2 were used for the isolation of mRNAs and proteins. The 
mRNAs were reversed transcribed to cDNA and used as template in a Real Time PCR reaction run with 
primers specific for Id1 (A) or Id2 (B). The extracted proteins were western immuno blotted with an 
antibody specific for Id1 (C) or Id2 protein (D). To confirm equal loading of the samples the blots were 
stripped and reprobed with anti β tubulin antibody. 
 
The analysis of Id1 or Id2 mRNA expression by Real Time PCR (Figure 3.36 A and 
B) showed that the selected siRNAs effectively down regulate the expression of Ids 
mRNA in stably transduced HC11 cells in comparison to control cells (transduced with 
empty  lentiviral  vector).  The  isolated  total  protein  extracts  were  western  immuno 
blotted with an antibody against Id1 or an antibody against Id2 protein. To verify the 
equal  samples  loading  the  membranes  were  stripped  and  reprobed  with  antibody 
specific  for  β tubulin.  The  western  blot  analysis  (Figure  3.36  C  and  D)  further 
confirmed  the  Real Time  PCR  results.  The  expression  of  Id1  and  Id2  in  siRNA 
expressing HC11 cells was clearly down regulated on the protein level. The HC11 
population transfected with the most effective siRNA (for Id1 the sequence A115 and 
for Id2 the sequence 7 and 9) were used for further functional experiments. 
 
 
0
2
4
6
8
10
12
14
16
Control siRNA A115 siRNA B131 siRNA C152
 
F
o
l
d
 
I
d
1
 
m
R
N
A
 
e
x
p
r
e
s
s
i
o
n
0
0,5
1
1,5
2
2,5
3
3,5
4
4,5
5
Control siRN A  7 siRNA  9
F
o
l
d
 
I
d
2
 
m
R
N
A
 
e
x
p
r
e
s
s
i
o
n
Control          siRNA
Id1
β tubulin
WB: Ibb2
B A
β tubulin
D C
Id2
A115   B131  C152
Control          siRNA
7             9   
0
2
4
6
8
10
12
14
16
Control siRNA A115 siRNA B131 siRNA C152
 
F
o
l
d
 
I
d
1
 
m
R
N
A
 
e
x
p
r
e
s
s
i
o
n
0
0,5
1
1,5
2
2,5
3
3,5
4
4,5
5
Control siRN A  7 siRNA  9
F
o
l
d
 
I
d
2
 
m
R
N
A
 
e
x
p
r
e
s
s
i
o
n
Control          siRNA
Id1
β tubulin
WB: Ibb2
B A
β tubulin
D C
Id2
A115   B131  C152
Control          siRNA
7             9   Results 
  128 
3.4.4 Differentiation of HC11 cells expressing siRNA against Id2 
Id2 plays an essential role during late stages of mammary  gland development.  Id2 
knock out mice have a lactation defect with a strong inhibition of β casein expression 
(Mori et al., 2000; Miyoshi et al., 2002). To test the effect of Id2 silencing on the 
functional differentiation of mammary epithelial cells, the HC11 cells transfected with 
siRNA 7 and 9 effectively down regulating the Id2 expression level were grown to the 
competent  stage  and  then  induced  with  lactogenic  hormones  (DIP)  for  functional 
differentiation. Total RNA was isolated after 24 h (β casein mRNA accumulation is 
high at this point) of incubation with DIP and  reverse transcribed into  cDNA that 
served  as  a  template  in  Real Time  PCR  reactions.  Primers  specific  for  β casein 
(differentiation marker) or the 18S ribosomal subunit were used. Total proteins were 
isolated after 4 days of stimulation with DIP (β casein protein expression is high at this 
time point) and western immuno blotted with an anti β casein antibody. To control the 
equal  loading  the  membrane  was  stripped  and  reprobed  with  an  anti  β tubulin 
antibody. 
 
Figure 3.37 Down regulation of Id2 by siRNA inhibits expression of milk protein β casein. HC11 
cells stably expressing siRNA against Id2 were induced with DIP. (A) After 24h lactogenic stimulation 
the mRNA was isolated and reversed transcribed into cDNA which was used as template in Real Time 
PCR reactions run with primers specific for β casein and 18S ribosomal subunit which serve as internal 
loading control. (B). After 96 h of lactogenic stimulation total proteins were extracted and western 
immuno blotted with antibody specific for β casein. To control the equal loading of the samples the 
membrane was reprobed with anti β tubulin antibody.  
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As can be seen in Figure 3.37A the silencing of Id2 expression by siRNA 7 or 9 leads 
to  a  clear  reduction  of  β casein  mRNA.  The  obtained  Real Time  PCR  data  are  in 
correlation  with  results  from  western  blot  analysis  showed  in  Figure  3.37B.  The 
expression  of  β casein  protein  is  clearly  reduced  in  comparison  to  control  cells 
transduced  with  empty  vector.  These  results  clearly  show  that  Id2  is  involved  in 
transcriptional  regulation  of  β casein  and  indicate  that  Id2  is  one  of  the  major 
regulators of the terminal differentiation of HC11 cells in vitro. 
3.4.5  Morphological  differentiation  of  HC11  cells  expressing  siRNA 
targeting Id1 
If mammary epithelial cells are seeded in a three dimensional context they are able to 
form  branch like  structures.  It  order  to  study  the role  of  Id1  in  the  morphological 
differentiation of mammary epithelial cells, the HC11 cells stably expressing siRNA 
A115, which silence Id1 expression (Figure 3.36) and control HC11 cells transduced 
with empty vector, were seeded in a collagen gel, and induced for differentiation. After 
8 days of cultivation the formation of branch like structures was analyzed under the 
fluorescence  microscope.  The  presence  of  GFP  positive  branch like  structures 
confirmed that they are exclusively formed by HC11 cells transduced with lentiviral 
particles and not by non transduced HC11 cells. 
 
Figure 3.38 Inhibition of branching due to silencing of Id1 protein expression. Around 2000 HC11 
cells stably expressing siRNA against Id1 were seeded in 100  l of collagen gel and were induced for 
differentiation. After 8 days the picture was taken using the fluorescence microscope associated camera. 
GFP protein is a marker for transgene positive HC11 cells expressing siRNA targeting Id1. 
 
 
 
Control   siRNA Id1 Results 
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As can be seen in Figure 3.38, HC11 cells stably expressing siRNA silencing Id1 were 
not able to drive the morphological differentiation. No or only small branches were 
observed. The cell growth is not totally impaired indicating that the cells were not able 
to invade the stroma. Most of cells formed only globular colonies. The control HC11 
cells transduced with empty vector formed normal branch like structures indicating 
that expression of GFP did not influence the morphological differentiation process. 
The obtained results are due to silencing of Id1 expression. The experiment indicates 
that Id1 controls the ability of HC11 cells to invade the stroma ultimately influencing 
the formation of branch like structures. In addition, it seemed that also proliferation 
was reduced, which could have contributed to the reduced outgrowth. Therefore in 
next experiment the effect of silencing of Id1 on HC11 cell proliferation was measured 
using the XTT proliferation assay. 
3.4.6 Proliferation of HC11 expressing siRNA silencing Id1 
The  experiment  using  3D  cultures  indicated  that  Id1  regulates  the  morphological 
differentiation of mammary epithelial cells. Since Id1 has been shown to be involved 
in the regulation of epithelial cell proliferation it was necessary to investigate if the 
inhibition of branching is due to a reduction in mammary epithelial cell proliferation. 
Therefore, proliferation rate of HC11 cells stably expressing siRNA A115 targeting 
Id1  mRNA  was  compared  with  control  cells  transduced  with  empty  vector.  The 
number of living cells was measured every 24 h using the XTT proliferation assay.  
 
Figure 3.39 The siRNA targeting Id1 inhibits proliferation of HC11 cells in vitro. The HC11 cells 
were  stably  transduced  with  empty  lentiviral  particle  or  lentiviral  vector  expressing  siRNA A115 
targeting Id1. 5x10
3 of transduced HC11 cells were seeded in a 96 well plate in growing medium and 
cultured for the next 96 h at 37°C. The amount of living cells was quantified by using the XTT assay at 
indicated time points.  
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As shown in Figure 3.39 the silencing of Id1 expression by siRNA clearly inhibited the 
proliferation of HC11 cells in comparison to control cells. The experiment indicated 
that Id1 is one of the regulators of proliferation of mammary epithelial HC11 cells. 
Reducing  its  expression  inhibited  cell  growth  possibly  blocking  the  morphological 
differentiation in a collagen gel.  
The obtained results parallel the studies performed with rapamycin, presented in first 
part  of  this  work.  Treatment  with  rapamycin  negatively  influenced  branching  and 
proliferation. The results obtain with HC11 silencing Id1 in 3D culture was similar to 
the action of rapamycin on the morphological differentiation of HC11 cells in the gels. 
Rapamycin inhibits also expression of β casein, whose expression was dependent on 
Id2.  The  siRNA  and  the  rapamycin  experiments  show  that  mTOR  regulates 
proliferation  and  differentiation  of  mammary  epithelial  cells  by  controlling  the 
expression of Id1 and Id2. 
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4. DISCUSSION 
The development of organs requires a perfect coordination of multiple extracellular 
signals to assure a perfect balance between growth, proliferation, and differentiation. 
This is essential to achieve and maintain the specialized functions of tissue structures. 
Many signaling pathways and their activated targets genes involved in regulation of 
organogenesis are still unknown. This work contributes to a better understanding of the 
intracellular pathways and the transcriptional events, which regulate the process of 
mammary gland development. The importance of the obtained data presented in this 
work will be discussed in more detail below. 
4.1  The  mTOR  pathway  plays  a  role  in  proliferation  and 
differentiation of the mammary gland 
The mTOR signaling pathway was implicated in controlling many cellular functions 
(Schmelzle  and  Hall,  2000).  However,  the  role  of  the  mTOR  pathway  in  the 
development of mammary gland had not been studied in detail. Therefore, the activity 
of mTOR was inhibited with rapamycin, and the consequences on proliferation and 
differentiation of mammary epithelial cells were studied in this work. 
4.1.1 HC11 cells as a model system to study the mTOR pathway  
The development of the mammary gland occurs mainly after birth and unlike for most 
other organs, the experiments on developmental regulation can be performed in adult 
organisms. During each pregnancy a cycle of proliferation, functional differentiation 
and massive apoptosis occurs in the mammary gland. The mammary gland reaches the 
peak  of  its  development  during  pregnancy  when  mammary  epithelial  cells  start  to 
proliferate extensively, to extend the ductal system and to form alveolar units. The 
epithelial  cells  contributing  to  the  alveolar  compartment  terminally  differentiate, 
become functional and start to secrete milk, which is necessary for proper development 
of  newborns.  Therefore,  the  mammary  gland  is  a  perfect  system  for  studying  the 
pathways and genes regulating the process of organogenesis (Medina, 1996). However, 
molecular  analysis  of  signaling  pathways  in  mammary  epithelial  cells  in  vivo  is 
complicated  by  the  presence  of  other  cell  types  in  the  gland  like  adipocytes  and 
fibroblasts, contributing to the mammary gland stroma. Therefore, the initial studies 
were performed using an in vitro model.  Discussion 
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The  isolated  mammary  epithelial  cell  line  HC11  shows  similar  characteristics  as 
mammary  epithelial  cells  in  vivo.  The  HC11  cell  line  is  an  established  mammary 
epithelial cell line selected as a cell clone from the COMMA 1D cell line, which was 
initially isolated from a mid pregnant Balb/c mouse (Ball et al., 1988). Stimulation 
with  hormones  leads  to  proliferation  and  functional  differentiation  of  these  cells 
(Wartman  et  al.  1996).  Terminal  differentiation  can  be  monitored  by  studying  the 
expression level of β casein mRNA and protein, which is a component of milk and 
serves as a marker for functionally differentiated mammary epithelial cells. The HC11 
cell system has been used in this work to analyze the role of the mTOR pathway on 
proliferation  and  differentiation  of  mammary  epithelial  cells.  The  results  were 
compared to results obtained with primary mammary epithelial cells and showed that 
HC11 cells are able to respond in similar way to freshly isolated cells (Figure 3.1 and 
3.14). These experiments clearly show that HC11 cells can be used as a model system 
to study the role of signaling pathways essential for mammary gland development. 
4.1.2  Morphological  differentiation  of  mammary  epithelial  cells  can  be 
studied in 3D culture 
The inhibition of mTOR with rapamycin influenced the morphological differentiation 
of mammary epithelial cells. It is not possible to investigate the effect of the drug on 
cell  morphogenesis  in  petri dish,  since  the  cells  can  only  grow  in  two  dimensions 
resulting in a single layer of cells. The use of a 3D culture system allows epithelial 
cells to proliferate and to form structures that resemble the glandular organization of 
the  cells  in  vivo.  The  3D  cultures  have  been  used  in  the  past  also  to  investigate 
pathways required for branching and alveolar morphogenesis (Niemann et al., 1998). 
For  example,  to  study  oncogene  induced  changes  in  the  morphology  of  mammary 
epithelial cells (Shaw et al., 2004) and to analyze epithelial plasticity and metastasis 
(Jeschlinger et al., 2002) as well as to investigate mechanisms governing apoptosis in 
normal and malignant mammary epithelial cells (Weaver and Bissell, 1999).  
Therefore, in this study the 3D culture system was chosen to study the role of mTOR 
in mammary epithelial morphogenesis. If the HC11 cells are seeded in a collagen gel 
or matrigel they  form branch like structures (Figure 3.4).  The studies in this work 
using  the  3D  culture  system  showed  that  the  morphological  differentiation  was 
inhibited by rapamycin treatment (Figure 3.5). The same effect on morphogenesis was 
observed when Id1 was silenced with siRNA (Figure 3.38).  Discussion 
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This  result  corresponds  to  other  studies  showing  that  Id1  is  an  important  factor 
regulating proliferation, migration and invasiveness of normal (Lin et al., 1999) as well 
as of cancer cells (Norton, 2000; Sikder et al., 2003). Moreover, over expression of the 
Id1 protein in HC11 cells prevented the inhibition of morphological differentiation 
with rapamycin indicating that mTOR may regulate the proliferation and migration by 
influencing Id1. The Id1 protein has been shown to be expressed at high levels during 
puberty and early pregnancy, when cells proliferate and migrate into the stroma to 
form  the  ductal  system  (Parrinello  et  al.,  2001;  Richter  et  al.,  2000).  Also  insulin 
signaling  has  previously  been  implicated  in  regulation  of  ductal  morphogenesis 
(Hadsell and Bonnette, 2000). In agreement with this observation, both mTOR (Rosen 
et  al.,  1999)  and  Id1  (Navarro  et  al.,  2001;  Belletti  et  al.,  20002)  are  downstream 
components of insulin signaling. From the 3D culture study presented here it can be 
concluded that mTOR mediates signals from insulin to Id1, which in turn regulate 
proliferation and migration of mammary epithelial cells leading to the formation of the 
ductal system during mammary gland development.  
4.1.3 The mTOR pathway controls the proliferation of mammary epithelial 
cells 
The analysis of branch like growth of HC11 cells in 3D cultures indicates that mTOR 
plays an important role in the regulation of morphological differentiation. It seemed 
that  proliferation  was  reduced  if  the  drug  was  added  to  HC11  cells,  which  is  not 
surprising since rapamycin has been shown in other studies to reduce proliferation of 
normal as well as of malignant cells (Metcalfe et al., 1997; Hidalgo and Rowinsky, 
2000).  The  performed  proliferation  assay  confirmed  that  rapamycin  reduced  the 
proliferation rate of HC11 cells (Figure 3.6), indicating that the inhibition of branch 
like structure formation by rapamycin was in part due to a reduction of proliferation. 
Like in the case of rapamycin treated cells, the growth rate of HC11 cells in which the 
expression  of  Id1  was  silenced  with  siRNA  resulted  in  a  similar  inhibition  of 
proliferation  (Figure  3.39).  From  these  results  it  can  be  concluded  that  rapamycin 
reduced  the  proliferation  of  mammary  epithelial  cells  by  inhibiting  mTOR,  which 
caused the down regulation of the expression of Id1 (Figure 3.12).  Discussion 
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4.1.4 The mTOR pathway is essential for the functional differentiation of 
mammary epithelial cells  
4.1.4.1 Rapamycin inhibits β casein expression in vitro 
The  expression  of  the  milk  protein  β casein  serves  as  a  marker  for  terminally 
differentiated secretory cells. This protein can be detected in the mammary gland of 
late pregnant mice and is highly expressed during lactation. The HC11 cells can be 
induced for functional differentiation by adding a lactogenic hormone mix (DIP) to the 
medium (Figure 3.1). It was shown that expression of β casein is dependent on an 
intact mTOR signaling pathway. By adding rapamycin into the medium HC11 cells 
stop to express β casein on the protein as well as on the mRNA level (Figure 3.2). This 
indicates that mTOR controls the expression of β casein not (only) on the translation 
level, although the control of translation is a well known major function of mTOR 
(Schmelzle  and  Hall,  2000).  It  also  regulates  the  expression  of  β casein  on  the 
transcriptional or post transcriptional level. To confirm that the results obtained with 
HC11  cells  are  not  only  true  for  this  in  vitro  established  epithelial  cell  line  the 
influence of rapamycin on functional differentiation was also investigated on primary 
mammary epithelial cells. Therefore, the freshly isolated primary mammary epithelial 
cells were induced for differentiation while mTOR was blocked. Like in HC11 cells, 
rapamycin also blocked the terminal differentiation of primary cells as shown by the 
lack of β casein protein in the treated cells (Figure 3.14).  
The  fact,  that  mTOR  plays  a  role  in  differentiation  is  consistent  with  recent  data 
showing a role for mTOR in the regulation of differentiation of many other types of 
cells. It was shown to be involved in differentiation of Drosophila melanogaster cells 
(Bateman et al., 2004). Furthermore, the differentiation of megakaryocytes (Raslova et 
al., 2006), myoblast (Sarker et al., 2004) and vascular smooth muscle cells (Martin et 
al., 2003), the differentiation of female granulosa cells (Alam et al., 2004), the control 
of adipogenesis in murine (Yeh et al., 1995) and human adipocytes (Bell et al., 2000) 
were all found to be regulated by the mTOR signaling pathway. 
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4.1.4.2 Intact mTOR signaling is essential during mammary gland development 
To  study  the  role  of  mTOR  in  vivo  mid pregnant  female  mice  were  injected  with 
rapamycin. However, the used drug concentration had an acute teratogenic activity, 
and  completely  inhibited  the  development  of  embryos  (Figure  3.15),  making  it 
impossible to study the effects of rapamycin on the mammary gland during pregnancy. 
This inhibitory effect of rapamycin on embryonic development is in correlation with 
other  studies  showing  that  functional  mTOR  is  required  during  early  embryonic 
development to support growth and proliferation of embryonic stem cells (Gangloff et 
al., 2004; Murakami et al., 2004). To overcome this limitation it is possible to study 
the effect of rapamycin on ductal and alveolar formation during pregnancy in vitro 
using whole organ cultures of the mammary gland. In such a culture the development 
of the mammary gland can be stimulated by the addition of lactogenic hormones and is 
in this way independent of pregnancy (Ginsburg and Vonderhaar, 2000).  
It was possible to investigate the role of mTOR during proliferation and differentiation 
of epithelial cells in the lactating mammary gland in vivo. Mice were treated starting at 
day 19 of pregnancy and up to 10 days of lactation before the mammary glands were 
isolated. Lactating glands from rapamycin treated mice appeared smaller; the volume 
of secretory  compartment was less developed in comparison with the control mice 
(Figure 3.19). This was accompanied by a decreased wet weight (Figure 3.17) and a 
decreased milk production, explaining the decreased gland mass and the reduced gain 
of weight of the pups (Figure 3.16). The histological analysis of glands of the treated 
mothers showed that the lumina of the alveoli were less extended than the controls, 
confirming the reduction in milk production. The alveolar cells still had a cuboidial 
shape similar to the epithelial cells at the beginning of functional alveoli formation 
indicating that the cells were not fully differentiated. As expected, a reduction in the 
amount  of  β casein  was  detected  in  protein  extracts  of  rapamycin treated  glands 
(Figure  3.20),  which  correlated  with  the  decrease  in  volume  of  functionally 
differentiated  secretory  compartment  in  mammary  glands  of  treated  mice  (Figure 
3.19). Taken together, these in vitro and in vivo results showed that mTOR is required 
to establish the secretory function of mammary epithelial cells. Discussion 
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4.1.4.3  The  mTOR dependent  expression  of  β casein  is  not  mediated  by  Stat5 
signaling. 
The inhibition of mTOR with rapamycin had no influence on the stability of β casein 
mRNA  as  indicated  by  experiments  using  actinomycin  D  (Figure  3.3).  Therefore 
inhibition of mTOR must influence other important signaling pathways controlling the 
functional differentiation and transcription of the milk protein β casein gene.  
To induce terminal differentiation and expression of β casein a mixture of lactogenic 
hormones (DIP) was used. These lactogenic hormones (dexamethasone, insulin and  
prolactin) in turn activate three major signaling pathways regulating the transcription 
of target genes involved in differentiation, including the milk genes (Hennighausen, 
1997). The prolactin pathway is a very important pathway in this respect and regulates 
the phosphorylation and activation of Stat5 (Gouilleux et al., 1994). Stat5 is the major 
player  in  prolactin activated  signaling  governing  proliferation  and  functional 
differentiation of alveolar epithelial cells (Miyoshi et al., 2001), and is also required 
for the maintenance of their secretory ability during lactation (Cui et al., 2004). From 
these data it can be surmised that rapamycin prevents β casein expression by inhibiting 
the Stat5 signaling. However, western blot analysis showed that rapamycin has no 
influence  either  on  phosphorylation  of  Stat5  (Figure  3.7)  or  on  the  nuclear 
translocation  of  Stat5  (Figure  3.8).  Both  experiments  showed  that  there  was  no 
significant  difference  between  treated  and  control  cells.  Finally,  luciferase  assays 
revealed that the transcriptional activation of the target gene by Stat5 was comparable 
in treated and control cells (Figure 3.9). From these results it can be concluded that 
mTOR  mediates  its  effect  on  the  differentiation  of  mammary  epithelial  cells 
independently of the Prolactin/Stat5 signaling.  
The mTOR protein is a down stream target of the insulin signaling pathway (Wang et 
al., 2006). Many studies have shown that activation of the insulin pathway is required 
for the expression of milk proteins (Rosen et al., 1999). Maximal activation of β casein 
expression in vitro requires insulin in addition to prolactin (Henninghausen, 1997). 
Insulin signaling regulates the activity of Idb proteins (Belletti at al., 2002; Navarro et 
al.,  2001),  which  are  crucial  for  milk  protein  expression  (Parrinello  et  al.,  2001). 
Therefore, in this work it was tested if mTOR influences the functional differentiation 
and the level of β casein through regulation of Idb protein expression. The results are 
discussed in the following chapter. Discussion 
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4.1.5  mTOR  controls  morphological  and  functional  differentiation  of 
mammary epithelial cells through Idb proteins. 
The important question remaining to be answered was how mTOR actually controls 
the fate of mammary epithelial cells. Various experiments performed in this work have 
shown  that  proliferation  and  differentiation  of  mammary  epithelial  cells  can  be 
blocked.  First,  inhibition  of  mTOR  with  rapamycin  blocks  both  proliferation  and 
morphological  differentiation  of  mammary  epithelial  cells  in  vitro.  Similar  effects 
could be observed when HC11 cells were stably transduced with siRNA silencing the 
expression  of  Id1.  Intact  mTOR  signaling  was  also  essential  for  proper  functional 
differentiation of mammary epithelial cells in culture. Treatment of female mice with 
rapamycin during lactation impaired milk protein expression. Reducing the expression 
of  Id2  by  siRNA  decreased  the  β casein  level,  indicating  a  block  in  functional 
differentiation. 
These  observations  raised  the  question  if  mTOR  regulates  the  proliferation  and 
differentiation by influencing the expression of Idb proteins. Indeed, cells treated with 
rapamycin showed a reduced level of Id1 during proliferation. More importantly, over 
expression  of  Id1  in  HC11  cells  completely  rescued  the  mammary  cells  from  the 
inhibitory effect of rapamycin on proliferation confirming the essential role of Id1 in 
proliferation. Interestingly, the cells over expressing Id1 were not able to functionally 
differentiate and have a reduced level of Id2 (Figure 3.28). The results indicate that Id1 
in  addition  to  promote  proliferation  inhibits  the  expression  of  Id2,  blocks 
differentiation, and confirm a previously postulated model of Idb protein action in the 
mammary gland (Desprez et al., 2003). In protein extracts isolated from rapamycin 
treated cultures and from the lactating gland, a reduction in the level of milk protein β 
casein was accompanied by a decrease in the Id2 level (Figure 3.20). The cells over 
expressing  Id2  could  bypass  the  requirement  of  functional  mTOR  for  β casein 
expression (Figure 3.30). The results demonstrate for the first time a central role for 
mTOR  in  the  precise  regulation  of  pathways  governing  proliferation  and 
differentiation  of  mammary  epithelial  cells  in  the  developing  mammary  gland  and 
identify the Id1 and Id2 as major downstream mediators of mTOR action. 
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4.1.5.1 mTOR regulates Idb expression on the mRNA level 
Rapamycin treatment during proliferation down regulates the mRNA of Id1 (Figure 
3.12)  whereas  rapamycin  addition  to  induced  cells  reduced  the  Id2  mRNA  level 
(Figure 3.13). Regulation of Id1 and Id2 by mTOR on the mRNA level was surprising, 
since the mTOR signaling pathway is known to affect the expression of genes involved 
in  the  protein  translation  machinery.  mTOR  regulates  the  initiation  of  protein 
translation by controlling the activity of its down stream targets eIF4E/4E BP1 and 
S6Kinase (Manteuffel et al., 1996; Brown et al., 1995). Therefore, the regulation of Id1 
and Id2 on the mRNA level is probably only indirectly affected by mTOR possibly via 
the enhanced or decreased translation of certain transcription factors important for Id1 
and Id2 expression.  
4.1.5.2 Potential transcriptional regulation of Idb proteins by C/EBPβ β β β 
Since Id1 and Id2 are regulated on the mRNA level, a specific transcription factor is 
involved  in  their  transcriptional  regulation,  which  also  plays  a  role  in  the  mTOR 
pathway. The C/EBPβ transcription factor could be an interesting candidate, since it is 
activated by the insulin pathway. 
The insulin/PI3K pathway induces the activation of mTOR and has been shown to 
dramatically increase the phosphorylation of the mTOR down stream targets S6Kinase 
and 4E BP1 involved in the regulation of protein expression on the translational level 
(Chung et al., 1994; Brunn et al., 1996; Brunn et al., 1997). An intact insulin/IGF 
pathway  is  essential  for  terminal  end  bud  formation,  for  ductal  morphogenesis 
(Kleinberg et al., 2000) as well as for proper lactation during functional differentiation 
of the mammary gland (Lau et al., 1993). Furthermore, insulin has been shown to 
regulate the transcription of C/EBPβ in adipocytes, which plays an essential role in 
proper  formation  of  the  mammary  gland  (MacDougald  et  al.,  1995).  The  C/EBPβ 
protein  (CCAAT/enhancer  binding  protein  β)  is  a  member  of  a  highly  conserved 
family  of  transcription  factors,  which  belongs  to  the  leucine  zipper  class  of  DNA 
binding  proteins  (Lekstrom  et  al.,  1998).  C/EBPs  contain  an  amino  terminal 
transactivation domain followed by a highly basic DNA binding region, and a carboxy 
terminal leucine rich dimerization domain (Landschulz et al., 1989).  Discussion 
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They can form dimers with other C/EBP family members, or with different groups of 
leucine zipper proteins. Dimerization is essential for their transcriptional activity (Patel 
et al., 1994).  
The C/EBPs transcription factors are involved in the regulation of proliferation and 
differentiation of a number of cells and tissue types, including the mammary gland 
(Grimm et al., 2003).  Mice deficient for C/EBPβ were  generated  (Screpanti et al., 
1995) and development of the mammary gland was found to be impaired. In particular 
the ductal morphogenesis in the knock out virgin mouse was found to be affected, 
showing  distended  ducts  and  decrease  branching.  In  addition,  the  lobuloalveolar 
proliferation and functional differentiation of mouse epithelial cells during mammary 
gland  development  was  affected.  Furthermore,  the  expression  of  the  functional 
differentiation  marker  β casein  was  dramatically  inhibited  in  C/EBPβ  null  glands 
(Seagroves et al., 1998). These observations resemble the phenotype seen in rapamycin 
treated cells or mice. 
Transcription of the C/EBPβ gene results in a unique intronless mRNA that can be 
translated  via  alternative  start  sites  into  three  isoforms:  full  length  liver enriched 
transcriptional activator protein LAP1, a shorter isoforms LAP2, and a transcriptional 
inhibitory protein  LIP. The  LIP protein lacks more than half of the transactivation 
domain and as a consequence is not able to activate gene transcription. LIP can thus 
compete  with  LAP  for  the  same  DNA  binding  site  as  homodimer  or  by  forming 
heterodimers with LAP, blocking the transcription of LAP target genes. Since the LIP 
isoform  has  a  high  affinity  for  DNA  the  inhibitory  effect  occurs  even  at 
substoichiometric ratios of LIP: LAP (Descombes et al., 1991). LAP expression is not 
changing dramatically during mammary gland development, the protein level increases 
2 3 fold at onset of pregnancy and decreases at parturition. It is readily detectable 
again during lactation and involution. The LIP isoform is expressed at low level in the 
virgin  gland  and  is  strongly  upregulated  (about  100  fold)  during  pregnancy.  At 
parturition  the  LIP  level  decreases  to  almost  undetectable  and  stays  low  during 
lactation (Raught et al., 1995 Seagroves et al., 1998). Therefore the LIP: LAP ratio is a 
very important determinant of the overall C/EBPβ function during mammary gland 
development.  
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The translational regulation of the C/EBP isoforms (Calkhoven et al., 2000) by mTOR 
during mammary gland development might be the mechanism by which the mTOR 
pathway affects proliferation and differentiation of mammary epithelial cells (Jundt et 
al., 2005; Kim et al., 2004). Similar to the inhibition of mTOR by rapamycin, the lack 
of C/EBPβ in mammary cells severely inhibits the expression of β casein. Moreover, 
the phenotype of mammary glands treated with mTOR inhibitor was close to that of 
C/EBPβ null gland, which displayed only limited lobuloalveolar development of the 
mammary gland in response to pregnancy hormones (Robinson et al., 1998; Seagroves 
et al., 1998). Interestingly, the C/EBPβ null mammary gland phenotype resembles that 
of the gland of Id2 null mammary epithelium, where the formation of the functional 
secretory alveolar compartment is impaired and the expression of β casein is clearly 
reduced (Mori et al., 2000). More importantly, preliminary evidence linking C/EBPβ 
to Id2 was recently provided by a study, which demonstrated that Id2 is a direct target 
of  C/EBPβ  since  the  expression  of  Id2  is  reduced  during  pregnancy  in  C/EBPβ 
deficient mammary glands (Karaya et al., 2005). Additionally, it has previously been 
shown that Id1 is regulated by C/EBPβ in pro B cells (Saisanit et al., 1997). However, 
if mTOR controls Id1 and/or Id2 protein expression through the regulation of C/EBPβ 
protein has to be investigated in more detail.  
4.1.5.3 Potential regulation of Idb proteins by HIF 
The downstream targets of mTOR influencing the regulation of Idb protein expression 
might  vary  depending  on  the  developmental  stage  of  the  mammary  gland,  and  as 
discussed above, other transcription factors regulated by mTOR pathway might play a 
role.  In this respect it is of interest to mention hypoxia inducible factor 1 (HIF1). 
Treatment of mice with the mTOR inhibitor rapamycin during lactation resulted in a 
phenotype similar to that of mice deficient for the transcription factor HIF1 (Seagroves 
et  al.,  2003).  Although  the  mammary  glands  of  these  mice  displayed  normal 
development of the alveolar compartment during pregnancy, loss of HIF1 leads to a 
defect in terminal differentiation. The lactation was impaired and striking changes in 
the milk composition were observed (Seagroves et al., 2003). The insulin/PI3K/mTOR 
pathway regulates HIF1 protein expression through a translation dependent pathway 
and is required for transcriptional activity of HIF1 (Dekanty et al., 2005, Treins et al., 
2002).  Discussion 
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It can thus be surmised that rapamycin inhibiting insulin/PI3K/mTOR signaling affects 
the function of the lactating mammary gland at least partly due to a reduction of HIF1 
protein translation. Moreover, recent studies have provided evidence that Id2 is a novel 
target of HIF1. Id2 expression is regulated by HIF1, since it induces the transcription 
of the Id2 gene in response to hypoxia in neuroblastoma cell lines (Lofstedt et al., 
2004).  Interestingly,  the  activation  of  HIF1  by  the  PI3K/Rheb/mTOR  pathway  is 
necessary for induction of several protein markers of follicular differentiation (Alam et 
al., 2004). 
Thus, a model can be postulated in which mTOR signaling during development of the 
mammary gland controls the translation of the HIF1 protein. HIF1 in turn activates the 
transcription of the Id2 gene, promoting functional differentiation and milk secretion in 
mammary  alveolar  cells  during  lactation.  Further  studies  will  be  necessary  to 
investigate this model. 
 
Figure 4.1 Model of regulation of the Id1 and Id2 protein level by the mTOR signaling pathway 
during proliferation and differentiation of mammary epithelial cells. The mTOR pathway, activated 
by  nutrients  and  growth  factors  may  stimulate  translation  of  HIF1  and/or  C/EBPβ  or  unknown 
transcription factor (UTF). These transcription factors in turn are potentially involved in the activation 
of the transcription of Id1 or Id2. Id1 promotes proliferation by counteracting the anti proliferative 
action of bHLH protein (TF1). Id2 promotes differentiation by inhibiting the action of TF2 which is an 
inhibitor of differentiation. Dotted lines indicate a possible link. 
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4.1.6 Role of mTOR and Idb proteins in cancer 
Apart from its role during the development of the mammary gland, the mTOR pathway 
has been implicated in  development of cancer.  Several studies clearly showed that 
various components of the mTOR signaling pathway, including PI3K, Akt, Rheb, Pten, 
TSC upstream of mTOR as well as the mTOR downstream targets 4EBP, eIF4E and 
S6  Kinase  which  are  involved  in  regulation  of  translation,  are  frequently  mutated, 
over expressed  or  deregulated  during  tumor  development.  Inhibitors  of  the  mTOR 
pathway are currently used in several clinical studies to treat various types of tumors, 
including breast cancer. The investigations performed in patients revealed, however 
differences  in  patient  responses  and  drug  efficacy  (Janus  et  al.,  2005:  Hynes  and 
Boulay,  2006).  To  develop  a  more  tolerable  but  efficient  anti cancer  treatment 
targeting  the  mTOR  signaling  pathway  it  is  crucial  to  identify  more  downstream 
targets (genes and proteins) regulated by mTOR.  
To gain a better understanding of the function of mTOR in mammary tumorigenesis 
the role of mTOR during normal mammary gland development was investigated in this 
work. Obviously, mTOR controls the proliferation and differentiation  of mammary 
epithelial cells through Id1 and Id2, respectively. Interestingly, overexpression of Id1 
correlates with an aggressive form of breast tumors (Lin et al., 2000) whereas Id2 
maintains a differentiated and non invasive phenotype of breast cancer cells (Itahana et 
al.,  2003).  Deregulation  of  the  expression  of  Id1  and  Id2  proteins  also  altered 
proliferation  and  differentiation  of  many  other  cell  types  resulting  in  uncontrolled 
growth and increase invasiveness (Perk et al., 2005).  
As discussed above, the Idb proteins were shown to be regulated by C/EBPβ (Saisanit 
et  al.,  1997;  Karaya  et  al.,  2005).  Interestingly,  an  increased  level  of  one  of  the 
downstream targets of mTOR (eIF4E) favors LIP translation (Calkoven et al., 2000) 
and  eIF4E  over expression  correlates  with  high  level  of  LIP  translation  found  in 
tumors (DeBenedetti et al., 1999). However, if mTOR controls Id1 and/or Id2 protein 
expression  through  the  regulation  of  translation  of  C/EBPβ  isoforms  in  normal 
mammary gland and the role of mTOR/C/EBPβ/Idb axis in cancer development has to 
be investigated in more detail. The presented findings broadening our understanding of 
the  events  that  contribute  to  breast  cancer  development  and  should  help  to  design 
better anticancer therapies targeting the components of the mTOR pathway including 
its downstream targets contributing to cancer.  Discussion 
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4.1.7 Conclusions and Outlook 
The  analysis  of  the  effect  of  inhibiting  the  mTOR  signaling  pathway  by  using 
rapamycin on mammary epithelial cells for the first time demonstrate that mTOR plays 
a  central  role  in  the  coordination  of  pathways  governing  the  proliferation  and 
differentiation of epithelial cells during mammary gland development. More detailed 
analysis led to the identification of Id1 and Id2 as two major down stream effectors of 
the mTOR signaling pathway regulating proliferation and differentiation respectively. 
These findings clearly contribute to our understanding of the signals regulating the 
expression of the genes involved in the development of mammary gland.  
Future studies will be performed to investigate the effect of mTOR inhibition during 
puberty and pregnancy, using for example whole organ gland cultures. Studying the 
components  of  the  mTOR  pathway  especially  downstream  of  mTOR  will  help  to 
identify their role in tumor development and/or progression.  
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4.2  Identification  of  genes  involved  in  mammary  gland 
development may help to identify factors essential for breast 
cancer 
Breast cancer is the leading cause of cancer related deaths among women around the 
world. The factors that contribute to breast cancer development can be divided into 
genetic and non genetic components. Genetically inherited breast cancer accounts for 
around  10%  of  all  breast  cancer  cases  (Nathanson  et  al.,  2001).  However,  the 
development  of  the  majority  of  diagnosed  breast  cancers  appears  to  be  primarily 
induced  by  non genetic  factors  like  diet,  obesity,  alcohol  consumption,  age,  race, 
geographic location, parity, early menarche, late menopause, use of postmenopausal 
hormones, ect. (Ketcham and Sindelar, 1975; Russo and Russo, 1999; Lichtenstein et 
al.,  2000).  These  non genetic  factors  cause  genetic  alterations  leading  to  the 
deregulation  of  the  expression  profile  of  genes  governing  proliferation  and 
differentiation (Perou et al., 1999). Knowing the gene expression profile during normal 
mammary gland development will be important to understand the molecular basis of 
breast cancer induction. Identification of potent genes involved in the regulation of 
growth and differentiation will help to design more effective anti cancer drugs, since 
deregulation of such genes can possibly be observed in breast cancer samples (Perou et 
al 2000; Desai et al., 2002). Therefore, in this study the gene expression profile of 
mammary epithelial cells was analyzed in detail and HC11 cells were used for this 
purpose. This immortal cell line was established as a cell clone from COMMA 1D 
cells initially isolated from a mid pregnant Balb/c mouse (Ball et al., 1988). The HC11 
cells  are  able  to  grow  and  functionally  differentiate  when  induced  with  lactogenic 
hormones in vitro (Wartman et al. 1996). The terminal differentiation is accompanied 
by  an  increase  in  the  level  of  total  mRNA  expression,  which  at  later  stages  of 
differentiation correlates with the appearance of β casein protein (Rosen et al., 1999). 
To  characterize  the  genes  that  are  involved  in  proliferation  and  differentiation  of 
mammary  epithelial  cells  the  expression  patterns  of  HC11  cells  during  growing, 
competent  and  induced  stage,  were  compared  to  each  other  using  the  microarray 
technology. The important findings will be discussed in the following chapters. 
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4.2.1  The  use  of  microarrays  allowed  the  identification  of  differently 
expressed genes. 
The first arrays were performed with radioactively labeled cDNA from one sample 
which  was  hybridized  to  cDNA  clones  of  a  second  sample  spotted  on  nylon 
membranes (Drmanac and Drmanac, 1994). Arrays on glass were first used to study 
the expression pattern of 45 selected genes of Arabidopsis thaliana (Schena et al., 
1995). Nowadays, thousands of cDNA clones are robotically spotted on chemically 
treated  glass  slides  giving  the  “printed”  microarray  containing  a  collection  of 
thousands of different genes (Eisen and Brown, 1999).  
The  microarray  technology  was  also  used  in  this  study  for  the  identification  of 
hundreds  of  genes  differently  regulated  during  proliferation  and  differentiation  of 
mammary  epithelial  cells.  The  obtained  data  provided  additional  insight  into  the 
molecular basis of mammary gland development (Rudolph et al., 2003). The RNA 
isolated  from  growing,  competent  and  induced  cells  were  directly  labeled  during 
Reverse  Transcription  PCR  with  one  of  the  two  (Cy 3  or  Cy 5)  fluorescent  dye 
conjugated deoxyuridine triphosphates (dUTPs)(Manduchi et al., 2002).  
The use of Cy 3 and Cy 5 labelled cDNA is important as a control. This color switch 
is  included  to  eliminate  false  positive  cDNAs  which  can  appear  as  results  of 
differences  in  incorporation  of  the  dye conjugated  nucleotide  during  labeling.  It  is 
known  that  Cy3 dUTP  is  more  efficiently  used  than  Cy5 dUTP  during  cDNA 
synthesis.  Furthermore,  it  is  possible  that  the  dye conjugated  nucleotide  is  not 
incorporated  with  the  same  efficacy  into  cDNA  transcribed  from  different  RNA 
sequences. The cDNA sequence during reverse transcription could have more or less 
dye incorporation than expected from the sequence, so the gene could appear in the 
microarray analysis to be down regulated although it is defacto up regulated in the 
tested sample and reversibly the gene that is normally activated appears to be silenced. 
The labeled cDNA samples were mixed in equal quantities in following pairs G/I and 
G/C and C/I and then hybridized to cDNA spotted on a microarray chip. The NIA chip 
used  in  this  study  was  a  PCR based  cDNA  library  and  contained  15,264  genes 
expressed during mouse embryonic development (Tanaka et al., 2000). In parallel, a 
second microarray was hybridized with the same RNA but the cDNA samples in each 
compared pair G/C, C/I or G/I had opposite dye labeling (Cy 3/Cy 5 color switch) in 
comparison to the initial array.  Discussion 
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With  the  microarray  technique  initially  the  differential  expression  of  around  3000 
genes was detected in the HC11 samples. Furthermore, around 1800 replicates in all 
hybridization experiments were identified (60% of the total detected genes). The color 
switch allowed identification of the genes which expression pattern was inconsistent. 
In total, 7% of the detected genes showed an inconsistent regulation pattern after the 
color switch. With this step false positive genes were eliminated from further analysis. 
4.2.2 Selection of candidate genes  
Around 1800 genes were identified in the micro array analysis, which were differently 
regulated during different stages of mammary epithelial cell culture. The genes that 
were expressed in growing cultures and showed a 2 fold up regulation compared to the 
induced stage were chosen for further analysis. Using this selection criteria around 397 
candidates  were  selected  as  proliferation  and  growth  associated  genes.  The  genes, 
which  were  2 fold  up regulated  in  induced  stages  in  comparison  to  growing  and 
competent  cultures  were  selected  as  differentiation  associated  genes.  Around  639 
candidate  genes  matched  these  criteria.  To  obtain  detailed  information  about  the 
selected genes the UniGene Databank as well as the Locus Link and the HomoGene 
databases were used. In this way it was possible to find out more about the function of 
the  selected  genes  and  if  they  are  known  to  play  a  role  during  mammary  gland 
development, during organogenesis or other important cellular processes. 
4.2.3 Characterization and functional analysis of genes identified in the 
microarray 
The differential expression of multiple genes was verified using Real Time PCR. The 
Real Time PCR analysis has confirmed the regulation for many genes whereas others 
showed an inconsistent regulation pattern and were not used for further analysis. The 
Idb genes were the first candidate genes analyzed in more detail, since their crucial 
role during proliferation and differentiation of  mammary  epithelial cells as well as 
mammary  gland  development  was  shown  in  previous  studies  (Mori  et  al.,  2000; 
Desprez et al., 2003). The analysis was performed with the HC11 cell model system 
and the expression pattern of the Idb genes in these cells served as a first control to 
verify microarray and PCR data.  
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Apart from Idb genes various other genes were found to be of interest and can be 
analyzed in a similar way in future studies. A selection of these genes will be described 
in the following chapters. They are possibly important players in proliferation and/or 
differentiation of mammary epithelial cells as well as in the process of tumorigenesis. 
4.2.3.1 Nkd2  
The  Nkd2  gene  (nacked  cuticle  2,  a  homolog  of  Drosophila  melanogaster  Nkd1) 
showed in micro array the expression pattern indicating its involvement in the process 
of regulation of the functional differentiation of mammary epithelial cells. The same 
regulation pattern of Nkd2 was found in Real Time PCR experiment, showing a 12.9 
fold up regulation in DIP induced cells.  
The Nkd2 protein has been shown to play a role in the regulation of the Wnt signalling 
pathway. The intracellular signaling events activated by Wnt proteins can be divided 
into two categories: canonical and noncanonical. One of the targets of the canonical 
Wnt pathway is β catenin (Peifer et al., 1992). In the absence of Wnt signaling, the β 
catenin  undergoes  phosphorylation dependent  ubiquitination  by  Dishevelled  which 
induces rapid degradation of β catenin by the proteasome (Aberle et al., 1997). The 
activation of the Wnt signaling stabilizes β catenin by antagonzing its phosphorylation. 
This leads to β catenin accumulation (Peifer et al., 1994) and its nuclear translocation 
(Schneider  et  al.,  1996).  To  stabilize  β catenin  the  Wnt  proteins  interact  with  the 
cytoplasmic  protein  Dishevelled.  Normally,  Dishevelled  inhibits  the  activities  of  a 
multiprotein complex, which function is to phosphorylate β catenin. In the nucleus, β 
catenin binds TCF/Lef family DNA binding proteins to directly regulate many Wnt 
responsive target genes (Riese et al., 1997).  
There  are  at  least  two  noncanonical  pathways,  which  do  not  involve  β catenin 
stabilization  and  accumulation  in  the  cytosol.  The  Wnt/PCP  (Planar  Cell  Polarity) 
pathway shares the Dishevelled protein with the canonical pathway (Strutt, 2003). This 
pathway is thought to regulate the expression of cytoskeletal elements and possibly of 
JNK (Yamanaka et al., 2002). The Wnt/Ca
2+ signaling also involves the Dishevelled 
protein  (Sheldahl  et  al.,  2003).  The  Wnt/Ca
2+  pathway  activates  the  release  of 
intracellular calcium that affects the function of calcium modulated kinases (Kuhl et 
al., 2000). 
 Discussion 
  149 
 
Figure 4.2 Model of regulation of Wnt signalling by Nkd2 during proliferation and differentiation. 
Activation of Wnt/β catenin signalin leads to extensive proliferation. Nkd may interact with Dishevelled 
to inhibit the canonical Wnt pathway. The Nkd2 may act then as a switch to direct the Dishevelled 
activity  towards  the  PCP  (Planar  Cell  Polarity)  pathway.  Proper  cell  polarity  is  required  for 
differentiation and polarized milk secretion. 
 
Excessive Wnt signaling can lead to an up regulated cell proliferation and therefore the 
activity of the Wnt pathway controlling development is auto regulated via a positive 
and negative feedback loop (Warton et al., 2001). Nkd2 is a cytoplasmic Wingless 
(Wg, Wnt protein) inducible protein that can bind the Dishevelled protein and thereby 
antagonize Wnt signaling (Rousset et al., 2001, Yan et al., 2001). The Nkd2 antagonist 
acts then in a negative feedback loop with Wg. The Nkd2 protein accumulates and 
inhibits Wnt signaling in proportion to the strength and duration of the Wg signal. 
(Zeng et al., 2000). The Wnt pathway has been also implicated in the regulation of 
mammary gland development.  
The  Wnt  proteins  stimulate  growth  of  mammary  rudiments  during  puberty  and 
regulate ductal branching and alveolar compartment morphogenesis during pregnancy 
(Brennan and Brown, 2004). Analysis of the expression pattern of Nkd2 in mammary 
epithelial  cells  predicts  that  the  level  of  Nkd2  protein  during  mammary  gland 
development is important to control the proper switch from extensive growth to pre 
differentiation.  The  Nkd2  protein  can  also  be  necessary  for  the  establishment  of 
mammary  epithelial  cells  in  the  induced  stage  by  blocking  the  Wnt  activated 
proliferation. Another important function of Nkd2 could involve the maintenance of 
the normal epithelial cell phenotype.  
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In this context it is of interest to mention that in 50% of human breast cancers the Wnt 
signalling  pathway  is  hyper active  as  measured  by  the  accumulation  of  β catenin 
(Brennan and Brown 2004). The role of Nkd2 in mammary gland development and 
tumorigenesis will be of high interest in the future. 
4.2.3.2 Nol5  
The Nucleolar protein 5 (Nol5) showed in the microarray analysis a higher expression 
level in growing cells and down regulation in induced cells. Real Time PCR analysis 
confirmed this expression pattern (7.5 fold up regulation in growing cells comparing to 
induced cells) indicating its possible contribution to regulate mammary epithelial cell 
proliferation.  Nol5  (known  also  as  SIK  similar  protein)  belongs  to  the  Nop5/Sik 
protein family that consists of highly conserved nucleolar proteins (Vorburggen et al., 
2000). The family members bind to the C/D box of small nucleolar RNA (Newman et 
al., 2000). The obtained complexes, known as small nucleolar ribonucleoproteins play 
an essential role in rRNA processing required for ribosome assembly (Maxwell and 
Fournier  1995).  Importantly,  their  functional  analysis  indicated  that  Nol5  increases 
rRNA synthesis (Nakamoto et al., 2001). As shown in this study elevated proliferation 
leads  to  the  expression  of  proteins  of  the  biogenesis  machinery  required  during 
proliferation. The elevated synthesis of new cellular components is necessary to enable 
cell  division.  The  function  of  the  Nol5  protein  in  stimulating  ribosome  biogenesis 
correlates well with the high Nol5 gene expression level observed in growing cells. 
Nol5 could be a mediator of hormone induced pathways regulating the level of protein 
biogenesis machinery components during the mammary gland development especially 
during  puberty  and  pregnancy,  when  the  mammary  epithelial  cells  extensively 
proliferate and need to constantly express the cellular building elements. 
Apart from its role during mammary gland development, Nol5 might play a role during 
cancer progression. Hypertrophy of the nucleolus is a characteristic cytological feature 
of cancer cells (Busch and Smetana 1970). The increased nucleolar size is thought to 
reflect the increase in activity of nuclear and nucleolar processes during the malignant 
progression of mammalian cells (Nakamoto et al., 2001). Nol5 might be essential for 
proliferation of cancer cells. Future detailed analysis of the function of Nol5 and other 
Nop5/Sik family members will show if these proteins can be considered as possible 
targets for the development of novel anticancer drugs. Discussion 
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4.2.3.3 Kpna2 
The Kpna2 gene (karyopherin (importin) alpha 2) on microarray and Real Time PCR 
analysis  was  found  to  show  a  higher  expression  level  (12  fold  up regulation)  in 
growing cells as compared to induced cells. Such an expression pattern indicates that 
Kpna2, like Nol5 might be involved in the proliferation process of mammary epithelial 
cells.  
The  karyopherins  play  a  key  role  in  the  nuclear  import  of  proteins  containing  a 
classical nuclear localization signal (NLS). Proteins smaller than 60 kDa can diffuse 
non selectively through the nuclear pore complex. The transport of larger proteins is a 
carrier mediated process and depends on cellular signaling (Gorlich and Kutay, 1999).  
The karyopherin (importin) alpha 2 protein is a part of the karyopherin alpha beta 
heterodimer and serves as the NLS binding site for transported proteins. The substrate 
in the cytoplasm binds to karyopherin alpha beta heterodimer via the alpha subunit. 
The  resulting  protein karyopherin  alpha beta  heterodimer  complex  docks  to  the 
nuclear  pore  complex  (NPC)  via  the  beta  subunit  and  is  subsequently  translocated 
through the nuclear pore, which is an energy consuming process. In the nucleus the 
karyopherin alpha beta heterodimer releases its cargo upon binding to the nuclear Ran 
GTP protein (Gorlich and Kutay, 1999). 
 
Figure 4.3 The role of Kpna2 in nuclear import. Proteins larger than 60 kDa are imported by nuclear 
import factors belonging to the karyopherin protein family. In the cytoplasm the karyopherin alpha beta 
heterodimer binds its protein cargo. The resulting protein karyopherin complex docks to the nuclear 
pore complex (NPC) via the beta subunit and is subsequently translocated through the nuclear pore. In 
the nucleus the karyopherins release their cargo upon binding to nuclear Ran GTP. 
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Interestingly,  the  diverse  karyopherin  alpha  subunits  have  different  NLS  binding 
specificities (Kohler  et  al., 1999) and the members of this family show in various 
tissues a differential expression pattern on both the RNA and protein level (Nachury et 
al.,  1998).  Thus  the  nuclear  import  system  is  regulated  by  the  expression  of  the 
different  karyopherin  family  members.  Additionally  regulation  occurs  through 
competition of different proteins for the same karyopherin or different karyopherins for 
one protein (Jans et al., 2000). Kpna2 may play a role in the regulation of mammary 
epithelial cell growth, since many proteins involved in growth regulation have to be 
transported into the nucleus to fulfill their function. 
Recent results suggested that a mutated form of human Kpna2 is involved in tumor 
formation and/or progression of breast cancer by preventing sufficient nuclear import 
of p53 and/or other tumor suppressor proteins. In the studied breast cell line Kpna2 
was truncated and p53 was found in the cytoplasm but not in the nucleus (Kim et al., 
2000).  The  cytoplasmic  localization  of  wild  type  p53  was  also  detected  in  tissue 
samples from breast cancer patient cases (Moll et al., 1992). Additionally, BRCA1 was 
shown to interact with Kpna2 (Chen at al., 1996) and the wild type form of BRCA1 
was found aberrantly located in the cytoplasm of advanced breast cancer cells (Chen et 
al.,  1995).  The  mislocation  of  nuclear  tumor  suppressor  proteins  leads  to  their 
inactivation.  
In  conclusion,  Kpna2  is  expressed  in  growing  cells  and  mutations  and/or  its 
deregulation may contribute to cancer formation and progression. Therefore it would 
be interesting to uncover the signaling pathway that regulates the function of Kpna2 
during  normal  mammary  gland  development  and  to  determine  in  more  detail  how 
mutations and/or deregulation of Kpna2 contribute to breast cancer.  
4.2.3.4 Cited4  
The regulation pattern of the Cited4 gene (CBP/p300 interacting transactivator, with 
Glu/Asp rich carboxy terminal domain 4) obtained with the microarray analysis and 
Real Time  PCR  experiments  indicates  that  Cited4  could  be  required  for  proper 
differentiation since it was found 4.9 fold up regulated in induced cells. Cited4 was 
shown  to  have  strong  milk  cycle  dependent  induction  in  pregnant  and  lactating 
mammary epithelial cells. Stronger expression of Cited4 was also noticed in vitro in 
the murine mammary cell line SCp2 during induction of differentiation with prolactin 
(Yahata et al., 2000).  Discussion 
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These results are in correlation with our data and suggest possible role of Cited4 in 
regulation of differentiation associated gene expression in HC11 mammary epithelial 
cells.  
The  Cited  protein  family  bind  directly  to  p300/CBP  through  their  conserved  C 
terminal acidic domain (Yahata et al., 2000). The p300/CBP (histone acetyltransferases 
p300/CREB binding protein) are transcriptional integrators and play a crucial role in 
regulation  of  gene  expression  involved  in  cell  growth,  transformation  and 
development. The interaction with Cited4 proteins is required for full transcriptional 
activation of target genes (Goodman and Smolnik, 2000). 
Hypoxia inducible  factor  1  alpha  (HIF1α)  was  shown  to  be  a  critical  regulator  of 
secretory differentiation during mammary gland development (Seagroves et al., 2003). 
The  transactivation  of  target  genes  by  HIF  complexes  requires  the  recruitment  of 
p300/CBP by HIF1α and HIF2α (Sang et al., 2003). Since Cited4 binds to p300/CBP it 
is possible that Cited4, expressed at high level during pregnancy and lactation, may act 
as a co activator linking the transcriptional regulator HIF to p300/CBP. Silencing the 
expression  of  Cited4  using  siRNA  in  mammary  epithelial  cells  can  elucidate  its 
possible  role  as  a  transcriptional  co activator  during  differentiation  of  mammary 
epithelial cells and mammary gland development. 
 
 
Figure 4.4 Model of Cited4 action during activation of genes involved in differentiation. Cited4 can 
bind  to  p300/CBP  and  may  positively  influence  transcription  of  genes  required  for  functional 
differentiation. Cited4 may also act as co activator linking the transcription regulator HIF to p300/CBP 
and in this way co activating the transcription of HIF targets genes involved in terminal differentiation 
of mammary epithelial cells. 
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4.2.4 Conclusions and Outlook 
The  data  presented  in  this  study  describe  an  initial  step  to  analyze  genes  found 
differentially  regulated  in  mammary  epithelial  cells  during  their  proliferation  and 
differentiation. Various genes identified in microarrays are of high interest to analyze 
in more detail in order to determine their role in mammary gland development. Among 
the genes mentioned in the discussion two contribute to the process of proliferation 
Nol5,  Kpna2,  whereas  two  other  genes  are  possibly  required  for  proper  functional 
differentiation Nkd2, Cited4. Apart from their normal function it was found that the 
selected genes can possibly contribute to breast cancer formation. To study the role of 
these  selected  candidate  genes  in  proliferation  and  functional  differentiation  of 
mammary epithelial cells the established mammary epithelial cells HC11 line as well 
as freshly isolated primary mammary epithelial cells can be used, as shown in this 
study for the Idb proteins. Depending on their regulation pattern the chosen genes can 
be down regulated using siRNA interference or stably over expressed employing the 
lentiviral vector system for delivery and stable expression of the transgene. The effect 
of  silencing  or  up regulation  of  candidate  genes  on  morphological  and  functional 
differentiation can be analyzed in a 3D culture system as described for Idb proteins.  
If these genes show a clear phenotype if down regulated or over expressed, the role of 
these  genes  can  be  further  studied  in  vivo.  Transplantation  of  stably  transduced 
mammary epithelial cells into cleared fat pads of the mammary gland will provide 
interesting  data  about  the  role  of  the  candidate  genes  during  the  mammary  gland 
development, in vivo. Importantly, the candidates are also interesting regarding the 
cancer drug development since it is possible that deregulation of their expression may 
contribute to tumor development. The described functional study of these genes will 
reveal if they can be consider as novel potential targets for anti cancer therapies.  
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ABBREVIATIONS 
4EBP1   Eukaryotic initiation factor 4E binding protein 1  
aa    Amino acid 
ATP    Adenosine three phosphoran 
APC    Adenomatous polyposis coli 
APS    Ammoniumpersulfat 
bp    Base pair 
BSA    Bovine serum albumine 
BRCA1  Breast Cancer Gene 1 
BSA    Bovine Serum Albumine 
CBP    CREB binding protein 
C/EBPβ  CCAAT enhancer binding protein beta 
CIP    Calf intestinal phosphatase 
Cm    Centi meter  
CREB   Cre element binding protein  
DAPI    4´,6 diamidin 2´ phenylidol 
DIP    Dexamethasone, insulin, prolactin 
DMEM  Dulbeccos modified eangle medium 
DMSO   Dimethylsulfoxide 
DNA    Deoxyribonucleic acid 
DTT    Dithiothreitol 
ECM     Extra cellular matrix 
E.Coli   Escherichia coli 
EDTA   Ethylene diamine tetraacetic acid 
EGF    Epidermal growth factor 
EGTA   Ethylene glycol tetraacetic acid 
eIF4A    Eukaryotic initiation factor 4A  
eIF4B    Eukaryotic initiation factor 4B  
eIF4E    Eukaryotic initiation factor 4E  
Elk 1    Ets like protein 1 
ERKs    Extracellular signal regulated kinases 
FBS    Foetal bovine serum 
FCS    Foetal calf serum 
FKBP12  FK506 binding protein 12 kDa 
FRAP    Rapamycin associated protein  
GβL     G protein β  subunit like protein 
GAS     Gamma interferon activation site 
GAP     GTPase activating protein 
Grb2    Growth factor receptor bund protein 2 
GSG 3β   Glycogen synthase kinase 3β 
h    Hour 
HBSS    Hanks bufferd salt solution 
HRP    Horse raddish peroxidase 
HIF     Hypoxia inducible factor 
Ig    Immunoglobulin 
IGFs     Insulin like growth factors 
IR     Insulin receptor 
IRES     Internal ribosome binding site 
IRS     Insulin receptor substrate Abbreviations 
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JAK2    Janus kinase 2 
kDa    kilo Dalton 
LAP    Liver enriched activator protein 
LB    Luria Beatani Medium 
LEF    Lymphoid enhancer factor 
LIP    Liver enriched inhibitory protein 
LZ     Leucine zipper domain 
M    Molar 
MAPK   Mitogen activated protein kinase 
MEK     MAPK/Erk kinase 
MGF    Mammary gland factor 
mM    mili Molar 
mm    mili meter 
MMP    Matrix metalloproteinase 
MOI     Multiplicity Of Infection 
mRNA   messenger RNA 
mTOR   Mammalian target of rapamycin  
NLS    nuclear localization signal  
nm    nano meter 
NPC    nuclear pore complex  
OD600    Optical wave lengh 600 nm 
p    Plasmid 
PAGE   Polyacrylamidgelelectrophorese 
PAS     Per arnt sim homology 
PBS     Phosphat Buffered Saline 
PCR    Polymerase Chain Reaction 
PDCD4   Programmed cell death protein 4 
PDK1    Phosphoinositide dependent kinase 1 
PEI     Poliethylenimin 
PI3K     Phosphoinositide 3 kinases 
PKB     Protein Kinase B 
PKCα    Protein kinase C alpha 
Prl    Prolactin 
PTEN    Phosphatase and tensin homolog 
RAPT1   Rapamycin target 1 
Rheb     Ras homolog enriched in brain) 
RISC     RNA inducing silencing complex 
RNA    Ribonucleic acid 
rpm    Rotation per minute 
RT    Room temperature 
S6K     S6 Protein kinase 
SDS    Sodium dodecylsulfate 
SDS PAGE  Sodium dodecylsulfate  Polyacrylamidgelelectrophorese 
SEP     Sirolimus effector protein 
Shc     SRC homology 2 domain transforming protein 
siRNA   small interfering RNA 
SOS    Son of sevenless 
Stat5    Signal transducer and activator of transcription 
TBS    Tris Buffered Saline 
TCF    T cell factor Abbreviations 
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TSC    Tuberous sclerosis protein 
TEB    Terminal end buds 
TEMED  N,N,N´,N´ Tetramethylendiamin 
TOR    Target of rapamycin 
U    Unit 
V/v    Volume to volume 
WB    Western blot 
WT    Wild type 
W/v    Mass to volume 
XTT  Sodium 3´ (1(phenylaminocarbonyl) 3,4 tetrazolium) bis(4 methoxy 6 
nitro)bezene sulfonic acid 
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ZUSAMMENFASSUNG 
In  der  vorliegenden  Promotionsarbeit  wurde  die  Funktion  des  Proteins  mTOR 
(mammalian  target  of  rapamycin)  in  der  Organentwicklung  am  Modellsystem  der 
murinen  Brustdrüse  untersucht.  Der  mTOR Signalweg  ist  in  die  Regulation  vieler 
zellulärer Prozesse involviert. Die Rolle des Proteins in der Organogenese scheint bis 
heute jedoch noch unklar zu sein. Hierbei wurde ein einzigartiges Organ (die murine 
Brustdrüse) verwendet, das im Laufe der Individualentwicklung verschiedene Stadien 
mit  unterschiedlichen  Proliferations   und  Differenzierungseigenschaften  durchläuft. 
Dadurch war es möglich, die Rolle von mTOR am adulten Tier unabhängig von der 
Embryonalentwicklung  zu  studieren.  Um  die  Funktion  des  mTOR Signalweges 
während  des  Wachstums  und  der  Differenzierung  zu  untersuchen,  wurden  diverse 
Studien mit der Brustepithelzelllinie HC11 durchgeführt. Die Vorläufer dieser Zellen 
wurden ursprünglich aus einer schwangeren Maus in der Mitte der Schwangerschaft 
isoliert und für eine in vitro Kultivierung optimiert. Die HC11 Zellen proliferierten als 
adhärente Zellen in einer Plastikkulturschale. Durch eine laktogene Hormon Mischung 
aus Dexamethason, Insulin und Prolaktin (DIP) konnte in diesen Zellen die Expression 
von β Casein induziert werden. Aus der  Expression dieses Milchproteins ließ sich 
ableiten,  dass  sich  die  Zellen  im  Stadium  der  vollen  funktionellen  Differenzierung 
befanden.  
Die Zusammenfassung der Promotionsarbeit gibt einen Überblick über die erhaltenen 
Ergebnisse und die möglichen Schlussfolgerungen. Zu Beginn wurde die Aktivität von 
mTOR  und  vom  Differenzierungsmarkerprotein  β Casein  mit  und  ohne  Inhibitor 
Behandlung  (Rapamycin)  untersucht.  Anschließend  wurden  Versuche  durchgeführt, 
die  zeigen,  wie  mTOR  die  Proliferation  und  die  funktionelle  bzw.  morphologische 
Differenzierung  der  Brustepithelzellen  durch  Regulation  sogenannter  Idb Proteine 
kontrolliert. Um die in vitro Daten in einem in vivo ähnlichen System zu bestätigen, 
wurden primäre, murine Brustepithelzellen einer Rapamycin Behandlung unterzogen 
und die Auswirkungen auf ihre Differenzierung bestimmt. In einem weiteren Schritt 
wurden die Effekte einer Rapamycin Behandlung auf die Entwicklung der murinen 
Brustdrüse und auf die Neugeborenen in einem Mausmodell in vivo analysiert. Ferner 
wurde die Rolle von mTOR in der Laktation von Brustepithelzellen in vivo untersucht.  
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Darüber  hinaus  wurden  Funktionsstudien  unter  Verwendung  zweier  lentiviraler 
Systeme zur stabilen Überexpression bzw. zur Ausschaltung  (RNA Interferenz) der 
Idb Proteine  durchgeführt.  Im  letzten  Teil  der  Arbeit  wurden  mittels  Micro Array 
Technologie weitere Gene identifiziert, die in die Proliferation und die Differenzierung 
der Brustepithelzellline HC11 involviert sind. 
In ersten Experimenten konnte gezeigt werden, dass mTOR in proliferierenden HC11 
Zellen aktiviert ist. Seine für die Funktion benötigte Phosphorylierung war nach der 
Induktion  mit  laktogenen  Hormonen  stark  erhöht,  was  darauf  hindeutet,  dass  die 
mTOR Aktivität in den späten Stadien der Differenzierung eine wichtige Rolle spielt. 
Um  dies  genauer  zu  untersuchen,  wurden  HC11  Zellen  mit  Rapamycin  behandelt, 
einem spezifischen Inhibitor für mTOR, der die Aktivität von mTOR gegenüber seinen 
nachgeschalteten  Zielproteinen  hemmt.  Wie  erwartet,  verloren  die  Rapamycin 
behandelten  Zellen  ihre  Fähigkeit  funktionell  zu  differentieren.  Die  Expression  der 
Milchproteine  und  die  Menge  an  β Casein  mRNA  wurden  reduziert.  Weitere 
Experimente mit Actinomycin D (Inhibitor der Replikation und Transkription) zeigten, 
dass Rapamycin die mRNA Stabilität nicht beeinflusst. Dies bedeutete, dass mTOR 
die Transkription von β Casein regulieren konnte. Stat5 sind nachweislich essentiell 
für die Aktivierung der Transkription der Milchproteine. Es wäre daher möglich, dass 
mTOR  die  β Casein  Transkription  durch  Stat5  kontrolliert.  Allerdings  konnten 
entsprechende Experimente zeigen, dass mTOR die transkriptionelle Aktivierung des 
β Casein Gens nicht durch Stat5 beeinflußt. Trotz Bindung von Stat5 an den β Casein 
Promotor wurden andere wichtige Elemente für die vollständige Aktivierung der β 
Casein Expression benötigt, die aber durch Rapamycin hemmbar waren. Aus diesem 
Grund  wurde  in  der  vorliegenden  Arbeit  untersucht,  welche  Transkriptionsfaktoren 
durch mTOR reguliert werden. 
Es  ist  aus  der  Literatur  bereits  bekannt,  dass  mTOR  ein  Zielprotein  im  Insulin 
Signalweg ist. Zahlreiche Studien belegen deutlich, dass die Aktivierung des Insulin  
Signalweges notwendig ist für die Expression von Milchproteinen. Sogenannte Idb 
Proteine  (Inhibitoren  der  DNA Bindung)  werden  ebenfalls  durch  diesen  Signalweg 
reguliert.  Diese  Proteine  sind  Transkriptionsfaktoren.  Ob  zwischen  den  Proteinen 
mTOR  und  den  Idb Proteinen  eine  Verknüpfung  auf  Basis  einer  abhängigen 
Expression oder Aktivität besteht, ist noch nicht untersucht worden. Eine Vermutung 
ist, dass mTOR als Mediator durch Insulin stimuliert wird und die Expression bzw. 
Aktivität von Idb Proteinen kontrolliert.  Zusammenfassung 
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Es existieren zwei Idb Proteine: Id1 und Id2. Id1 wird in hohem Maße während der 
Proliferation  exprimiert.  Eine  Blockade  der  Expression  dagegen  bewirkt  eine 
Abnahme  in  der  Proliferationsrate.  In  der  präsentierten  Arbeit  konnte  klar  gezeigt 
werden,  dass  eine  Rapamycin Behandlung  eine  Inhibition  der  Id1  Expression  zur 
Folge  hat.  Diese  Experimente  lassen  die  Schlussfolgerung  zu,  dass  mTOR  die 
Proliferation der HC11 Zellen kontrolliert, indem es die Expression von Id1 steuert. Da 
Id1  auch  in  die  Regulation  der  Zellinvasivität  involviert  zu  sein  scheint,  wurde 
vermutet,  dass  eine  Inhibition  seiner  Expression  durch  Rapamycin  nicht  nur  die 
zelluläre Proliferationsrate reduziert. Gleichzeitig wurde die Fähigkeit der Zellen im 
Laufe  einer  morphologischen  Differenzierung  in  einer  dreidimensionalen  Kultur  in 
eine  umgebende  Matrix  zu  migrieren  negativ  beeinflusst.  Studien  mit  der  HC11 
Zelllinie zeigten, dass Id2 für eine funktionelle Differenzierung benötigt wird. Einer 
Inhibition  von  Id2  folgte  eine  Abnahme  in  der  β Casein  Expression.  Es  ist  daher 
vorstellbar, dass mTOR die Differenzierung durch die Kontrolle der Id2 Expression 
kontrolliert.  Tatsächlich  war  Expression  von  Id2  signifikant  reduziert  nach  einer 
Behandlung der Zellen mit Rapamycin. Auch trotz einer Induktion der Zellen mit DIP 
war die Proteinexpression von Id2 stark gesenkt im Vergleich zu den Kontrollzellen. 
Diese Resultate weisen darauf hin, dass mTOR in die Regulation der funktionellen 
Differenzierung der Brustepithelzellen involviert ist, indem es die Id2 Expression auf 
transkriptionellem Level kontrolliert.  
Um diese mittels in vitro Untersuchungen erhaltenen Ergebnissen der HC11 Zellen zu 
bestätigen,  wurden  die  Auswirkungen  einer  Rapamycin Behandlung  auf  die 
morphologische  und  funktionelle  Differenzierung  von  primären,  murinen 
Brustepithelzellen bestimmt. Diese Zellen gleichen in ihrem Verhalten einer in vivo-
Zellantwort.  Der  Effekt  von  Rapamycin  auf  die  morphologische  Differenzierung 
wurde  ermittelt,  indem  isolierte  primäre  Brustepithelzellen  in  einem  Kollagen Gel 
ausgesät und durch DIP eine morphologische Differenzierung induziert wurden. Die 
mit  Rapamycin  behandelten  primären  Zellen  waren  nicht  mehr  in  der  Lage,  die 
charakteristischen,  verzweigungsähnlichen  Strukturen  zu  bilden.  Morphologisch 
gesehen ähnelten sie den Rapamycin behandelten HC11 Zellen. Das heißt, dass die 
Fähigkeit von primären, murinen Brustepithelzellen in einer dreidimensionalen Kultur 
zu differenzieren von einem intakten mTOR Signalweg abhing. Es zeigte außerdem, 
dass  die  in  vitro-Daten  der  HC11  Zelllinie  mit  den  Ergebnissen  der  Versuche  der 
primären  Zellen  vergleichbar  waren  und  die  HC11  Zellen  als  zuverlässiges Zusammenfassung 
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Modellsystem  für  diese  Art  von  Studien  verwendet  werden  konnten.  Die  DIP 
induzierten  und  Rapamycin  behandelten  Primärzellen  waren  nicht  mehr  fähig 
funktionell zu differenzieren, was zu dem beobachteten Fehlen des β Casein Proteins 
passt.  Daraus  ließ  sich  schließen,  dass  der  mTOR  Signalweg  wichtig  war  für  die 
morphologische  und  funktionelle  Differenzierung  der  primäre  Brustepithelzellen  in 
vitro  und  dass  diese  Ergebnisse  im  Einklang  stehen  mit  den  Studien  der  HC11 
Zelllinie. Um die in vitro Studien zu bestätigen, war es nötig die Rolle vom mTOR 
Signalweg  in  vivo  zu  analysieren.  Darum  wurde  der  Effekt  einer  Rapamycin 
Behandlung auf die Brustdrüsenentwicklung in einem Tiermodell getestet. Während 
der Schwangerschaft der Maus begannen die Brustepithelzellen in hohem Maße zu 
proliferieren. Dieser Prozess führte zu Verlängerung der Drüsengänge und letztendlich 
zur  Formation  von  sekretorischen  Kompartimenten,  welche  am  Ende  der 
Schwangerschaft fast die gesamte Brustdrüse ausfüllten. Zu Studienzwecken wurden 
Wildtyp Mäuse  ab  der  Mitte  ihrer  Schwangerschaft  bis  zum  Tage  der  Geburt  mit 
Rapamycin  behandelt,  um  die  Rolle  von  mTOR  in  vivo  zu  bestimmen.  Die 
Kontrollgruppe dagegen erhielt nur das Lösungsmittel des Inhibitors ohne Rapamycin. 
Am  Tage  der  Geburt  wurden  die  Brustdrüsen  isoliert  und  analysiert,  ebenso  die 
Embryos. Es zeigte sich, dass Rapamycin die Entwicklung der Embryos vollkommen 
blockiert hatte.  Dies ist entweder auf eine direkte  Inhibition der Proliferation bzw. 
Differenzierung  der  Brustepithelzellen  zurückzuführen  oder  auf  eine  indirekte 
Hemmung  der  Embryonalentwicklung  durch  Rapamycin.  Die  Neugeborenen  der 
Kontrollgruppe waren im Vergleich dazu normal entwickelt. 
Die Aktivierung des Insulin Signalweges ist essentiell für die korrekte Laktation der 
Brustdrüse  (Milchabsonderung),  wobei  mTOR  ein  nachgeschaltetes  Zielproteinen 
dieses Signalweges ist. Diese Tatsache war der Anlaß, die Rolle von mTOR in der 
Laktation  von  Brustepithelzellen  in  vivo  zu  analysieren.  Die  Brustdrüsenzellen 
erreichen den Zeitpunkt der stärksten funktionellen Differenzierung in der Laktation, 
wenn sie Teil des aveolaren Kompartiments sind, dass die Milchproteine sekretiert. 
Um die Funktion von mTOR während dieses Entwicklungsstadiums zu untersuchen, 
wurden  schwangere  Mäuse  ab  dem  Tag  19  der  Empfängnis  bis  zum  Tag  10  der 
Laktation entweder mit Rapamycin oder mit einem Placebo behandelt. In der Zeit der 
12tägigen  Behandlung  wurde die Entwicklung  der mütterlichen Brustdrüse und der 
Nachkommen  beobachtet.  Der  entscheidende  Faktor,  der  das  Wachstum  der 
Nachkommen beeinflusste, ist die Milch, die in den mütterlichen Brustdrüsen gebildet Zusammenfassung 
  179 
wurde. Die Wachstumskurve der Nachkommen wurde bis zum Tag 10 nach der Geburt 
erstellt.  Hier  zeigte  sich,  dass  die  Nachkommen  der  mit  Rapamycin  behandelten 
Mütter  wesentlich  langsamer  an  Gewicht  zunahmen  als  die  Nachkommen  der 
unbehandelten  Kontrollmäuse.  Das  verringerte  Wachstum  der  Nachkommen  der 
behandelten  Mäuse  konnte  seine  Ursachen  in  der  Hemmung  der  terminalen 
Entwicklung der Brustdrüsen und damit der Milchproduktion haben. Um diese These 
zu  bestätigen,  wurden  die  Brustdrüsen  von  laktierenden  Mäusen  am  Tag  10  der 
Laktation  isoliert.  Die  Brustdrüsen  der  mit  Rapamycin  behandelten  Mäuse  waren 
signifikant  kleiner  als  die  der  unbehandelten  Kontrollgruppe.  Die  Expression  der 
Milchproteine in den Brustdrüsen der behandelten Mäuse war um 60% verringert und 
ist zurückzuführen auf eine verschlechterte Entwicklung der aveolaren Kompartimente 
(Aveoli).  Dies  korrelierte  mit  dem  durchschnittlichen  Gewichtsrückstand  der 
behandelten  Nachkommen.  Rapamycin  hemmte  somit  klar  die  funktionelle 
Differenzierung der Brustepithelzellen in vivo. Die Aveoli der Kontrollmäuse waren 
größer  und  vollständig  mit  Milchproteinen  gefüllt  im  Vergleich  zu  den  Aveoli  der 
behandelten Mäuse. Um zu zeigen, dass Rapamycin die terminale Differenzierung der 
Brustepithelzellen in vivo inhibiert, wurde die β Casein Expression untersucht. Wie zu 
Beginn  erwähnt,  wurde  die  β Casein  Expression  in  vitro  durch  mTOR  mittels  Id2 
reguliert. Es wurde daher vermutet, dass auch in vivo der gleiche Mechanismus zum 
Tragen  kommt.  Eine  Abnahme  der  β Casein  Expression  sollte  demnach  mit  einer 
Reduktion der Id2 Expression verbunden sein. Es konnte gezeigt werden, dass in den 
Brustdrüsen  von  Rapamycin  behandelten  Mäusen  am  Tag  10  der  Laktation    die 
Expression von Id2 gegenüber den Kontrollmäusen reduziert war. 
Die  Experimente  mit  den  HC11  Zellen  deuteten  an,  dass  eine  Behandlung  der 
Brustepithelzellen mit Rapamycin die Expressionslevel von Id1 und Id2 reduziert. Es 
wurde vermutet, dass mTOR das Wachstum und die funktionelle Differenzierung der 
Brustepithelzellen  durch  Idb Proteine  reguliert.  Um  diese  Annahme  zu  bestätigen, 
wurden  beide  Idb Proteine  in  HC11  Zellen  überexprimiert.  Ein  lentivirales  System 
wurde benutzt, um eine stabile Integration des Transgens (Id1 bzw. Id2) in das Genom 
von HC11  Zellen zu bewirken und um eine konstante Expression zu erzielen. Die 
entsprechenden Experimente zeigten, dass die HC11 Zellen das Id1 Protein in hohem 
Maße  überexprimierten  und  resistent  gegenüber  einer  Inhibition  von  Id1  durch 
Rapamycin waren. Zusammenfassung 
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Die  Proliferation  dieser  modifizierten  Zellen  wurde  durch  eine  Behandlung  mit 
Rapamycin  nicht  beeinträchtigt.  Diese  Experimente  deuteten  stark  darauf  hin,  dass 
mTOR die Proliferation von Brustepithelzellen durch die Expression von Id1 reguliert. 
Es  war  desweiteren  in  der  vorliegenden  Arbeit  gelungen,  zu  analysieren,  wie  eine 
Überexpression  von  Id1  die  Differenzierung  von  HC11  Zellen  beeinflusst.  Im 
Normalzustand wurde Id1 in proliferierenden Zellen hoch exprimiert. Die Expression 
nahm erst wieder ab, wenn das Stadium der Konfluenz erreicht war. Beides war eine 
Voraussetzung für eine in vitro Differenzierung. Interessanterweise unterdrückte eine 
Überexpression  von  Id1  eine  Expression  von  Id2  und  eine  Induktion  der  β Casein 
Expression durch laktogene Hormone. Dies heißt, dass Id1 verantwortlich war für ein 
Verharren  der  Zellen  im  Proliferationsstadium  und  eine  Blockade  der  frühreifen 
Differenzierung durch Hemmung von Proteinen wie Id2, die in die Aktivierung der 
Differenzierung involviert waren. Eine Behandlung der HC11 Zellen mit Rapamycin 
inhibierte  die  Entwicklung  der  verzweigungsähnlichen  Strukturen  in  der 
Kollagenmatrix.  Der  gleiche  Effekt  konnte  im  Falle  der  HC11  Zellen  beobachtet 
werden,  in  denen  mittels  RNA Interferenz  die  Id1  Expression  stillgelegt  wurde. 
Rapamycin  bewirkte  eine  Runter Regulation  der  Id1  Proteinexpression  und  damit 
einen Arrest der zellulären Proliferation. Die  Id1 überexprimierenden  HC11 Zellen 
waren dagegen insensitiv gegenüber dem inhibitorischen Effekt von Rapamycin und 
können Verzeigungsähnlichen Strukturen ausbilden. Dies stand im starken Gegensatz 
zu den Kontrollzellen, die nur sehr langsam proliferieren und nicht in die umgebende 
Matrix  eindringen  konnten.  Diese  Ergebnisse  deuten  darauf  hin,  dass  mTOR  die 
morphologische Differenzierung von Brustepithelzellen durch Id1 kontrolliert, welches 
direkt die Proliferation und das invasive Potential dieser Zellen reguliert. Nicht nur Id1 
sondern auch Id2 scheint eine wichtige Rolle in der Entwicklung der Brustdrüsen zu 
spielen.  Eine  Ausschaltung  der  Id2  Expression  verursachte  eine  Blockade  der 
funktionellen  Differenzierung  der  Epithelzellen  durch  eine  Reduktion  der 
Milchproteinexpression.  Die  Kontrollzellen,  die  mit  dem  leeren  lentiviralen  Vektor 
transduziert und mit Rapamycin bzw. DIP behandelt wurden, zeigten aufgrund von 
unvollständiger  terminaler  Differenzierung  keine  β Casein  Expression.  Die  Id2 
überexprimierenden  HC11  Zellen  dagegen  waren  weiterhin  in  der  Lage,  trotz 
Rapamycin Behandlung funktionell zu differenzieren, was sich in der Expression von 
β Casein zeigte.  
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Diese Ergebnisse zusammen mit früheren Beobachtungen beweisen, dass mTOR die 
terminale  Differenzierung  der  Brustepithelzellen  durch  die  Regulation  der  Id2 
Expression beeinflusst.  
An der  Brustdrüsenentwicklung sind neben dem mTOR Signalweg noch zahlreiche 
andere Signalwege beteiligt, die die Transkription von vielen Genen aktivieren, die 
allesamt involviert sind in der Bildung einer funktionellen Brustdrüse. Obwohl einige 
wichtige  Signalwege  und  ihre  Aktivatoren  bereits  bekannt  sind,  existieren  wenige 
Kenntnisse    über  die  Regulation  ihrer  nachgeschalteten  Zielproteine.  In  der 
vorliegenen Arbeit wurde daher eine Methode (Micro Array Technologie) angewandt, 
um  Gene  zu  identifizieren,  die  in  die  Proliferation  und  die  Differenzierung  der 
Brustepithelzellline HC11 involviert sind und um anschließend ihr Expressionsmuster 
bzw.  ihre  Funktion  genauer  zu  studieren.  Die  Entwicklung  der  Micro Array 
Technologie ermöglicht parallele Studien von Transkriptionsprofilen tausender Gene 
in  einem  Experiment.  Zu  diesem  Zweck  wurde  die  Gesamt RNA  von  drei 
verschiedenen  Zellstadien  der  HC11  Zellen  (Proliferationsphase,  Wachstumsarrest  
aufgrund  von  Konfluenz,  Stimulationsphase  mittels  DIP)  isoliert.  Dies  erlaubte  die 
Identifizierung  von  Genen,  die  zu  den  drei  Zeitpunkten  unterschiedlich  stark 
exprimiert  werden.  Die  Gesamt DNA  wurde  in  einem  zweiten  Schritt  in  cDNA 
(kodierende  DNA)  reverse  transkribiert.  Die  Micro Array  Analyse  wurde  in 
Kooperation  mit  Dr.  Peter  Angel  (Deutsches  Krebsforschungszentrum,  Heidelberg) 
durchgeführt.  Die  cDNA  wurde  dabei  mit  einem  NIA Chip  hybridisiert.  Dabei 
handelte  es  sich  um  einen  PCR basierenden  cDNA  Micro Array,  der  15000 
verschiedene  Gene  abdeckt,  von  denen  bekannt  ist,  dass  sie  während  der  murinen 
Embryonalentwicklung  exprimiert  werden.  Anfangs  konnte  die  Expression  von  ca. 
3000 Genen in den HC11 Proben detektiert werden. Als nächstes wurden ca. 1800 
Replikate identifiziert, d.h. Proben, bei denen durch einen Farbwechsel auf dem Micro 
Array Chip ein gleichbleibendes Regulationsmuster nachgewiesen werden konnte. Als 
Kandidaten  für  die  weitere  Analyse  wurden  397  proliferations   bzw.  639 
differenzierungs assoziierte Gene ausgewählt. Das Expressionsmuster von einigen der 
identifizierten Zielgenen wurde in der vorliegenden Arbeit verifiziert. Nur Gene, deren 
Expressionsmuster  bestätigt  werden  konnte,  wurden  für  die  weiteren  funktionellen 
Tests verwendet.  
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Abschließend lässt sich aus der vorliegenden Arbeit zusammenfassen, dass Id1 und Id2 
sowohl essentielle Transkriptionsfaktoren in der Entwicklung der Brustdrüsen sind als 
auch in der Proliferation und der Differenzierung der Brustepithelzellen in vitro.  
Die Ergebnisse der RNA Interferenz  und Rapamycin Versuche zeigen, dass mTOR 
die Proliferation und die Differenzierung der Brustepithelzellen durch die Expression 
beider  Idb Proteine  kontrolliert.  Die  Aktivität  von  mTOR  wird  demnach  für  das 
Anschalten  der  Proliferationsphase  durch  Id1  und  für  die  Expression  von 
differenzierungsspezifischen  Genen  durch  Id2  benötigt.  Das  richtige  Gleichgewicht 
zwischen der Expression der individuellen Idb Proteine ist ein kritischer Faktor für die 
Entwicklung  der  Brustepithelzellen  und  ist  vermutlich  während  der  Tumorgenese 
gestört. Aus diesem Grund ist ein besseres Verständnis des mTOR Signalweges und 
der damit verbundenen Idb Protein Expression hilfreich, um weitere effektive Ansätze 
in der Krebstherapie zu etablieren.  Beide Proteine wurden  auch mittels der Micro 
Array Analyse  identifiziert  und  ihr  differenzielles  Expressionsmuster  während  der 
Proliferation und Differenzierung der HC11 Zellen bestätigt. 
Die Arbeit bietet eine Basis für weitere Studien bezüglich der Genexpressionsmuster 
während der Proliferation und der Differenzierung der Brustepithelzellen. Zahlreiche 
der  mittels  Micro Array Analyse  identifizierten  Gene  eignen  sich  für  eine  weitere 
Untersuchung  ihrer  Rolle  in  der  Brustdrüsenentwicklung.  Einige  dieser  Gene  sind 
möglicherweise  an  der  Bildung  von  Brustkrebstumoren  beteiligt.  Die  Rolle  dieser 
Gene in der Proliferation und der funktionellen Differenzierung der Brustepithelzellen 
wird  deshalb  in  dieser  Arbeitsgruppe  weiter  untersucht.  Abhängig  vom 
Regulationsmuster werden die genannten Gene mittels RNA Interferenz ausgeschaltet 
oder stabil überexprimiert mittels der lentiviralen Transduktion. Die Epithelzellen, die 
diese  Modifikationen  über  einen  längeren  Zeitraum  zeigen,  können  in 
Transplantationsexperimente mit Mäusen in das präparierte Fettpolster der Brustdrüse 
eingesetzt  werden.  Solche  in  vivo Experimente  würden  interessante  Daten  zur 
Funktion  der  einzelnen  Gene  während  der  Brustdrüsenentwicklung  liefern.  Solche 
Gene  können  auch  in  der  Wirkstoffentwicklung  eine  Rolle  spielen,  da  eine 
Fehlregulation  ihrer  Proteinexpression  möglicherweise  mit  einer  Krebsentstehung 
assoziiert ist. Sie könnten dann als potentielle Ausgangspunkte für eine neue Strategie 
in der Krebstherapie verwenden werden. 
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